Form 20-F
|
☐
|
Form 40-F
|
☑
|
Yes
|
☐
|
No
|
☑
|
Exhibit
|
Description of Exhibit
|
99.1
|
Third Quarter Report to Shareholders
|
99.2
|
Certification Chief Executive Officer
|
99.3
|
Certification Chief Financial Officer
|
MANULIFE FINANCIAL CORPORATION
|
|
By:
/s/
James D. Gallagher
|
|
Name:
James D. Gallagher
|
|
Title:
Executive Vice President and General Counsel
|
|
Date: November 8, 2017
|
Exhibit
|
Description of Exhibit
|
99.1
|
Third Quarter Report to Shareholders
|
99.2
|
Certification Chief Executive Officer
|
99.3
|
Certification Chief Financial Officer
|
1 |
Commencing in 1Q17,
Manulife Asset Management's Institutional Asset Management net flows and gross flows are reported by the division corresponding to their geographic source.
|
2 |
Core earnings before interest, taxes, depreciation and amortization
.
|
Quarterly Results
|
YTD Results
|
|||||||||||||||||||
($ millions)
|
3Q17
|
2Q17
|
3Q16
|
2017
|
2016
|
|||||||||||||||
Core earnings
|
||||||||||||||||||||
Asia Division
|
$
|
428
|
$
|
405
|
$
|
394
|
$
|
1,241
|
$
|
1,107
|
||||||||||
Canadian Division
|
466
|
345
|
354
|
1,130
|
1,025
|
|||||||||||||||
U.S. Division
|
445
|
452
|
394
|
1,412
|
1,144
|
|||||||||||||||
Corporate and Other
Excluding expected cost of macro hedges and core investment gains
|
(342
|
)
|
(168
|
)
|
(102
|
)
|
(676
|
)
|
(334
|
)
|
||||||||||
Expected cost of macro hedges
|
(12
|
)
|
(14
|
)
|
(61
|
)
|
(47
|
)
|
(225
|
)
|
||||||||||
Core investment gains
|
100
|
154
|
17
|
300
|
17
|
|||||||||||||||
Core earnings
|
$
|
1,085
|
$
|
1,174
|
$
|
996
|
$
|
3,360
|
$
|
2,734
|
||||||||||
Investment-related experience outside of core earnings
|
11
|
138
|
280
|
149
|
-
|
|||||||||||||||
Core earnings and investment-related experience outside of core earnings
|
$
|
1,096
|
$
|
1,312
|
$
|
1,276
|
$
|
3,509
|
$
|
2,734
|
||||||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities
|
47
|
(37
|
)
|
414
|
277
|
718
|
||||||||||||||
Changes in actuarial methods and assumptions
|
(2
|
)
|
-
|
(455
|
)
|
(2
|
)
|
(443
|
)
|
|||||||||||
Integration and acquisition costs
|
(14
|
)
|
(20
|
)
|
(23
|
)
|
(52
|
)
|
(56
|
)
|
||||||||||
Other
|
(22
|
)
|
-
|
(95
|
)
|
(22
|
)
|
(87
|
)
|
|||||||||||
Net income attributed to shareholders
|
$
|
1,105
|
$
|
1,255
|
$
|
1,117
|
$
|
3,710
|
$
|
2,866
|
· |
Japan APE sales in 3Q17 were US$257 million, the same level as 3Q16. Strong growth in our Corporate and foreign currency denominated products were offset by lower other wealth sales through bancassurance channels
.
|
· |
Hong Kong APE sales in 3Q17 were US$152 million, a 27% increase, benefiting from continued strong sales from recently-launched customer solutions. Both our agency and bank channels experienced strong double-digit growth.
|
· |
Asia Other (excludes Japan and Hong Kong) APE sales in 3Q17 were US$325 million, an increase of 25%. We experienced strong double-digit growth in Singapore, mainland China, Vietnam, Malaysia and Cambodia, and continued growth in the Philippines, partially offset by lower sales in Indonesia and Thailand
.
|
· |
Japan WAM gross flows of US$53 million in 3Q17 more than doubled compared with 3Q16
,
driven by strong mutual fund sales reflecting bank distribution channel expansion and continued success of existing fund solutions.
|
· |
Hong Kong WAM gross flows of US$1.1 billion in 3Q17 increased 57% compared with 3Q16, reflecting a strong increase in both pension and mutual fund business in all of our distribution channels.
|
· |
Asia Other (excludes Japan and Hong Kong) WAM gross flows of US$3.6 billion increased 41% compared with 3Q16, reflecting an increase in money market flows in mainland China and strong retail flows in Singapore, Malaysia and Indonesia driven by bank channel distribution expansion
.
|
· |
Institutional asset management gross flows in 3Q17 of US$0.8 billion increased 45% compared with 3Q16, due to strong inflows in Japan, Indonesia and Hong Kong partially offset by lower flows from mainland China.
|
· |
Japan NBV in 3Q17 of US$60 million decreased 19% as a result of a change in product mix.
|
· |
Hong Kong NBV in 3Q17 of US$94 million increased 51% as a result of higher sales and continued strong margins
.
|
· |
Asia Other NBV in 3Q17 of US$75 million increased 43% as a result of continued growth in sales, scale benefits and product actions. The growth was most notable in Singapore, mainland China, Vietnam and the Philippines.
|
· |
Retail insurance sales in 3Q17 of $35 million decreased 34% compared with 3Q16, reflecting pricing actions and higher universal life sales in 3Q16 in anticipation of regulatory changes that took effect in 1Q17
.
|
· |
Institutional Markets sales in 3Q17 of $151 million increased $23 million compared with 3Q16, due to higher sales in the group benefits small and mid-market segments.
|
· |
Retail gross flows of $2.5 billion in 3Q17 decreased 7% compared with strong 3Q16 results, which benefited from successful sales campaigns.
|
· |
Retirement gross flows of $1.7 billion in 3Q17 decreased 11% compared with 3Q16, mainly due to several large
-
case sales in 3Q16.
|
· |
Institutional asset management gross flows were $0.7 billion, an increase of 11% compared with 3Q16, driven by the funding of a new custom balanced
-
solution mandate and additional funds from existing clients.
|
· |
Segregated fund product
1
sales in 3Q17 were $532 million, a decrease of 5% compared with 3Q16 for the reason noted above.
|
· |
Fixed product sales in 3Q17 were $126 million, a decrease of 21% compared with 3Q16 for the reason noted above.
|
· |
Retail 3Q17 gross flows of US$6.0 billion were in line with 3Q16 reflecting continued success of our product line-up and strong fund performance
.
|
· |
Retirement 3Q17 gross flows of US$5.5 billion decreased 19% compared with 3Q16, due to a record-size plan sale included in 3Q16 results. The business continued to generate solid sales and consistent ongoing contributions in 3Q17 from both the small- and mid-case markets.
|
· |
Institutional asset management 3Q17 gross flows of US$1.0 billion increased 163% compared with 3Q16 due to higher sales of public equity, strategic and fixed income products as well as timber mandates.
|
A.
OVERVIEW
1.
Earnings
2.
Sales
3.
Capital related items
B.
FINANCIAL HIGHLIGHTS
1.
Third quarter earnings analysis
2.
Revenue
3.
Premiums and deposits
4.
Assets under management and administration
5.
Capital
6.
Impact of fair value accounting
7.
Impact of foreign currency exchange rates
C.
PERFORMANCE BY DIVISION
1.
Asia
2.
Canadian
3.
U.S.
4.
Corporate and Other
D.
PERFORMANCE BY BUSINESS LINE
1.
Additional information for Wealth and Asset Management
2.
Additional information by business line
|
E.
RISK MANAGEMENT AND RISK FACTORS UPDATE
1.
Draft U.S. tax reform legislation
2.
Variable annuity and segregated fund guarantees
3.
Caution related to sensitivities
4.
Publicly traded equity performance risk
5.
Interest rate and spread risk
6.
Alternative long-duration asset ("ALDA") performance risk
F.
ACCOUNTING MATTERS AND CONTROLS
1.
Critical accounting and actuarial policies
2.
Actuarial methods and assumptions
3.
Sensitivity of policy liabilities to asset related assumptions
4.
Accounting and reporting changes
5.
Quarterly financial information
6.
Other
G.
OTHER
1.
Quarterly dividend
2.
Outstanding shares - selected information
3.
Performance and Non-GAAP Measures
4.
Caution regarding forward-looking statements
|
A |
OVERVIEW
|
2 |
See "Caution regarding forward -looking statements" below.
|
A2 |
Sales
|
A3 |
Capital related items
|
1 |
This item is a non-GAAP measure. See "Performance and Non-GAAP Measures" below.
|
2 |
Percentage growth (declines) in sales, gross flows and net flows are stated on a constant currency basis. Constant currency basis is a non-GAAP measure. See "Performance and Non-GAAP Measures" below.
|
3 |
Commencing in 1Q17,
Manulife Asset Management's Institutional asset management net flows and gross flows are reported by the division corresponding to their geographic source.
|
Quarterly Results
|
YTD Results
|
|||||||||||||||||||
($ millions, unless otherwise stated, unaudited)
|
3Q17
|
2Q17
|
3Q16
|
2017
|
2016
|
|||||||||||||||
Net income attributed to shareholders
|
$
|
1,105
|
$
|
1,255
|
$
|
1,117
|
$
|
3,710
|
$
|
2,866
|
||||||||||
Preferred share dividends
|
(39
|
)
|
(39
|
)
|
(34
|
)
|
(119
|
)
|
(100
|
)
|
||||||||||
Common shareholders' net income
|
$
|
1,066
|
$
|
1,216
|
$
|
1,083
|
$
|
3,591
|
$
|
2,766
|
||||||||||
Core earnings
(1)
|
$
|
1,085
|
$
|
1,174
|
$
|
996
|
$
|
3,360
|
$
|
2,734
|
||||||||||
Basic earnings per common share ($)
|
$
|
0.54
|
$
|
0.62
|
$
|
0.55
|
$
|
1.82
|
$
|
1.40
|
||||||||||
Diluted earnings per common share ($)
|
$
|
0.54
|
$
|
0.61
|
$
|
0.55
|
$
|
1.81
|
$
|
1.40
|
||||||||||
Diluted core earnings per common share
($)
(1)
|
$
|
0.53
|
$
|
0.57
|
$
|
0.49
|
$
|
1.63
|
$
|
1.34
|
||||||||||
Return on common shareholders' equity ("ROE")
|
10.8
|
%
|
12.4
|
%
|
11.1
|
%
|
12.3
|
%
|
9.7
|
%
|
||||||||||
Core ROE
(1)
|
10.6
|
%
|
11.5
|
%
|
9.8
|
%
|
11.1
|
%
|
9.2
|
%
|
||||||||||
Sales
(1)
Insurance products
|
$
|
1,052
|
$
|
1,364
|
$
|
1,010
|
$
|
3,701
|
$
|
2,878
|
||||||||||
Wealth and Asset Management gross flows
|
$
|
27,494
|
$
|
30,939
|
$
|
27,418
|
$
|
91,387
|
$
|
82,290
|
||||||||||
Wealth and Asset Management net flows
|
$
|
4,009
|
$
|
5,588
|
$
|
2,694
|
$
|
13,887
|
$
|
9,192
|
||||||||||
Other Wealth products
|
$
|
1,939
|
$
|
1,956
|
$
|
2,038
|
$
|
5,976
|
$
|
6,422
|
||||||||||
Premiums and deposits
(1)
Insurance products
|
$
|
8,892
|
$
|
8,595
|
$
|
8,347
|
$
|
25,958
|
$
|
24,955
|
||||||||||
Wealth and Asset Management products
|
$
|
27,494
|
$
|
30,939
|
$
|
27,418
|
$
|
91,387
|
$
|
82,290
|
||||||||||
Other Wealth products
|
$
|
1,742
|
$
|
1,605
|
$
|
1,476
|
$
|
5,020
|
$
|
4,629
|
||||||||||
Corporate and Other
|
$
|
47
|
$
|
22
|
$
|
22
|
$
|
90
|
$
|
65
|
||||||||||
Assets under management and administration ($ billions)
(1)
|
$
|
1,006
|
$
|
1,012
|
$
|
966
|
$
|
1,006
|
$
|
966
|
||||||||||
Capital
($ billions)
(1)
|
$
|
51.8
|
$
|
52.0
|
$
|
51.8
|
$
|
51.8
|
$
|
51.8
|
||||||||||
MLI's MCCSR ratio
|
234
|
%
|
230
|
%
|
234
|
%
|
234
|
%
|
234
|
%
|
(1) |
This item is a non-GAAP measure. See "Performance and Non-GAAP Measures" below.
|
B1 |
Third quarter earnings analysis
|
Quarterly Results
|
YTD Results
|
|||||||||||||||||||
($ millions, unaudited)
|
3Q17
|
2Q17
|
3Q16
|
2017
|
2016
|
|||||||||||||||
Core earnings
(1)
|
||||||||||||||||||||
Asia Division
|
$
|
428
|
$
|
405
|
$
|
394
|
$
|
1,241
|
$
|
1,107
|
||||||||||
Canadian Division
|
466
|
345
|
354
|
1,130
|
1,025
|
|||||||||||||||
U.S. Division
|
445
|
452
|
394
|
1,412
|
1,144
|
|||||||||||||||
Corporate and Other
Excluding expected cost of macro hedges and core investment gains
|
(342
|
)
|
(168
|
)
|
(102
|
)
|
(676
|
)
|
(334
|
)
|
||||||||||
Expected cost of macro hedges
(2)
|
(12
|
)
|
(14
|
)
|
(61
|
)
|
(47
|
)
|
(225
|
)
|
||||||||||
Core investment gains
(3)
|
100
|
154
|
17
|
300
|
17
|
|||||||||||||||
Core earnings
|
$
|
1,085
|
$
|
1,174
|
$
|
996
|
$
|
3,360
|
$
|
2,734
|
||||||||||
Investment-related experience outside of core earnings
(3)
|
11
|
138
|
280
|
149
|
-
|
|||||||||||||||
Core earnings and investment-related experience outside of core earnings
|
$
|
1,096
|
$
|
1,312
|
$
|
1,276
|
$
|
3,509
|
$
|
2,734
|
||||||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities (see table below)
(2),(3),(4)
|
47
|
(37
|
)
|
414
|
277
|
718
|
||||||||||||||
Changes in actuarial methods and assumptions
|
(2
|
)
|
-
|
(455
|
)
|
(2
|
)
|
(443
|
)
|
|||||||||||
Integration and acquisition costs
|
(14
|
)
|
(20
|
)
|
(23
|
)
|
(52
|
)
|
(56
|
)
|
||||||||||
Other
|
(22
|
)
|
-
|
(95
|
)
|
(22
|
)
|
(87
|
)
|
|||||||||||
Net income attributed to shareholders
|
$
|
1,105
|
$
|
1,255
|
$
|
1,117
|
$
|
3,710
|
$
|
2,866
|
(1) |
This item is a non-GAAP measure. See "Performance and Non-GAAP Measures" below.
|
(2) |
Actual market performance differed from our valuation assumptions in 3Q17, which resulted in a macro hedge experience loss of $18 million. This loss is included in the direct impact of equity markets and interest rates and variable annuity guarantee liabilities below
.
|
(3) |
As outlined under "Critical Accounting and Actuarial Policies" below, net insurance contract liabilities under International Financial Reporting Standards ("IFRS") for Canadian insurers are determined using the Canadian Asset Liability Method ("CALM"). Under CALM, the measurement of policy liabilities includes estimates regarding future expected investment income on assets supporting the policies. Experience gains and losses are reported when current period activity differs from what was assumed in the policy liabilities at the beginning of the period. These gains and losses can relate to both the investment returns earned in the period, as well as to the change in our policy liabilities driven by the impact of current period investing activities on future expected investment income assumptions. The direct impact of equity markets and interest rates is separately reported. Our definition of core earnings (see "Performance and Non-GAAP Measures") includes up to $400 million of favourable investment-related experience reported in a single year.
|
(4) |
The direct impact of equity markets and interest rates is relative to our policy liability valuation assumptions and includes changes to interest rate assumptions, including experience gains and losses on derivatives associated with our macro equity hedges. We also include gains and losses on derivative positions and the sale of available-for-sale ("AFS") bonds in the Corporate and Other segment. See table below for components of this item.
|
Quarterly Results
|
YTD Results
|
|||||||||||||||||||
($ millions, unaudited)
|
3Q17
|
2Q17
|
3Q16
|
2017
|
2016
|
|||||||||||||||
Direct impact of equity markets and variable annuity guarantee liabilities
|
$
|
126
|
$
|
55
|
$
|
96
|
$
|
403
|
$
|
(151
|
)
|
|||||||||
Fixed income reinvestment rates assumed in the valuation of policy liabilities
|
(22
|
)
|
(73
|
)
|
218
|
(45
|
)
|
512
|
||||||||||||
Sale of AFS bonds and derivative positions in the Corporate and Other segment
|
(57
|
)
|
(19
|
)
|
255
|
(81
|
)
|
512
|
||||||||||||
Risk Reduction related items
(1)
|
-
|
-
|
(155
|
)
|
-
|
(155
|
)
|
|||||||||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities
|
$
|
47
|
$
|
(37
|
)
|
$
|
414
|
$
|
277
|
$
|
718
|
(1) |
The risk reduction actions in 3Q16 included selling equity investments supporting our
products with guarantee features
and increasing the amount of interest rate hedges. The sale of equity investments resulted in a decrease in our underlying earnings sensitivity before hedging and also reduced the amount of hedging instruments used in the macro hedging program (see section E4 "Publicly traded equity performance risk" below).
|
B2 |
Revenue
|
Quarterly Results
|
YTD Results
|
|||||||||||||||||||
($ millions, unaudited)
|
3Q17
|
2Q17
|
3Q16
|
2017
|
2016
|
|||||||||||||||
Net premium income
|
$
|
7,243
|
$
|
6,974
|
$
|
7,197
|
$
|
21,267
|
$
|
20,631
|
||||||||||
Investment income
|
3,309
|
3,444
|
3,568
|
10,070
|
10,081
|
|||||||||||||||
Other revenue
|
2,544
|
2,872
|
2,921
|
8,009
|
8,544
|
|||||||||||||||
Revenue before items noted below
|
13,096
|
13,290
|
13,686
|
39,346
|
39,256
|
|||||||||||||||
Realized and unrealized gains (losses) on assets supporting insurance and investment contract liabilities and on the macro hedge program
|
(1,163
|
)
|
3,303
|
771
|
2,730
|
17,555
|
||||||||||||||
Total revenue
|
$
|
11,933
|
$
|
16,593
|
$
|
14,457
|
$
|
42,076
|
$
|
56,811
|
B3 |
Premiums and deposits
1
|
B4 |
Assets under management and administration
1,2
|
B5 |
Capital
1
|
B6 |
Impact of fair value accounting
|
1 |
This item is a non-GAAP measure. See "Performance and Non-GAAP Measures" below.
|
2 |
Percentage growth (declines) in sales, gross flows, premiums and deposits and assets under management and administration are stated on a constant currency basis. Constant currency basis is a non-GAAP measure. See "Performance and Non-GAAP Measures" below.
|
C |
PERFORMANCE BY DIVISION
|
C1 |
Asia Division
|
($ millions, unless otherwise stated)
|
Quarterly Results
|
YTD Results
|
||||||||||||||||||
Canadian dollars
|
3Q17
|
2Q17
|
3Q16
|
2017
|
2016
|
|||||||||||||||
Net income
attributed to shareholders
|
$
|
409
|
$
|
555
|
$
|
561
|
$
|
1,551
|
$
|
710
|
||||||||||
Core earnings
(1)
|
428
|
405
|
394
|
1,241
|
1,107
|
|||||||||||||||
Sales
|
||||||||||||||||||||
Annualized premium equivalent ("APE") sales
|
920
|
923
|
865
|
2,863
|
2,483
|
|||||||||||||||
Wealth and asset management gross flows
(2)
|
6,923
|
6,671
|
4,981
|
19,108
|
14,662
|
|||||||||||||||
Wealth and asset management net flows
(2)
|
1,784
|
1,428
|
1,332
|
4,250
|
3,736
|
|||||||||||||||
Revenue
|
5,226
|
5,645
|
4,665
|
16,205
|
16,517
|
|||||||||||||||
Revenue before realized and unrealized investment income gains and losses
(3)
|
4,889
|
4,875
|
4,866
|
14,617
|
14,225
|
|||||||||||||||
Premiums and deposits
(2)
|
11,890
|
11,380
|
9,611
|
33,461
|
28,126
|
|||||||||||||||
Assets under management ($ billions)
(2)
|
153.7
|
152.9
|
139.7
|
153.7
|
139.7
|
|||||||||||||||
U.S. dollars
|
||||||||||||||||||||
Net income attributed to shareholders
|
US$ | 327 | US$ |
413
|
US$ |
430
|
US$ |
1,183
|
US$ |
540
|
||||||||||
Core earnings
(1)
|
342
|
301
|
302
|
951
|
838
|
|||||||||||||||
Sales
|
||||||||||||||||||||
Annualized premium equivalent ("APE") sales
|
734
|
686
|
663
|
2,191
|
1,880
|
|||||||||||||||
Wealth and asset management gross flows
(2)
|
5,525
|
4,959
|
3,817
|
14,651
|
11,135
|
|||||||||||||||
Wealth and asset management net flows
(2)
|
1,424
|
1,061
|
1,020
|
3,270
|
2,890
|
|||||||||||||||
Revenue
|
4,170
|
4,200
|
3,572
|
12,399
|
12,465
|
|||||||||||||||
Revenue before realized and unrealized investment income gains and losses
(3)
|
3,901
|
3,627
|
3,727
|
11,194
|
10,759
|
|||||||||||||||
Premiums and deposits
(2)
|
9,490
|
8,461
|
7,362
|
25,651
|
21,316
|
|||||||||||||||
Assets under management ($ billions)
(2)
|
123.2
|
117.9
|
106.5
|
123.2
|
106.5
|
(1) |
See "Performance and Non-GAAP Measures" for a reconciliation between IFRS net income attributed to shareholders and core earnings.
|
(2) |
Effective January 1, 2017, the operations of Investment Division's external asset management businesses (MAM) has been reflected in the respective Divisional results. Previously, they were reported in the Corporate and Other segment. The
2016 wealth and asset management gross flows, wealth and asset management net flows,
premiums and deposits and assets under management have been restated to reflect the inclusion of MAM in the Division's results. As a result of internal transfer pricing in 2016, the 2016 reporting of MAM earnings were not material and remain in Corporate and Other.
|
(3) |
See section B6 "Impact of fair value accounting".
|
1 |
This item is a non-GAAP measure. See "Performance and Non-GAAP Measures" below.
|
2 |
Percentage growth (declines) in
Annualized premium equivalent ("APE") sales, gross flows, premiums and deposits and assets under management and administration are stated on a constant currency basis. Constant currency basis is a non-GAAP measure. See "Performance and Non-GAAP Measures" below.
|
C2 |
Canadian Division
|
Quarterly Results
|
YTD Results
|
|||||||||||||||||||
($ millions, unless otherwise stated)
|
3Q17
|
2Q17
|
3Q16
|
2017
|
2016
|
|||||||||||||||
Net income (loss) attributed to shareholders
|
$
|
448
|
$
|
84
|
$
|
435
|
$
|
720
|
$
|
1,394
|
||||||||||
Core earnings
(1)
|
466
|
345
|
354
|
1,130
|
1,025
|
|||||||||||||||
Sales:
Insurance sales
|
186
|
458
|
181
|
943
|
456
|
|||||||||||||||
Wealth and asset management gross flows
(2)
|
4,876
|
5,473
|
5,215
|
16,907
|
15,018
|
|||||||||||||||
Wealth and asset management net flows
(2)
|
782
|
500
|
1,277
|
2,328
|
3,635
|
|||||||||||||||
Other wealth sales
|
658
|
730
|
719
|
2,252
|
2,479
|
|||||||||||||||
Revenue
|
1,188
|
3,619
|
4,029
|
8,153
|
14,169
|
|||||||||||||||
Revenue before realized and unrealized investment income gains and losses
(3)
|
2,948
|
3,138
|
3,119
|
9,098
|
9,255
|
|||||||||||||||
Premiums and deposits
(2)
|
7,978
|
8,581
|
7,995
|
26,291
|
24,833
|
|||||||||||||||
Assets under management ($ billions)
(2)
|
270.8
|
271.7
|
262.5
|
270.8
|
262.5
|
(1) |
See "Performance and Non-GAAP Measures" below for a reconciliation between IFRS net income attributed to shareholders and core earnings.
|
(2) |
Effective January 1, 2017, the operations of Investment Division's external asset management businesses (MAM) has been reported in the respective Divisional results. Previously, they were reported in the Corporate and Other segment. The 2016
wealth and asset management gross flows, wealth and asset management net flows,
premiums and deposits and assets under management have been restated to reflect the inclusion of MAM in the Division's results. As a result of internal transfer pricing in 2016, the 2016 reporting of MAM earnings were not material and remain in Corporate and Other.
|
(3) |
See section B6 "Impact of fair value accounting".
|
C3 |
U.S. Division
|
($ millions, unless otherwise stated)
|
Quarterly Results
|
YTD Results
|
||||||||||||||||||
Canadian dollars
|
3Q17
|
2Q17
|
3Q16
|
2017
|
2016
|
|||||||||||||||
Net income attributed to shareholders
|
$
|
635
|
$
|
774
|
$
|
559
|
$
|
2,177
|
$
|
1,207
|
||||||||||
Core earnings
(1)
|
445
|
452
|
394
|
1,412
|
1,144
|
|||||||||||||||
Sales
(2)
:
|
||||||||||||||||||||
JH Life Insurance sales
|
135
|
165
|
133
|
450
|
403
|
|||||||||||||||
Wealth and asset management gross flows
(3)
|
15,695
|
18,795
|
17,222
|
55,372
|
52,610
|
|||||||||||||||
Wealth and asset management net flows
(3)
|
1,444
|
3,660
|
85
|
7,310
|
1,821
|
|||||||||||||||
Revenue
|
5,638
|
7,466
|
5,502
|
18,127
|
25,080
|
|||||||||||||||
Revenue before realized and unrealized investment income gains and losses
(4)
|
5,336
|
5,332
|
5,200
|
15,870
|
14,384
|
|||||||||||||||
Premiums and deposits
(3)
|
18,260
|
21,177
|
19,635
|
62,613
|
58,915
|
|||||||||||||||
Assets under management and administration ($ billions)
(3)
|
584.3
|
591.4
|
572.3
|
584.3
|
572.3
|
|||||||||||||||
U.S. dollars
|
||||||||||||||||||||
Net income attributed to shareholders
|
US$ |
507
|
US$ |
575
|
US$ | 428 | US$ |
1,662
|
US$ | 920 | ||||||||||
Core earnings
(1)
|
355
|
336
|
302
|
1,080
|
865
|
|||||||||||||||
Sales
(2)
:
|
||||||||||||||||||||
JH Life Insurance sales
|
107
|
123
|
102
|
343
|
305
|
|||||||||||||||
Wealth and asset management gross flows
(3)
|
12,529
|
13,974
|
13,197
|
42,277
|
39,752
|
|||||||||||||||
Wealth and asset management net flows
(3)
|
1,153
|
2,722
|
64
|
5,540
|
1,368
|
|||||||||||||||
Revenue
|
4,502
|
5,550
|
4,216
|
13,846
|
18,935
|
|||||||||||||||
Revenue before realized and unrealized investment income gains and losses
(4)
|
4,261
|
3,963
|
3,985
|
12,153
|
10,904
|
|||||||||||||||
Premiums and deposits
(3)
|
14,576
|
15,746
|
15,047
|
47,829
|
44,538
|
|||||||||||||||
Assets under management and administration ($ billions)
(3)
|
468.2
|
455.7
|
436.3
|
468.2
|
436.3
|
(1) |
See "Performance and Non-GAAP Measures" below for a reconciliation between IFRS net income attributed to shareholders and core earnings.
|
(2) |
Does not include sales of stand-alone retail individual long-term care products of US$8 million in 3Q16 and US$34 million in the first nine months of 2016. Sales of this product were discontinued in 4Q16.
|
(3) |
Effective January 1, 2017, the operations of Investment Division's external asset management businesses (MAM) has been reported in the respective Divisional results. Previously, they were reported in the Corporate and Other segment. The 2016 wealth and asset management gross flows, wealth and asset management net flows, premiums and deposits and assets under management have been restated to reflect the inclusion of MAM in the Division's results.
As a result of internal transfer pricing in 2016, the 2016 reporting of MAM earnings were not material and remain in Corporate and Other.
|
(4) |
See section B6 "Impact of fair value accounting".
|
C4 |
Corporate and Other
|
Quarterly Results
|
YTD Results
|
|||||||||||||||||||
($ millions, unless otherwise stated)
|
3Q17
|
2Q17
|
3Q16
|
2017
|
2016
|
|||||||||||||||
Net income (loss) attributed to shareholders
|
$
|
(387
|
)
|
$
|
(158
|
)
|
$
|
(438
|
)
|
$
|
(738
|
)
|
$
|
(445
|
)
|
|||||
Core loss excluding expected cost of macro hedges and core investment gains
(1)
|
$
|
(342
|
)
|
$
|
(168
|
)
|
$
|
(102
|
)
|
$
|
(676
|
)
|
$
|
(334
|
)
|
|||||
Expected cost of macro hedges
|
(12
|
)
|
(14
|
)
|
(61
|
)
|
(47
|
)
|
(225
|
)
|
||||||||||
Core investment gains
|
100
|
154
|
17
|
300
|
17
|
|||||||||||||||
Total core gain (loss)
|
$
|
(254
|
)
|
$
|
(28
|
)
|
$
|
(146
|
)
|
$
|
(423
|
)
|
$
|
(542
|
)
|
|||||
Revenue
|
$
|
(119
|
)
|
$
|
(137
|
)
|
$
|
261
|
$
|
(409
|
)
|
$
|
1,045
|
|||||||
Premiums and deposits
(2)
|
47
|
22
|
22
|
90
|
65
|
|||||||||||||||
Assets under management ($ billions)
(2)
|
(2.7
|
)
|
(4.1
|
)
|
(8.6
|
)
|
(2.7
|
)
|
(8.6
|
)
|
(1) |
See "Performance and Non-GAAP Measures" for a reconciliation between IFRS net income attributed to shareholders and core earnings.
|
(2) |
Effective January 1, 2017, the operations of Investment Division's external asset management businesses (MAM) has been reported in the respective Divisional results. Previously, they were reported in the Corporate and Other segment. The 2016 premiums and deposits and assets under management have been restated to reflect the inclusion of MAM in the Division's results.
As a result of internal transfer pricing in 2016, the 2016 reporting of MAM earnings were not material and remain in Corporate and Other.
|
D |
PERFORMANCE BY BUSINESS LINE
|
Quarterly Results
|
YTD Results
|
|||||||||||||||||||
($ millions, unless otherwise stated)
|
3Q17
|
2Q17
|
3Q16
|
2017
|
2016
|
|||||||||||||||
Core earnings
|
$
|
206
|
$
|
207
|
$
|
159
|
$
|
595
|
$
|
451
|
||||||||||
Core EBITDA
|
344
|
369
|
288
|
1,048
|
861
|
|||||||||||||||
Core EBITDA Margin
|
27.3
|
%
|
28.4
|
%
|
23.4
|
%
|
27.5
|
%
|
23.8
|
%
|
||||||||||
Net flows
|
4,009
|
5,588
|
2,694
|
13,887
|
9,192
|
|||||||||||||||
Gross flows
|
27,494
|
30,939
|
27,418
|
91,387
|
82,290
|
|||||||||||||||
Assets under management ("AUM") ($ billions)
|
489
|
487
|
446
|
489
|
446
|
|||||||||||||||
Assets under management and administration ("AUMA") ($ billions)
|
574
|
572
|
525
|
574
|
525
|
D2 |
Additional information by business line
|
Quarterly Results
|
YTD Results
|
|||||||||||||||||||
($ millions)
|
3Q17
|
2Q17
|
3Q16
|
2017
|
2016
|
|||||||||||||||
Wealth and Asset Management
|
$
|
206
|
$
|
207
|
$
|
159
|
$
|
595
|
$
|
451
|
||||||||||
Insurance
|
721
|
647
|
638
|
2,059
|
1,799
|
|||||||||||||||
Other Wealth
|
412
|
348
|
337
|
1,129
|
1,018
|
|||||||||||||||
Corporate and Other
(1)
|
(254
|
)
|
(28
|
)
|
(138
|
)
|
(423
|
)
|
(534
|
)
|
||||||||||
Total core earnings
|
$
|
1,085
|
$
|
1,174
|
$
|
996
|
$
|
3,360
|
$
|
2,734
|
(1) |
2016 core earnings for Corporate and Other exclude Manulife Asset Management results that are included in WAM. Effective January 1, 2017, MAM is no longer reported in the Corporate and Other segment. (See section C "Performance By Division" above.)
|
As at
|
September 30,
|
June 30,
|
September 30,
|
|||||||||
($ billions)
|
2017
|
2017
|
2016
|
|||||||||
Wealth and Asset Management
|
$
|
574.2
|
$
|
572.5
|
$
|
525.4
|
||||||
Insurance
|
266.8
|
271.2
|
267.0
|
|||||||||
Other Wealth
|
167.8
|
172.3
|
182.2
|
|||||||||
Corporate and Other
|
(2.7
|
)
|
(4.1
|
)
|
(8.6
|
)
|
||||||
Total assets under management and administration
|
$
|
1,006.1
|
$
|
1,011.9
|
$
|
966.0
|
Quarterly Results
|
YTD Results
|
|||||||||||||||||||
($ millions)
|
3Q17
|
2Q17
|
3Q16
|
2017
|
2016
|
|||||||||||||||
Wealth and Asset Management
|
||||||||||||||||||||
Asia
|
$
|
55
|
$
|
55
|
$
|
52
|
$
|
161
|
$
|
127
|
||||||||||
Canada
|
52
|
59
|
33
|
168
|
118
|
|||||||||||||||
U.S.
|
99
|
93
|
82
|
266
|
214
|
|||||||||||||||
Corporate and Other
|
-
|
-
|
(8
|
)
|
-
|
(8
|
)
|
|||||||||||||
Total Wealth and Asset Management
|
206
|
207
|
159
|
595
|
451
|
|||||||||||||||
Insurance
|
||||||||||||||||||||
Asia
|
280
|
260
|
240
|
802
|
721
|
|||||||||||||||
Canada
|
246
|
162
|
207
|
542
|
553
|
|||||||||||||||
U.S.
|
195
|
225
|
191
|
715
|
525
|
|||||||||||||||
Total Insurance
|
721
|
647
|
638
|
2,059
|
1,799
|
|||||||||||||||
Other Wealth
|
||||||||||||||||||||
Asia
|
93
|
90
|
101
|
278
|
258
|
|||||||||||||||
Canada
|
||||||||||||||||||||
Manulife Bank
|
37
|
32
|
30
|
105
|
85
|
|||||||||||||||
Canada excluding Manulife Bank
|
131
|
92
|
84
|
315
|
269
|
|||||||||||||||
Total Canada
|
168
|
124
|
114
|
420
|
354
|
|||||||||||||||
U.S.
|
151
|
134
|
122
|
431
|
406
|
|||||||||||||||
Total Other Wealth
|
412
|
348
|
337
|
1,129
|
1,018
|
|||||||||||||||
Corporate and Other
|
(254
|
)
|
(28
|
)
|
(138
|
)
|
(423
|
)
|
(534
|
)
|
||||||||||
Total core earnings
|
$
|
1,085
|
$
|
1,174
|
$
|
996
|
$
|
3,360
|
$
|
2,734
|
E |
RISK MANAGEMENT AND RISK FACTORS UPDATE
|
E2 |
Variable annuity and segregated fund guarantees
|
September 30, 2017
|
December 31, 2016
|
|||||||||||||||||||||||
As at
($ millions)
|
Guarantee
value
|
Fund value
|
Amount at
risk
(4),(5)
|
Guarantee
value
|
Fund value
|
Amount at
risk
(4),(5)
|
||||||||||||||||||
Guaranteed minimum income benefit
(1)
|
$
|
5,246
|
$
|
4,153
|
$
|
1,148
|
$
|
5,987
|
$
|
4,432
|
$
|
1,570
|
||||||||||||
Guaranteed minimum withdrawal benefit
|
62,104
|
56,295
|
6,337
|
68,594
|
59,593
|
9,135
|
||||||||||||||||||
Guaranteed minimum accumulation benefit
|
18,412
|
18,943
|
19
|
19,482
|
19,989
|
27
|
||||||||||||||||||
Gross living benefits
(2)
|
85,762
|
79,391
|
7,504
|
94,063
|
84,014
|
10,732
|
||||||||||||||||||
Gross death benefits
(3)
|
10,862
|
16,378
|
1,058
|
12,200
|
16,614
|
1,350
|
||||||||||||||||||
Total gross of reinsurance
|
96,624
|
95,769
|
8,562
|
106,263
|
100,628
|
12,082
|
||||||||||||||||||
Living benefits reinsured
|
4,563
|
3,630
|
976
|
5,241
|
3,903
|
1,349
|
||||||||||||||||||
Death benefits reinsured
|
3,031
|
3,015
|
450
|
3,429
|
3,202
|
564
|
||||||||||||||||||
Total reinsured
|
7,594
|
6,645
|
1,426
|
8,670
|
7,105
|
1,913
|
||||||||||||||||||
Total, net of reinsurance
|
$
|
89,030
|
$
|
89,124
|
$
|
7,136
|
$
|
97,593
|
$
|
93,523
|
$
|
10,169
|
(1) |
Contracts with guaranteed long-term care benefits are included in this category.
|
(2) |
Where a policy includes both living and death benefits, the guarantee in excess of the living benefit is included in the death benefit category as outlined in footnote 3.
|
(3) |
Death benefits include stand-alone guarantees and guarantees in excess of living benefit guarantees where both death and living benefits are provided on a policy.
|
(4) |
Amount at risk (in-the-money amount) is the excess of guarantee values over fund values on all policies where the guarantee value exceeds the fund value. This amount is not currently payable. For guaranteed minimum death benefit, the amount at risk is defined as the current guaranteed minimum death benefit in excess of the current account balance. For guaranteed minimum income benefit, the amount at risk is defined as the excess of the current annuitization income base over the current account value. For all guarantees, the amount at risk is floored at zero at the single contract level.
|
(5) |
The amount at risk net of reinsurance at September 30, 2017 was $7,136 million (December 31, 2016 – $10,169 million) of which: US$4,353 million (December 31, 2016 – US$6,008 million) was on our U.S. business, $1,292 million (December 31, 2016 – $1,499 million) was on our Canadian business, US$135 million (December 31, 2016 – US$206 million) was on our Japan business and US$194 million (December 31, 2016 – US$244 million) was related to Asia (other than Japan) and our run-off reinsurance business.
|
1 |
See "Caution regarding forward-looking statements" below.
|
E3 |
Caution related to sensitivities
|
E4 |
Publicly traded equity performance risk
|
As at September 30, 2017
|
||||||||||||||||||||||||
($ millions)
|
-30
|
%
|
-20
|
%
|
-10
|
%
|
10
|
%
|
20
|
%
|
30
|
%
|
||||||||||||
Underlying sensitivity to net income attributed to shareholders
(4)
|
||||||||||||||||||||||||
Variable annuity guarantees
|
$
|
(3,870
|
)
|
$
|
(2,260
|
)
|
$
|
(970
|
)
|
$
|
690
|
$
|
1,160
|
$
|
1,480
|
|||||||||
Asset based fees
|
(440
|
)
|
(290
|
)
|
(150
|
)
|
150
|
290
|
440
|
|||||||||||||||
General fund equity investments
(5)
|
(880
|
)
|
(570
|
)
|
(250
|
)
|
240
|
490
|
720
|
|||||||||||||||
Total underlying sensitivity before hedging
|
(5,190
|
)
|
(3,120
|
)
|
(1,370
|
)
|
1,080
|
1,940
|
2,640
|
|||||||||||||||
Impact of macro and dynamic hedge assets
(6)
|
3,080
|
1,800
|
770
|
(670
|
)
|
(1,130
|
)
|
(1,460
|
)
|
|||||||||||||||
Net potential impact on net income after impact of hedging
|
$
|
(2,110
|
)
|
$
|
(1,320
|
)
|
$
|
(600
|
)
|
$
|
410
|
$
|
810
|
$
|
1,180
|
|||||||||
As at December 31, 2016
|
||||||||||||||||||||||||
($ millions)
|
-30
|
%
|
-20
|
%
|
-10
|
%
|
10
|
%
|
20
|
%
|
30
|
%
|
||||||||||||
Underlying sensitivity to net income attributed to shareholders
(4)
|
||||||||||||||||||||||||
Variable annuity guarantees
|
$
|
(4,830
|
)
|
$
|
(2,920
|
)
|
$
|
(1,290
|
)
|
$
|
1,000
|
$
|
1,690
|
$
|
2,170
|
|||||||||
Asset based fees
|
(410
|
)
|
(280
|
)
|
(140
|
)
|
140
|
280
|
410
|
|||||||||||||||
General fund equity investments
(5)
|
(910
|
)
|
(590
|
)
|
(270
|
)
|
240
|
490
|
750
|
|||||||||||||||
Total underlying sensitivity before hedging
|
(6,150
|
)
|
(3,790
|
)
|
(1,700
|
)
|
1,380
|
2,460
|
3,330
|
|||||||||||||||
Impact of macro and dynamic hedge assets
(6)
|
4,050
|
2,440
|
1,060
|
(910
|
)
|
(1,610
|
)
|
(2,160
|
)
|
|||||||||||||||
Net potential impact on net income after impact of hedging
|
$
|
(2,100
|
)
|
$
|
(1,350
|
)
|
$
|
(640
|
)
|
$
|
470
|
$
|
850
|
$
|
1,170
|
(1) |
See "Caution related to sensitivities" above.
|
(2) |
The tables above show the potential impact on net income attributed to shareholders resulting from an immediate 10, 20 and 30% change in market values of publicly traded equities followed by a return to the expected level of growth assumed in the valuation of policy liabilities.
|
(3) |
Please refer to section F3 "Sensitivity of policy liabilities to asset related assumptions" for more information on the level of growth assumed and on the net income sensitivity to changes in these long-term assumptions.
|
(4) |
Defined as earnings sensitivity to a change in public equity markets including settlements on reinsurance contracts, but before the offset of hedge assets or other risk mitigants.
|
(5) |
This impact for general fund equities is calculated as at a point-in-time and does not include: (i) any potential impact on public equity weightings; (ii) any gains or losses on AFS public equities held in the Corporate and Other segment; or (iii) any gains or losses on public equity investments held in Manulife Bank. The participating policy funds are largely self-supporting and generate no material impact on net income attributed to shareholders as a result of changes in equity markets.
|
(6) |
Includes the impact of rebalancing equity hedges in the macro and dynamic hedging program. The impact of dynamic hedge rebalancing represents the impact of rebalancing equity hedges for dynamically hedged variable annuity guarantee best estimate liabilities at 5% intervals, but does not include any impact in respect of other sources of hedge ineffectiveness e.g. fund tracking, realized volatility and equity, interest rate correlations different from expected among other factors.
|
Impact on MLI's MCCSR ratio
|
||||||||||||||||||||||||
Percentage points
|
-30
|
%
|
-20
|
%
|
-10
|
%
|
10
|
%
|
20
|
%
|
30
|
%
|
||||||||||||
September 30, 2017
|
(13
|
)
|
(8
|
)
|
(3
|
)
|
7
|
17
|
21
|
|||||||||||||||
December 31, 2016
|
(12
|
)
|
(8
|
)
|
(4
|
)
|
3
|
14
|
18
|
(1) |
See "Caution related to sensitivities" above. In addition, estimates exclude changes to the net actuarial gains/losses with respect to the Company's pension obligations as a result of changes in equity markets, as the impact on the quoted sensitivities is not considered to be material.
|
(2) |
The potential impact is shown assuming that the change in value of the hedge assets does not completely offset the change in the dynamically hedged variable annuity guarantee liabilities. The estimated amount that would not be completely offset relates to our practices of not hedging the provisions for adverse deviation and of rebalancing equity hedges for dynamically hedged variable annuity liabilities at 5% intervals.
|
(3) |
OSFI rules for segregated fund guarantees reflect full capital impacts of shocks over 20 quarters within a prescribed range. As such, the deterioration in equity markets could lead to further increases in capital requirements after the initial shock.
|
September 30, 2017
|
December 31, 2016
|
|||||||||||||||
As at
|
-50
|
bp
|
+50
|
bp
|
-50
|
bp
|
+50
|
bp
|
||||||||
Net income attributed to shareholders ($ millions)
|
||||||||||||||||
Excluding change in market value of AFS fixed income assets held in the surplus segment
|
$
|
(100
|
)
|
$
|
-
|
$
|
-
|
$
|
-
|
|||||||
From fair value changes in AFS fixed income assets held in surplus, if realized
|
1,000
|
(900
|
)
|
1,000
|
(900
|
)
|
||||||||||
MLI's MCCSR ratio (Percentage points)
|
||||||||||||||||
Before impact of change in market value of AFS fixed income assets held in the surplus segment
(5)
|
(7
|
)
|
7
|
(6
|
)
|
5
|
||||||||||
From fair value changes in AFS fixed income assets held in surplus, if realized
|
3
|
(5
|
)
|
1
|
(4
|
)
|
(1) |
See "Caution related to sensitivities" above. In addition, estimates exclude changes to the net actuarial gains/losses with respect to the Company's pension obligations as a result of changes in interest rates, as the impact on the quoted sensitivities is not considered to be material.
|
(2) |
Includes guaranteed insurance and annuity products, including variable annuity contracts as well as adjustable benefit products where benefits are generally adjusted as interest rates and investment returns change, a portion of which have minimum credited rate guarantees. For adjustable benefit products subject to minimum rate guarantees, the sensitivities are based on the assumption that credited rates will be floored at the minimum.
|
(3) |
The amount of gain or loss that can be realized on AFS fixed income assets held in the surplus segment will depend on the aggregate amount of unrealized gain or loss.
|
(4) |
Sensitivities are based on projected asset and liability cash flows at a prior reporting date adjusted for the estimated impact of new business, investment markets and asset trading up to the current reporting date. Any true-up to these estimates is reflected in the sensitivities in the quarter that the projected cash flows are updated. The update of the projected cash flows take place at least annually. Impact of realizing fair value changes in AFS fixed income assets is as of the end of the quarter.
|
(5) |
The impact on MLI's MCCSR ratio includes both the impact of lower earnings on available capital as well as the increase in required capital that results from a decline in interest rates.
|
As at
|
||||||||
($ millions)
|
September 30, 2017
|
December 31,
2016
|
||||||
Corporate spreads
(4)
|
||||||||
Increase 50 basis points
|
$
|
700
|
$
|
700
|
||||
Decrease 50 basis points
|
(800
|
)
|
(800
|
)
|
||||
Swap spreads
|
||||||||
Increase 20 basis points
|
$
|
(400
|
)
|
$
|
(500
|
)
|
||
Decrease 20 basis points
|
400
|
500
|
(1) |
See "Caution related to sensitivities" above.
|
(2) |
The impact on net income attributed to shareholders assumes no gains or losses are realized on our AFS fixed income assets held in the surplus segment and excludes the impact of changes in segregated fund bond values due to changes in credit spreads. The participating policy funds are largely self-supporting and generate no material impact on net income attributed to shareholders as a result of changes in corporate and swap spreads.
|
(3) |
Sensitivities are based on projected asset and liability cash flows at a prior reporting date adjusted for the estimated impact of new business, investment markets and asset trading up to the current reporting date. Any true-up to these estimates is reflected in the sensitivities in the quarter that the projected cash flows are updated. The update of the projected cash flows take place at least annually.
|
(4) |
Corporate spreads
are assumed to grade to the long-term average over five years.
|
E6 |
Alternative long-duration asset ("ALDA") performance risk
|
As at
|
September 30, 2017
|
December 31, 2016
|
||||||||||||||
($ millions)
|
-10
|
%
|
10
|
%
|
-10
|
%
|
10
|
%
|
||||||||
Real estate, agriculture and timber assets
|
$
|
(1,300
|
)
|
$
|
1,200
|
$
|
(1,300
|
)
|
$
|
1,200
|
||||||
Private equities and other ALDA
|
(1,300
|
)
|
1,300
|
(1,200
|
)
|
1,200
|
||||||||||
Alternative long-duration assets
|
$
|
(2,600
|
)
|
$
|
2,500
|
$
|
(2,500
|
)
|
$
|
2,400
|
(1) |
See "Caution Related to Sensitivities" above.
|
(2) |
This impact is calculated as at a point-in-time impact and does not include: (i) any potential impact on ALDA weightings; (ii) any gains or losses on ALDA held in the Corporate and Other segment; or (iii) any gains or losses on ALDA held in Manulife Bank.
|
(3) |
The participating policy funds are largely self-supporting and generate no material impact on net income attributed to shareholders as a result of changes in ALDA returns. For some classes of ALDA, where there is not an appropriate long-term benchmark available, the return assumptions used in valuation are not permitted by the Standards of Practice and CIA guidance to result in a lower reserve than an assumption based on a historical return benchmark for public equities in the same jurisdiction.
|
(4) |
Net income impact does not consider any impact of the market correction on assumed future return assumptions.
|
(5) |
Please refer to section F3 "Sensitivity of policy liabilities to asset related assumptions" for more information on the level of growth assumed and on the net income sensitivity to changes in these long-term assumptions.
|
F |
ACCOUNTING MATTERS AND CONTROLS
|
F1 |
Critical accounting and actuarial policies
|
F2 |
Actuarial methods and assumptions
|
For the quarter ended September 30, 2017
Assumption
|
Change in gross insurance and investment contract liabilities
|
Change in insurance and investment contract liabilities net of reinsurance
(1)
|
Change in net income attributed to shareholders (post-tax)
|
|||||||||
Mortality and morbidity updates
|
$
|
(26
|
)
|
$
|
(235
|
)
|
$
|
285
|
||||
Lapses and policyholder behaviour
|
1,057
|
1,019
|
(783
|
)
|
||||||||
Other updates
|
||||||||||||
ALDA and public equity investment return assumptions
|
1,403
|
1,296
|
(892
|
)
|
||||||||
Corporate spread assumptions
|
(554
|
)
|
(515
|
)
|
344
|
|||||||
Refinements to liability and tax cash flows
|
(1,273
|
)
|
(1,049
|
)
|
696
|
|||||||
Other
|
(339
|
)
|
(463
|
)
|
348
|
|||||||
Net impact
|
$
|
268
|
$
|
53
|
$
|
(2
|
)
|
(1) |
The $53 million increase in insurance and investment contract liabilities net of reinsurance, included a decrease in net liabilities associated with participating insurance business resulting in a gain in net income attributed to participating policyholders of $72 million.
|
F3 |
Sensitivity of policy liabilities to asset related assumptions
|
As at
|
Increase (decrease) in after-tax income
|
|||||||||||||||
($ millions)
|
September 30, 2017
|
December 31, 2016
|
||||||||||||||
Asset related assumptions updated periodically in valuation basis changes
|
Increase
|
Decrease
|
Increase
|
Decrease
|
||||||||||||
100 basis point change in future annual returns for public equities
(1)
|
$
|
500
|
$
|
(500
|
)
|
$
|
500
|
$
|
(500
|
)
|
||||||
100 basis point change in future annual returns for ALDA
(2)
|
3,200
|
(3,900
|
)
|
2,900
|
(3,500
|
)
|
||||||||||
100 basis point change in equity volatility assumption for stochastic segregated fund modelling
(3)
|
(200
|
)
|
200
|
(200
|
)
|
200
|
(1) |
The sensitivity to public equity returns above includes the impact on both segregated fund guarantee reserves and on other policy liabilities. For a 100 basis point increase in expected growth rates, the impact from segregated fund guarantee reserves is a $200 million increase (December 31, 2016 – $200 million increase). For a 100 basis point decrease in expected growth rates, the impact from segregated fund guarantee reserves is a $200 million decrease (2016 – $200 million decrease). Expected long-term annual market growth assumptions for public equities pre-dividends for key markets are based on long-term historical observed experience and compliance with actuarial standards. The pre-dividend growth rates for returns in the major markets used in the stochastic valuation models for valuing segregated fund guarantees are 7.3% per annum in Canada, 7.6% per annum in the U.S. and 5.2% per annum in Japan. Growth assumptions for European equity funds are market-specific and vary between 6.06% and 7.86%.
|
(2) |
ALDA includes commercial real estate, timber and farmland real estate, power and infrastructure, direct oil and gas properties, and private equities, some of which relate to oil and gas. Expected long-term return assumptions are set in accordance with the Standards of Practice for the valuation of insurance contract liabilities and guidance published by the CIA. The guidance requires that the investment return assumption for these assets should not be higher than the historical long-term average returns of an appropriate broad-based index. Where such experience is not available, investment return assumptions should not result in a lower reserve than an assumption based on a historical return benchmark for public equities in the same jurisdiction. Annual best estimate return assumptions for ALDA and public equity include market growth rates and annual income, such as rent, production proceeds and dividends, and will vary based on our holding period. Over a 20 year horizon, our best estimate return assumptions range between 5.25% and 12%, with an average of 9.3% based on the asset mix backing our guaranteed insurance and annuity business as of September 30, 2017. Our return assumptions including the margins for adverse deviations in our valuation, which take into account the uncertainty of achieving the returns, range between 2.5% and 7.5%, with an average of 6.2% based on the asset mix backing our guaranteed insurance and annuity business as of September 30, 2017.
|
(3) |
Volatility assumptions for public equities are based on long-term historical observed experience and compliance with actuarial standards. The resulting volatility assumptions are 16.95% per annum in Canada and 17.15% per annum in the U.S. for large cap public equities, and 19.25% per annum in Japan. For European equity funds, the volatility varies between 16.50% and 18.4%
|
F4 |
Accounting and reporting changes
|
F5 |
Quarterly financial information
|
As at and for the three months ended
|
Sept 30,
|
Jun 30,
|
Mar 31,
|
Dec 31,
|
Sept 30,
|
Jun 30,
|
Mar 31,
|
Dec 31,
|
||||||||||||||||||||||||
($ millions, except per share amounts or otherwise stated, unaudited)
|
2017
|
2017
|
2017
|
2016
|
2016
|
2016
|
2016
|
2015
|
||||||||||||||||||||||||
Revenue
|
||||||||||||||||||||||||||||||||
Premium income
|
||||||||||||||||||||||||||||||||
Life and health insurance
|
$
|
6,321
|
$
|
6,040
|
$
|
5,994
|
$
|
6,093
|
$
|
5,950
|
$
|
5,497
|
$
|
5,728
|
$
|
5,331
|
||||||||||||||||
Annuities and pensions
|
922
|
934
|
1,056
|
908
|
1,247
|
1,209
|
1,000
|
1,381
|
||||||||||||||||||||||||
Net premium income
|
7,243
|
6,974
|
7,050
|
7,001
|
7,197
|
6,706
|
6,728
|
6,712
|
||||||||||||||||||||||||
Investment income
|
3,309
|
3,444
|
3,317
|
3,309
|
3,568
|
3,213
|
3,300
|
2,899
|
||||||||||||||||||||||||
Realized and unrealized gains (losses) on assets supporting insurance and investment
contract liabilities
(1)
|
(1,163
|
)
|
3,303
|
590
|
(16,421
|
)
|
771
|
7,922
|
8,862
|
(1,916
|
)
|
|||||||||||||||||||||
Other revenue
|
2,544
|
2,872
|
2,593
|
2,637
|
2,921
|
2,794
|
2,829
|
2,694
|
||||||||||||||||||||||||
Total revenue
|
$
|
11,933
|
$
|
16,593
|
$
|
13,550
|
$
|
(3,474
|
)
|
$
|
14,457
|
$
|
20,635
|
$
|
21,719
|
$
|
10,389
|
|||||||||||||||
Income (loss) before income taxes
|
$
|
1,269
|
$
|
1,618
|
$
|
1,737
|
$
|
(285
|
)
|
$
|
1,314
|
$
|
947
|
$
|
1,353
|
$
|
136
|
|||||||||||||||
Income tax (expense) recovery
|
(13
|
)
|
(304
|
)
|
(346
|
)
|
450
|
(117
|
)
|
(231
|
)
|
(298
|
)
|
76
|
||||||||||||||||||
Net income
|
$
|
1,256
|
$
|
1,314
|
$
|
1,391
|
$
|
165
|
$
|
1,197
|
$
|
716
|
$
|
1,055
|
$
|
212
|
||||||||||||||||
Net income attributed to shareholders
|
$
|
1,105
|
$
|
1,255
|
$
|
1,350
|
$
|
63
|
$
|
1,117
|
$
|
704
|
$
|
1,045
|
$
|
246
|
||||||||||||||||
Reconciliation of core earnings to net income attributed to shareholders
|
||||||||||||||||||||||||||||||||
Total core earnings
(2)
|
$
|
1,085
|
$
|
1,174
|
$
|
1,101
|
$
|
1,287
|
$
|
996
|
$
|
833
|
$
|
905
|
$
|
859
|
||||||||||||||||
Other items to reconcile net income
attributed to shareholders to core earnings
(3)
|
||||||||||||||||||||||||||||||||
Investment-related experience in excess
of amounts included in core earnings
|
11
|
138
|
-
|
-
|
280
|
60
|
(340
|
)
|
(361
|
)
|
||||||||||||||||||||||
Direct impact of equity markets, interest rates
and variable annuity guarantee liabilities
|
47
|
(37
|
)
|
267
|
(1,202
|
)
|
414
|
(170
|
)
|
474
|
(29
|
)
|
||||||||||||||||||||
Recapture of reinsurance treaties
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(52
|
)
|
|||||||||||||||||||||||
Change in actuarial methods and assumptions
|
(2
|
)
|
-
|
-
|
(10
|
)
|
(455
|
)
|
-
|
12
|
(97
|
)
|
||||||||||||||||||||
Net impact of acquisitions and divestitures
|
(14
|
)
|
(20
|
)
|
(18
|
)
|
(25
|
)
|
(23
|
)
|
(19
|
)
|
(14
|
)
|
(39
|
)
|
||||||||||||||||
Other
|
(22
|
)
|
-
|
-
|
13
|
(95
|
)
|
-
|
8
|
(35
|
)
|
|||||||||||||||||||||
Net income attributed to shareholders
|
$
|
1,105
|
$
|
1,255
|
$
|
1,350
|
$
|
63
|
$
|
1,117
|
$
|
704
|
$
|
1,045
|
$
|
246
|
||||||||||||||||
Basic earnings per common share
|
$
|
0.54
|
$
|
0.62
|
$
|
0.66
|
$
|
0.01
|
$
|
0.55
|
$
|
0.34
|
$
|
0.51
|
$
|
0.11
|
||||||||||||||||
Diluted earnings per common share
|
$
|
0.54
|
$
|
0.61
|
$
|
0.66
|
$
|
0.01
|
$
|
0.55
|
$
|
0.34
|
$
|
0.51
|
$
|
0.11
|
||||||||||||||||
Segregated funds deposits
|
$
|
8,179
|
$
|
8,544
|
$
|
9,632
|
$
|
8,247
|
$
|
8,291
|
$
|
7,899
|
$
|
8,693
|
$
|
8,324
|
||||||||||||||||
Total assets (in billions)
|
$
|
713
|
$
|
726
|
$
|
728
|
$
|
721
|
$
|
742
|
$
|
725
|
$
|
696
|
$
|
703
|
||||||||||||||||
Weighted average common shares (in millions)
|
1,978
|
1,977
|
1,976
|
1,974
|
1,973
|
1,972
|
1,972
|
1,972
|
||||||||||||||||||||||||
Diluted weighted average common shares
(in millions)
|
1,986
|
1,984
|
1,984
|
1,980
|
1,976
|
1,976
|
1,976
|
1,977
|
||||||||||||||||||||||||
Dividends per common share
|
$
|
0.205
|
$
|
0.205
|
$
|
0.205
|
$
|
0.185
|
$
|
0.185
|
$
|
0.185
|
$
|
0.185
|
$
|
0.170
|
||||||||||||||||
CDN$ to US$1 - Statement of Financial
Position
|
1.2480
|
1.2977
|
1.3323
|
1.3426
|
1.3116
|
1.3009
|
1.2970
|
1.3841
|
||||||||||||||||||||||||
CDN$ to US$1 - Statement of Income
|
1.2528
|
1.3450
|
1.3238
|
1.3343
|
1.3050
|
1.2889
|
1.3724
|
1.3360
|
(1) |
For fixed income assets supporting insurance and investment contract liabilities and for equities supporting pass-through products and derivatives related to variable hedging programs, the impact of realized and unrealized gains (losses) on the assets is largely offset in the change in insurance and investment contract liabilities.
|
(2) |
Core earnings is a non-GAAP measure. See "Performance and Non-GAAP Measures" below.
|
(3) |
For explanations of other items, see "Third quarter earnings analysis" table in section B "Financial Highlights" and for an operating segment split of these items see the 8 quarter trend tables in section G3 "Performance and Non-GAAP Measures" which reconciles net income attributed to shareholders to core earnings.
|
F6 |
Other
|
G |
OTHER
|
G1 |
Quarterly dividend
|
Class A Shares Series 2 – $0.29063 per share
|
Class 1 Shares Series 11 – $0.25 per share
|
Class A Shares Series 3 – $0.28125 per share
|
Class 1 Shares Series 13 – $0.2375 per share
|
Class 1 Shares Series 3 – $0.136125 per share
|
Class 1 Shares Series 15 – $0.24375 per share
|
Class 1 Shares Series 4 – $0.134008 per share
|
Class 1 Shares Series 17 – $0.24375 per share
|
Class 1 Shares Series 5 – $0.243188 per share
|
Class 1 Shares Series 19 – $0.2375 per share
|
Class 1 Shares Series 7 – $0.2695 per share
|
Class 1 Shares Series 21 – $0.35 per share
|
Class 1 Shares Series 9 – $0.271938 per share
|
Class 1 Shares Series 23 – $0.303125 per share
|
G2 |
Outstanding shares – selected information
|
G3 |
Performance and Non-GAAP Measures
|
1. |
Expected earnings on in-force policies, including expected release of provisions for adverse deviation, fee income, margins on group business and spread business such as Manulife Bank and asset fund management.
|
2. |
Macro hedging costs based on expected market returns.
|
3. |
New business strain.
|
4. |
Policyholder experience gains or losses.
|
5. |
Acquisition and operating expenses compared with expense assumptions used in the measurement of policy liabilities.
|
6. |
Up to $400 million of net favourable investment-related experience reported in a single year, which are referred to as "core investment gains". This means up to $100 million in the first quarter, up to $200 million on a year-to-date basis in the second quarter, up to $300 million on a year-to-date basis in the third quarter and up to $400 million on a full year basis in the fourth quarter. Any i
nvestment-related experience losses reported in a quarter will be offset against the net year-to-date investment-related experience gains with the difference being included in core earnings subject to a maximum of the year-to-date core investment gains and a minimum of zero, which reflects our expectation that investment-related experience will be positive through-the-business cycle. To the extent any investment-related experience losses cannot be fully offset in a quarter they will be carried forward to be offset against investment-related experience gains in subsequent quarters in the same year, for purposes of determining core investment gains.
|
· |
This favourable and unfavourable investment-related experience is a combination of reported investment experience as well as the impact of investing activities on the measurement of our policy liabilities. We do not attribute specific components of investment-related experience to amounts included or excluded from core earnings.
|
· |
The $400 million threshold represents the estimated average annualized amount of net favourable investment-related experience that the Company reasonably expects to achieve through-the-business cycle based on historical experience. It is not a forecast of expected net favourable investment-related experience for any given fiscal year.
|
· |
Our average net annualized investment-related experience calculated from the introduction of core earnings in 2012 to the end of 2016 was $456 million.
|
· |
While historical investment return time horizons may vary in length based on underlying asset classes generally exceeding 20 years, for purposes of establishing the threshold, we look at a business cycle that is five or more years and includes a recession. We monitor the appropriateness of the threshold as part of our annual five-year planning process and would adjust it, either to a higher or lower amount, in the future if we believed that our threshold was no longer appropriate.
|
· |
Specific criteria used for evaluating a potential adjustment to the threshold may include, but are not limited to, the extent to which actual investment-related experience differs materially from actuarial assumptions used in measuring insurance contract liabilities, material market events, material dispositions or acquisitions of assets, and regulatory or accounting changes.
|
7. |
Earnings on surplus other than mark-to-market items. Gains on available-for-sale ("AFS") equities and seed money investments are included in core earnings.
|
8. |
Routine or non-material legal settlements.
|
9. |
All other items not specifically excluded.
|
10. |
Tax on the above items.
|
11. |
All tax related items except the impact of enacted or substantially enacted income tax rate changes.
|
1. |
The direct impact of equity markets and interest rates and variable annuity guarantee liabilities includes the items listed below.
|
· |
The earnings impact of the difference between the net increase (decrease) in variable annuity liabilities that are dynamically hedged and the performance of the related hedge assets. Our variable annuity dynamic hedging strategy is not designed to completely offset the sensitivity of insurance and investment contract liabilities to all risks or measurements associated with the guarantees embedded in these products for a number of reasons, including; provisions for adverse deviation, fund performance, the portion of the interest rate risk that is not dynamically hedged, realized equity and interest rate volatilities and changes to policyholder behaviour.
|
· |
Gains (charges) on variable annuity guarantee liabilities not dynamically hedged.
|
· |
Gains (charges) on general fund equity investments supporting policy liabilities and on fee income.
|
· |
Gains (charges) on macro equity hedges relative to expected costs. The expected cost of macro hedges is calculated using the equity assumptions used in the valuation of insurance and investment contract liabilities.
|
· |
Gains (charges) on higher (lower) fixed income reinvestment rates assumed in the valuation of insurance and investment contract liabilities.
|
· |
Gains (charges) on sale of AFS bonds and open derivatives not in hedging relationships in the Corporate and Other segment.
|
2. |
Net favourable investment-related experience in excess of $400 million per annum or net unfavourable investment-related experience on a year-to-date basis.
|
3. |
Mark-to-market gains or losses on assets held in the Corporate and Other segment other than gains on AFS equities and seed money investments in new segregated or mutual funds.
|
4. |
Changes in actuarial methods and assumptions. As noted in the Critical Accounting and Actuarial Policies section above, policy liabilities for IFRS are valued in Canada under standards established by the Actuarial Standards Board. The standards require a comprehensive review of actuarial methods and assumptions to be performed annually. The review is designed to reduce the Company's exposure to uncertainty by ensuring assumptions for both asset related and liability related risks remain appropriate and is accomplished by monitoring experience and selecting assumptions which represent a current best estimate view of expected future experience, and margins that are appropriate for the risks assumed. By excluding the results of the annual reviews, core earnings assists investors in evaluating our operational performance and comparing our operational performance from period to period with other global insurance companies because the associated gain or loss is not reflective of current year performance and not reported in net income in most actuarial standards outside of Canada.
|
5. |
The impact on the measurement of policy liabilities of changes in product features or new reinsurance transactions, if material.
|
6. |
Goodwill impairment charges.
|
7. |
Gains or losses on disposition of a business.
|
8. |
Material one-time only adjustments, including highly unusual/extraordinary and material legal settlements or other items that are material and exceptional in nature.
|
9. |
Tax on the above items.
|
10. |
Impact of enacted or substantially enacted income tax rate changes.
|
Quarterly Results
|
||||||||||||||||||||||||||||||||
($ millions, unaudited)
|
3Q17
|
2Q17
|
1Q17
|
4Q16
|
3Q16
|
2Q16
|
1Q16
|
4Q15
|
||||||||||||||||||||||||
Core earnings (loss)
|
||||||||||||||||||||||||||||||||
Asia Division
|
$
|
428
|
$
|
405
|
$
|
408
|
$
|
388
|
$
|
394
|
$
|
342
|
$
|
371
|
$
|
334
|
||||||||||||||||
Canadian Division
|
466
|
345
|
319
|
359
|
354
|
333
|
338
|
352
|
||||||||||||||||||||||||
U.S. Division
|
445
|
452
|
515
|
471
|
394
|
361
|
389
|
332
|
||||||||||||||||||||||||
Corporate and Other (excluding expected cost of macro hedges and core investment gains)
|
(342
|
)
|
(168
|
)
|
(166
|
)
|
(75
|
)
|
(102
|
)
|
(125
|
)
|
(107
|
)
|
(85
|
)
|
||||||||||||||||
Expected cost of macro hedges
|
(12
|
)
|
(14
|
)
|
(21
|
)
|
(36
|
)
|
(61
|
)
|
(78
|
)
|
(86
|
)
|
(74
|
)
|
||||||||||||||||
Investment-related experience
included in core earnings
|
100
|
154
|
46
|
180
|
17
|
-
|
-
|
-
|
||||||||||||||||||||||||
Total core earnings
|
1,085
|
1,174
|
1,101
|
1,287
|
996
|
833
|
905
|
859
|
||||||||||||||||||||||||
Investment-related experience
outside of core earnings
|
11
|
138
|
-
|
-
|
280
|
60
|
(340
|
)
|
(361
|
)
|
||||||||||||||||||||||
Core earnings plus investment-related experience outside of
core earnings
|
1,096
|
1,312
|
1,101
|
1,287
|
1,276
|
893
|
565
|
498
|
||||||||||||||||||||||||
Other items to reconcile core earnings
to net income attributed to shareholders:
|
||||||||||||||||||||||||||||||||
Direct impact of equity markets
and interest rates and variable
annuity guarantee liabilities
|
47
|
(37
|
)
|
267
|
(1,202
|
)
|
414
|
(170
|
)
|
474
|
(29
|
)
|
||||||||||||||||||||
Recapture of reinsurance treaties
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(52
|
)
|
|||||||||||||||||||||||
Change in actuarial methods
and assumptions
|
(2
|
)
|
-
|
-
|
(10
|
)
|
(455
|
)
|
-
|
12
|
(97
|
)
|
||||||||||||||||||||
Integration and acquisition costs
|
(14
|
)
|
(20
|
)
|
(18
|
)
|
(25
|
)
|
(23
|
)
|
(19
|
)
|
(14
|
)
|
(39
|
)
|
||||||||||||||||
Other
|
(22
|
)
|
-
|
-
|
13
|
(95
|
)
|
-
|
8
|
(35
|
)
|
|||||||||||||||||||||
Net income attributed to
shareholders
|
$
|
1,105
|
$
|
1,255
|
$
|
1,350
|
$
|
63
|
$
|
1,117
|
$
|
704
|
$
|
1,045
|
$
|
246
|
Quarterly Results
|
||||||||||||||||||||||||||||||||
($ millions, unaudited)
|
3Q17
|
2Q17
|
1Q17
|
4Q16
|
3Q16
|
2Q16
|
1Q16
|
4Q15
|
||||||||||||||||||||||||
Asia Division core earnings
(1)
|
$
|
428
|
$
|
405
|
$
|
408
|
$
|
388
|
$
|
394
|
$
|
342
|
$
|
371
|
$
|
334
|
||||||||||||||||
Investment-related experience
outside of core earnings
|
48
|
62
|
69
|
74
|
62
|
(25
|
)
|
(20
|
)
|
(3
|
)
|
|||||||||||||||||||||
Core earnings plus investment-related experience outside
of core earnings
|
476
|
467
|
477
|
462
|
456
|
317
|
351
|
331
|
||||||||||||||||||||||||
Other items to reconcile core
earnings to net income attributed
to shareholders
|
||||||||||||||||||||||||||||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities
|
(61
|
)
|
95
|
119
|
(15
|
)
|
107
|
(287
|
)
|
(238
|
)
|
76
|
||||||||||||||||||||
Integration and acquisition costs
|
(6
|
)
|
(7
|
)
|
(9
|
)
|
(4
|
)
|
(2
|
)
|
(2
|
)
|
(2
|
)
|
-
|
|||||||||||||||||
Other
|
-
|
-
|
-
|
(12
|
)
|
-
|
-
|
10
|
2
|
|||||||||||||||||||||||
Net income attributed to
shareholders
(1)
|
$
|
409
|
$
|
555
|
$
|
587
|
$
|
431
|
$
|
561
|
$
|
28
|
$
|
121
|
$
|
409
|
(1) |
The 2015 earnings on assets backing capital allocated to each operating segment have been restated to align with the methodology used in 2016.
|
Quarterly Results
|
||||||||||||||||||||||||||||||||
($ millions, unaudited)
|
3Q17
|
2Q17
|
1Q17
|
4Q16
|
3Q16
|
2Q16
|
1Q16
|
4Q15
|
||||||||||||||||||||||||
Canadian Division core earnings
(1)
|
$
|
466
|
$
|
345
|
$
|
319
|
$
|
359
|
$
|
354
|
$
|
333
|
$
|
338
|
$
|
352
|
||||||||||||||||
Investment-related experience
outside of core earnings
|
(125
|
)
|
(11
|
)
|
(38
|
)
|
17
|
35
|
(88
|
)
|
(78
|
)
|
(180
|
)
|
||||||||||||||||||
Core earnings plus investment-
related experience outside of
core earnings
|
341
|
334
|
281
|
376
|
389
|
245
|
260
|
172
|
||||||||||||||||||||||||
Other items to reconcile core
earnings to net income (loss)
attributed to shareholders
|
||||||||||||||||||||||||||||||||
Direct impact of equity markets
and interest rates and variable
annuity guarantee liabilities
|
115
|
(238
|
)
|
(83
|
)
|
(266
|
)
|
60
|
130
|
346
|
(201
|
)
|
||||||||||||||||||||
Recapture of reinsurance treaties
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(52
|
)
|
|||||||||||||||||||||||
Integration and acquisition costs
|
(8
|
)
|
(12
|
)
|
(10
|
)
|
(18
|
)
|
(14
|
)
|
(16
|
)
|
(6
|
)
|
(23
|
)
|
||||||||||||||||
Net income (loss) attributed to
shareholders
(1)
|
$
|
448
|
$
|
84
|
$
|
188
|
$
|
92
|
$
|
435
|
$
|
359
|
$
|
600
|
$
|
(104
|
)
|
(1) |
The 2015 earnings on assets backing capital allocated to each operating segment have been restated to align with the methodology used in 2016.
|
Quarterly Results
|
||||||||||||||||||||||||||||||||
($ millions, unaudited)
|
3Q17
|
2Q17
|
1Q17
|
4Q16
|
3Q16
|
2Q16
|
1Q16
|
4Q15
|
||||||||||||||||||||||||
U.S. Division core earnings
(1)
|
$
|
445
|
$
|
452
|
$
|
515
|
$
|
471
|
$
|
394
|
$
|
361
|
$
|
389
|
$
|
332
|
||||||||||||||||
Investment-related experience
outside of core earnings
|
181
|
164
|
31
|
97
|
192
|
93
|
(233
|
)
|
(146
|
)
|
||||||||||||||||||||||
Core earnings plus investment
related experience outside of
core earnings
|
626
|
616
|
546
|
568
|
586
|
454
|
156
|
186
|
||||||||||||||||||||||||
Other items to reconcile core
earnings to net income (loss)
attributed to shareholders
|
||||||||||||||||||||||||||||||||
Direct impact of equity markets
and interest rates and variable
annuity guarantee liabilities
|
50
|
159
|
222
|
(623
|
)
|
72
|
(47
|
)
|
82
|
142
|
||||||||||||||||||||||
Integration and acquisition costs
|
-
|
(1
|
)
|
-
|
(1
|
)
|
(4
|
)
|
-
|
(4
|
)
|
(5
|
)
|
|||||||||||||||||||
Other
|
(41
|
)
|
-
|
-
|
(17
|
)
|
(95
|
)
|
-
|
7
|
-
|
|||||||||||||||||||||
Net income (loss) attributed to
shareholders
(1)
|
$
|
635
|
$
|
774
|
$
|
768
|
$
|
(73
|
)
|
$
|
559
|
$
|
407
|
$
|
241
|
$
|
323
|
(1) |
The 2015 earnings on assets backing capital allocated to each operating segment have been restated to align with the methodology used in 2016.
|
Quarterly Results
|
||||||||||||||||||||||||||||||||
($ millions, unaudited)
|
3Q17
|
2Q17
|
1Q17
|
4Q16
|
3Q16
|
2Q16
|
1Q16
|
4Q15
|
||||||||||||||||||||||||
Corporate and Other core loss
(excluding expected cost of
macro hedges and core
investment gains)
(1)
|
$
|
(342
|
)
|
$
|
(168
|
)
|
$
|
(166
|
)
|
$
|
(75
|
)
|
$
|
(102
|
)
|
$
|
(125
|
)
|
$
|
(107
|
)
|
$
|
(85
|
)
|
||||||||
Expected cost of macro hedges
|
(12
|
)
|
(14
|
)
|
(21
|
)
|
(36
|
)
|
(61
|
)
|
(78
|
)
|
(86
|
)
|
(74
|
)
|
||||||||||||||||
Core investment gains
|
100
|
154
|
46
|
180
|
17
|
-
|
-
|
-
|
||||||||||||||||||||||||
Total core earnings (loss)
|
(254
|
)
|
(28
|
)
|
(141
|
)
|
69
|
(146
|
)
|
(203
|
)
|
(193
|
)
|
(159
|
)
|
|||||||||||||||||
Investment-related experience
outside of core earnings
|
(93
|
)
|
(77
|
)
|
(62
|
)
|
(188
|
)
|
(9
|
)
|
80
|
(9
|
)
|
(32
|
)
|
|||||||||||||||||
Core loss plus investment-
related experience outside of
core earnings
|
(347
|
)
|
(105
|
)
|
(203
|
)
|
(119
|
)
|
(155
|
)
|
(123
|
)
|
(202
|
)
|
(191
|
)
|
||||||||||||||||
Other items to reconcile core
earnings (loss) to net income
(loss) attributed to shareholders
|
||||||||||||||||||||||||||||||||
Direct impact of equity markets
and interest rates and variable
annuity guarantee liabilities
|
(57
|
)
|
(53
|
)
|
9
|
(298
|
)
|
175
|
34
|
284
|
(46
|
)
|
||||||||||||||||||||
Changes in actuarial methods
and assumptions
|
(2
|
)
|
-
|
-
|
(10
|
)
|
(455
|
)
|
-
|
12
|
(97
|
)
|
||||||||||||||||||||
Integration and acquisition costs
|
-
|
-
|
1
|
(2
|
)
|
(3
|
)
|
(1
|
)
|
(2
|
)
|
(11
|
)
|
|||||||||||||||||||
Other
|
19
|
42
|
-
|
-
|
(9
|
)
|
(37
|
)
|
||||||||||||||||||||||||
Net income (loss) attributed to
shareholders
(1)
|
$
|
(387
|
)
|
$
|
(158
|
)
|
$
|
(193
|
)
|
$
|
(387
|
)
|
$
|
(438
|
)
|
$
|
(90
|
)
|
$
|
83
|
$
|
(382
|
)
|
(1) |
The Corporate and Other segment includes earnings on assets backing capital net of amounts allocated to operating divisions. The 2015 earnings on assets backing capital allocated to each operating segment have been restated to align with the methodology used in 2016.
|
Assets under management and administration
|
||||||||||||
As at
|
||||||||||||
($ millions)
|
September 30, 2017
|
June 30,
2017
|
September 30, 2016
|
|||||||||
Total invested assets
|
$
|
325,106
|
$
|
329,296
|
$
|
328,756
|
||||||
Segregated funds net assets
|
316,977
|
321,267
|
313,904
|
|||||||||
Assets under management per financial statements
|
642,083
|
650,563
|
642,660
|
|||||||||
Mutual funds
|
184,952
|
182,160
|
161,933
|
|||||||||
Institutional advisory accounts (excluding segregated funds)
|
87,045
|
86,916
|
75,428
|
|||||||||
Other funds
|
6,976
|
7,094
|
6,217
|
|||||||||
Total assets under management
|
921,056
|
926,733
|
886,238
|
|||||||||
Other assets under administration
|
85,015
|
85,127
|
79,719
|
|||||||||
Currency impact
|
-
|
(24,927
|
)
|
(34,923
|
)
|
|||||||
Constant currency assets under management and administration
|
$
|
1,006,071
|
$
|
986,933
|
$
|
931,034
|
Capital
|
||||||||||||
As at
|
||||||||||||
($ millions)
|
September 30, 2017
|
June 30,
2017
|
September 30,
2016
|
|||||||||
Total equity
|
$
|
43,755
|
$
|
44,225
|
$
|
43,315
|
||||||
Add AOCI loss on cash flow hedges
|
122
|
148
|
391
|
|||||||||
Add liabilities for capital instruments
|
7,903
|
7,630
|
8,134
|
|||||||||
Total capital
|
$
|
51,780
|
$
|
52,003
|
$
|
51,840
|
Quarterly Results
|
||||||||||||||||||||||||||||||||
($ millions, unaudited)
|
3Q17
|
2Q17
|
1Q17
|
4Q16
|
3Q16
|
2Q16
|
1Q16
|
4Q15
|
||||||||||||||||||||||||
Core EBITDA
|
$
|
344
|
$
|
369
|
$
|
335
|
$
|
306
|
$
|
288
|
$
|
288
|
$
|
285
|
$
|
302
|
||||||||||||||||
Amortization of deferred acquisition
costs and other depreciation
|
84
|
88
|
85
|
85
|
89
|
77
|
85
|
84
|
||||||||||||||||||||||||
Amortization of deferred sales
commissions
|
23
|
23
|
28
|
24
|
24
|
26
|
29
|
22
|
||||||||||||||||||||||||
Core earnings before income taxes
|
237
|
258
|
222
|
197
|
175
|
185
|
171
|
196
|
||||||||||||||||||||||||
Core income tax (expense) recovery
|
(31
|
)
|
(51
|
)
|
(40
|
)
|
(19
|
)
|
(16
|
)
|
(33
|
)
|
(31
|
)
|
(41
|
)
|
||||||||||||||||
Core earnings
|
$
|
206
|
$
|
207
|
$
|
182
|
$
|
178
|
$
|
159
|
$
|
152
|
$
|
140
|
$
|
155
|
G4 |
Caution regarding forward-looking statements
|
For the
|
three months ended
September 30,
|
nine months ended
September 30,
|
||||||||||||||
(Canadian $ in millions, unaudited)
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
Net income
|
$
|
1,256
|
$
|
1,197
|
$
|
3,961
|
$
|
2,968
|
||||||||
Other comprehensive income ("OCI") (loss), net of tax
|
||||||||||||||||
Items that may be subsequently reclassified to net income:
|
||||||||||||||||
Foreign exchange gains (losses) on:
|
||||||||||||||||
Translation of foreign operations
|
(1,472
|
)
|
357
|
(2,536
|
)
|
(1,243
|
)
|
|||||||||
Net investment hedges
|
170
|
(66
|
)
|
250
|
142
|
|||||||||||
Available-for-sale financial securities:
|
||||||||||||||||
Unrealized gains (losses) arising during the period
|
(23
|
)
|
46
|
407
|
845
|
|||||||||||
Reclassification of net realized gains and impairments to net income
|
(12
|
)
|
(230
|
)
|
-
|
(517
|
)
|
|||||||||
Cash flow hedges:
|
||||||||||||||||
Unrealized gains (losses) arising during the period
|
23
|
21
|
102
|
(135
|
)
|
|||||||||||
Reclassification of realized losses to net income
|
3
|
3
|
8
|
8
|
||||||||||||
Share of other comprehensive income of associates
|
-
|
-
|
1
|
-
|
||||||||||||
Total items that may be subsequently reclassified to net income
|
(1,311
|
)
|
131
|
(1,768
|
)
|
(900
|
)
|
|||||||||
Items that will not be reclassified to net income:
|
||||||||||||||||
Change in pension and other post-employment plans
|
8
|
(3
|
)
|
14
|
14
|
|||||||||||
Total items that will not be reclassified to net income
|
8
|
(3
|
)
|
14
|
14
|
|||||||||||
Other comprehensive income (loss), net of tax
|
(1,303
|
)
|
128
|
(1,754
|
)
|
(886
|
)
|
|||||||||
Total comprehensive income (loss), net of tax
|
$
|
(47
|
)
|
$
|
1,325
|
$
|
2,207
|
$
|
2,082
|
|||||||
Total comprehensive income (loss) attributed to:
|
||||||||||||||||
Non-controlling interests
|
$
|
33
|
$
|
67
|
$
|
148
|
$
|
121
|
||||||||
Participating policyholders
|
118
|
13
|
103
|
(18
|
)
|
|||||||||||
Shareholders
|
(198
|
)
|
1,245
|
1,956
|
1,979
|
For the nine months ended September 30,
|
||||||||
(Canadian $ in millions, unaudited)
|
2017
|
2016
|
||||||
Preferred shares
|
||||||||
Balance, beginning of period
|
$
|
3,577
|
$
|
2,693
|
||||
Issued during the period (note 9)
|
-
|
425
|
||||||
Issuance costs, net of tax
|
-
|
(8
|
)
|
|||||
Balance, end of period
|
3,577
|
3,110
|
||||||
Common shares
|
||||||||
Balance, beginning of period
|
22,865
|
22,799
|
||||||
Issued on exercise of stock options
|
65
|
20
|
||||||
Balance, end of period
|
22,930
|
22,819
|
||||||
Contributed surplus
|
||||||||
Balance, beginning of period
|
284
|
277
|
||||||
Exercise of stock options and deferred share units
|
(11
|
)
|
(4
|
)
|
||||
Stock option expense
|
13
|
16
|
||||||
Balance, end of period
|
286
|
289
|
||||||
Shareholders' retained earnings
|
||||||||
Balance, beginning of period
|
9,759
|
8,398
|
||||||
Net income attributed to shareholders
|
3,710
|
2,866
|
||||||
Preferred share dividends
|
(119
|
)
|
(100
|
)
|
||||
Common share dividends
|
(1,215
|
)
|
(1,068
|
)
|
||||
Balance, end of period
|
12,135
|
10,096
|
||||||
Shareholders' accumulated other comprehensive income (loss) ("AOCI")
|
||||||||
Balance, beginning of period
|
5,347
|
6,992
|
||||||
Change in actuarial gains (losses) on pension and other post-employment plans
|
14
|
14
|
||||||
Change in unrealized foreign exchange gains (losses) of net foreign operations
|
(2,286
|
)
|
(1,101
|
)
|
||||
Change in unrealized gains (losses) on available-for-sale financial securities
|
407
|
327
|
||||||
Change in unrealized gains (losses) on derivative instruments designated as cash flow hedges
|
110
|
(127
|
)
|
|||||
Share of other comprehensive income of associates
|
1
|
-
|
||||||
Balance, end of period
|
3,593
|
6,105
|
||||||
Total shareholders' equity, end of period
|
42,521
|
42,419
|
||||||
Participating policyholders' equity
|
||||||||
Balance, beginning of period
|
248
|
187
|
||||||
Net income (loss) attributed to participating policyholders
|
103
|
(18
|
)
|
|||||
Balance, end of period
|
351
|
169
|
||||||
Non-controlling interests
|
||||||||
Balance, beginning of period
|
743
|
592
|
||||||
Net income attributed to non-controlling interests
|
148
|
120
|
||||||
Other comprehensive income attributed to non-controlling interests
|
-
|
1
|
||||||
Contributions (distributions), net
|
(8
|
)
|
14
|
|||||
Balance, end of period
|
883
|
727
|
||||||
Total equity, end of period
|
$
|
43,755
|
$
|
43,315
|
||||
The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements.
|
For the nine months ended September 30,
|
||||||||
(Canadian $ in millions, unaudited)
|
2017
|
2016
|
||||||
Operating activities
|
||||||||
Net income
|
$
|
3,961
|
$
|
2,968
|
||||
Adjustments:
|
||||||||
Increase in insurance contract liabilities
|
10,104
|
29,658
|
||||||
Increase (decrease) in investment contract liabilities
|
142
|
(12
|
)
|
|||||
(Increase) decrease in reinsurance assets
|
2,120
|
(746
|
)
|
|||||
Amortization of (premium) discount on invested assets
|
178
|
41
|
||||||
Other amortization
|
405
|
549
|
||||||
Net realized and unrealized (gains) losses and impairments on assets
|
(3,962
|
)
|
(20,172
|
)
|
||||
Deferred income tax expense
|
345
|
343
|
||||||
Stock option expense
|
13
|
16
|
||||||
Cash provided by operating activities before undernoted item
|
13,306
|
12,645
|
||||||
Changes in policy related and operating receivables and payables
|
(651
|
)
|
(455
|
)
|
||||
Cash provided by operating activities
|
12,655
|
12,190
|
||||||
Investing activities
|
||||||||
Purchases and mortgage advances
|
(67,555
|
)
|
(81,123
|
)
|
||||
Disposals and repayments
|
55,078
|
64,956
|
||||||
Change in investment broker net receivables and payables
|
194
|
31
|
||||||
Net cash decrease from purchase of subsidiaries and businesses
|
(10
|
)
|
(103
|
)
|
||||
Cash used in investing activities
|
(12,293
|
)
|
(16,239
|
)
|
||||
Financing activities
|
||||||||
Increase (decrease) in repurchase agreements and securities sold but not yet purchased
|
252
|
768
|
||||||
Issue of long-term debt, net (note 7)
|
-
|
3,538
|
||||||
Redemption of long-term debt (note 7)
|
(7
|
)
|
(8
|
)
|
||||
Issue of capital instruments, net (note 8)
|
1,740
|
479
|
||||||
Redemption of capital instruments (note 8)
|
(899
|
)
|
-
|
|||||
Secured borrowing from securitization transactions
|
643
|
722
|
||||||
Changes in deposits from Bank clients, net
|
176
|
198
|
||||||
Shareholders' dividends paid in cash
|
(1,334
|
)
|
(1,193
|
)
|
||||
Contributions from (distribution to) non-controlling interests, net
|
(8
|
)
|
14
|
|||||
Common shares issued, net (note 9)
|
65
|
20
|
||||||
Preferred shares issued, net (note 9)
|
-
|
417
|
||||||
Cash provided by financing activities
|
628
|
4,955
|
||||||
Cash and short-term securities
|
||||||||
Increase during the period
|
990
|
906
|
||||||
Effect of foreign exchange rate changes on cash and short-term securities
|
(718
|
)
|
(394
|
)
|
||||
Balance, beginning of period
|
14,238
|
17,002
|
||||||
Balance, end of period
|
14,510
|
17,514
|
||||||
Cash and short-term securities
|
||||||||
Beginning of period
|
||||||||
Gross cash and short-term securities
|
15,151
|
17,885
|
||||||
Net payments in transit, included in other liabilities
|
(913
|
)
|
(883
|
)
|
||||
Net cash and short-term securities, beginning of period
|
14,238
|
17,002
|
||||||
End of period
|
||||||||
Gross cash and short-term securities
|
15,251
|
18,179
|
||||||
Net payments in transit, included in other liabilities
|
(741
|
)
|
(665
|
)
|
||||
Net cash and short-term securities, end of period
|
$
|
14,510
|
$
|
17,514
|
||||
Supplemental disclosures on cash flow information
|
||||||||
Interest received
|
$
|
7,907
|
$
|
7,856
|
||||
Interest paid
|
763
|
650
|
||||||
Income taxes paid
|
612
|
669
|
||||||
The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements.
|
Note 1 |
Nature of Operations and Significant Accounting Policies
|
Note 2 |
Accounting and Reporting Changes
|
(i) |
Amendments to IAS 28 "Investments in Associates and Joint Ventures"
|
(ii) |
Amendments to IFRS 9 "Financial Instruments"
|
Note 3 |
Invested Assets and Investment Income
|
(a) |
Carrying values and fair values of invested assets
|
As at September 30, 2017
|
FVTPL
(1)
|
AFS
(2)
|
Other
(3)
|
Total carrying
value
|
Total fair
value
|
|||||||||||||||
Cash and short-term securities
(4)
|
$
|
433
|
$
|
10,894
|
$
|
3,924
|
$
|
15,251
|
$
|
15,251
|
||||||||||
Debt securities
(5)
|
||||||||||||||||||||
Canadian government and agency
|
17,125
|
4,278
|
-
|
21,403
|
21,403
|
|||||||||||||||
U.S. government and agency
|
10,737
|
15,039
|
-
|
25,776
|
25,776
|
|||||||||||||||
Other government and agency
|
17,039
|
2,773
|
-
|
19,812
|
19,812
|
|||||||||||||||
Corporate
|
93,175
|
5,149
|
-
|
98,324
|
98,324
|
|||||||||||||||
Mortgage/asset-backed securities
|
2,910
|
251
|
-
|
3,161
|
3,161
|
|||||||||||||||
Public equities
|
17,327
|
3,103
|
-
|
20,430
|
20,430
|
|||||||||||||||
Mortgages
|
-
|
-
|
44,639
|
44,639
|
46,005
|
|||||||||||||||
Private placements
|
-
|
-
|
31,033
|
31,033
|
33,150
|
|||||||||||||||
Policy loans
|
-
|
-
|
5,739
|
5,739
|
5,739
|
|||||||||||||||
Loans to Bank clients
|
-
|
-
|
1,735
|
1,735
|
1,738
|
|||||||||||||||
Real estate
|
||||||||||||||||||||
Own use property
|
-
|
-
|
1,322
|
1,322
|
2,448
|
|||||||||||||||
Investment property
|
-
|
-
|
12,649
|
12,649
|
12,649
|
|||||||||||||||
Other invested assets
|
||||||||||||||||||||
Alternative long-duration assets
(6)
|
11,447
|
89
|
8,588
|
20,124
|
20,351
|
|||||||||||||||
Various other
|
141
|
-
|
3,567
|
3,708
|
3,707
|
|||||||||||||||
Total invested assets
|
$
|
170,334
|
$
|
41,576
|
$
|
113,196
|
$
|
325,106
|
$
|
329,944
|
||||||||||
As at December 31, 2016
|
FVTPL
(1)
|
AFS
(2)
|
Other
(3)
|
Total carrying value
|
Total fair value
|
|||||||||||||||
Cash and short-term securities
(4)
|
$
|
269
|
$
|
11,705
|
$
|
3,177
|
$
|
15,151
|
$
|
15,151
|
||||||||||
Debt securities
(5)
|
||||||||||||||||||||
Canadian government and agency
|
18,030
|
6,715
|
-
|
24,745
|
24,745
|
|||||||||||||||
U.S. government and agency
|
13,971
|
13,333
|
-
|
27,304
|
27,304
|
|||||||||||||||
Other government and agency
|
18,629
|
2,312
|
-
|
20,941
|
20,941
|
|||||||||||||||
Corporate
|
87,374
|
5,041
|
-
|
92,415
|
92,415
|
|||||||||||||||
Mortgage/asset-backed securities
|
2,886
|
331
|
-
|
3,217
|
3,217
|
|||||||||||||||
Public equities
|
16,531
|
2,965
|
-
|
19,496
|
19,496
|
|||||||||||||||
Mortgages
|
-
|
-
|
44,193
|
44,193
|
45,665
|
|||||||||||||||
Private placements
|
-
|
-
|
29,729
|
29,729
|
31,459
|
|||||||||||||||
Policy loans
|
-
|
-
|
6,041
|
6,041
|
6,041
|
|||||||||||||||
Loans to Bank clients
|
-
|
-
|
1,745
|
1,745
|
1,746
|
|||||||||||||||
Real estate
|
||||||||||||||||||||
Own use property
|
-
|
-
|
1,376
|
1,376
|
2,524
|
|||||||||||||||
Investment property
|
-
|
-
|
12,756
|
12,756
|
12,756
|
|||||||||||||||
Other invested assets
|
||||||||||||||||||||
Alternative long-duration assets
(6)
|
10,707
|
96
|
8,048
|
18,851
|
19,193
|
|||||||||||||||
Various other
|
164
|
-
|
3,745
|
3,909
|
3,910
|
|||||||||||||||
Total invested assets
|
$
|
168,561
|
$
|
42,498
|
$
|
110,810
|
$
|
321,869
|
$
|
326,563
|
(1) |
The FVTPL classification was elected for securities backing insurance contract liabilities to substantially reduce any accounting mismatch arising from changes in the value of these assets and changes in the value of the related insurance contract liabilities. There would otherwise be a mismatch if the available-for-sale ("AFS") classification was selected because changes in insurance contract liabilities are recognized in net income rather than in
OCI.
|
(2) |
Securities that are designated as AFS are not actively traded by the Company but sales do occur as circumstances warrant. Such sales result in a reclassification of any accumulated unrealized gain (loss) in
AOCI to net income as a realized gain (loss).
|
(3) |
Primarily includes assets classified as loans and carried at amortized cost, own use property, investment property, equity method accounted investments, oil and gas investments, and leveraged leases.
|
(4) |
Includes short-term securities with maturities of less than one year at acquisition amounting to $3,075 (December 31, 2016 – $3,111), cash equivalents with maturities of less than 90 days at acquisition amounting to $8,252 (December 31, 2016 – $8,863) and cash of $3,924 (December 31, 2016 – $3,177).
|
(5) |
Debt securities include securities which were acquired with maturities of less than one year and less than 90 days of $702 and $62, respectively (December 31, 2016 – $893 and $192, respectively).
|
(6) |
Includes investments in private equity of $4,820, power and infrastructure of $7,079, oil and gas of $2,663, timber and agriculture sectors of $5,037 and various other invested assets of $525 (December 31, 2016 – $4,619, $6,679, $2,093, $4,972 and $487, respectively).
|
three months ended
|
nine months ended
|
|||||||||||||||
September 30,
|
September 30,
|
|||||||||||||||
For the
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
Interest income
|
$
|
2,580
|
$
|
2,631
|
$
|
7,923
|
$
|
7,854
|
||||||||
Dividend, rental and other income
|
686
|
517
|
1,963
|
1,478
|
||||||||||||
Net recoveries (impairments and provisions)
|
(10
|
)
|
(15
|
)
|
(7
|
)
|
(162
|
)
|
||||||||
Other
|
53
|
435
|
191
|
911
|
||||||||||||
3,309
|
3,568
|
10,070
|
10,081
|
|||||||||||||
Realized and unrealized gains (losses) on assets supporting insurance and investment contract liabilities and on the macro equity hedging program
|
||||||||||||||||
Debt securities
|
(899
|
)
|
297
|
1,960
|
8,893
|
|||||||||||
Public equities
|
492
|
616
|
1,439
|
819
|
||||||||||||
Mortgages
|
31
|
17
|
49
|
60
|
||||||||||||
Private placements
|
24
|
(6
|
)
|
33
|
(100
|
)
|
||||||||||
Real estate
|
86
|
122
|
279
|
116
|
||||||||||||
Other invested assets
|
213
|
417
|
283
|
639
|
||||||||||||
Derivatives, including macro equity hedging program
|
(1,110
|
)
|
(692
|
)
|
(1,313
|
)
|
7,128
|
|||||||||
(1,163
|
)
|
771
|
2,730
|
17,555
|
||||||||||||
Total investment income
|
$
|
2,146
|
$
|
4,339
|
$
|
12,800
|
$
|
27,636
|
(c) |
Fair value measurement
|
As at September 30, 2017
|
Total fair value
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
Cash and short-term securities
|
||||||||||||||||
FVTPL
|
$
|
433
|
$
|
-
|
$
|
433
|
$
|
-
|
||||||||
AFS
|
10,894
|
-
|
10,894
|
-
|
||||||||||||
Other
|
3,924
|
3,924
|
-
|
-
|
||||||||||||
Debt securities
|
||||||||||||||||
FVTPL
|
||||||||||||||||
Canadian government and agency
|
17,125
|
-
|
17,125
|
-
|
||||||||||||
U.S. government and agency
|
10,737
|
-
|
10,737
|
-
|
||||||||||||
Other government and agency
|
17,039
|
-
|
16,815
|
224
|
||||||||||||
Corporate
|
93,175
|
2
|
92,472
|
701
|
||||||||||||
Residential mortgage/asset-backed securities
|
8
|
-
|
7
|
1
|
||||||||||||
Commercial mortgage/asset-backed securities
|
830
|
-
|
830
|
-
|
||||||||||||
Other securitized assets
|
2,072
|
-
|
2,045
|
27
|
||||||||||||
AFS
|
||||||||||||||||
Canadian government and agency
|
4,278
|
-
|
4,278
|
-
|
||||||||||||
U.S. government and agency
|
15,038
|
-
|
15,038
|
-
|
||||||||||||
Other government and agency
|
2,773
|
-
|
2,730
|
43
|
||||||||||||
Corporate
|
5,150
|
-
|
5,065
|
85
|
||||||||||||
Residential mortgage/asset-backed securities
|
41
|
-
|
41
|
-
|
||||||||||||
Commercial mortgage/asset-backed securities
|
122
|
-
|
122
|
-
|
||||||||||||
Other securitized assets
|
88
|
-
|
87
|
1
|
||||||||||||
Public equities
|
||||||||||||||||
FVTPL
|
17,327
|
17,323
|
-
|
4
|
||||||||||||
AFS
|
3,103
|
3,101
|
2
|
-
|
||||||||||||
Real estate - investment property
(1)
|
12,649
|
-
|
-
|
12,649
|
||||||||||||
Other invested assets
(2)
|
15,639
|
-
|
-
|
15,639
|
||||||||||||
Segregated funds net assets
(3)
|
316,977
|
279,051
|
33,735
|
4,191
|
||||||||||||
Total
|
$
|
549,422
|
$
|
303,401
|
$
|
212,456
|
$
|
33,565
|
As at December 31, 2016
|
Total fair value
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
Cash and short-term securities
|
||||||||||||||||
FVTPL
|
$
|
269
|
$
|
-
|
$
|
269
|
$
|
-
|
||||||||
AFS
|
11,705
|
-
|
11,705
|
-
|
||||||||||||
Other
|
3,177
|
3,177
|
-
|
-
|
||||||||||||
Debt securities
|
||||||||||||||||
FVTPL
|
||||||||||||||||
Canadian government and agency
|
18,030
|
-
|
18,030
|
-
|
||||||||||||
U.S. government and agency
|
13,971
|
-
|
13,971
|
-
|
||||||||||||
Other government and agency
|
18,629
|
-
|
18,357
|
272
|
||||||||||||
Corporate
|
87,374
|
2
|
86,721
|
651
|
||||||||||||
Residential mortgage/asset-backed securities
|
10
|
-
|
8
|
2
|
||||||||||||
Commercial mortgage/asset-backed securities
|
680
|
-
|
674
|
6
|
||||||||||||
Other securitized assets
|
2,196
|
-
|
2,161
|
35
|
||||||||||||
AFS
|
||||||||||||||||
Canadian government and agency
|
6,715
|
-
|
6,715
|
-
|
||||||||||||
U.S. government and agency
|
13,333
|
-
|
13,333
|
-
|
||||||||||||
Other government and agency
|
2,312
|
-
|
2,261
|
51
|
||||||||||||
Corporate
|
5,041
|
-
|
4,967
|
74
|
||||||||||||
Residential mortgage/asset-backed securities
|
65
|
-
|
64
|
1
|
||||||||||||
Commercial mortgage/asset-backed securities
|
123
|
-
|
121
|
2
|
||||||||||||
Other securitized assets
|
143
|
-
|
141
|
2
|
||||||||||||
Public equities
|
||||||||||||||||
FVTPL
|
16,531
|
16,524
|
-
|
7
|
||||||||||||
AFS
|
2,965
|
2,963
|
2
|
-
|
||||||||||||
Real estate - investment property
(1)
|
12,756
|
-
|
-
|
12,756
|
||||||||||||
Other invested assets
(2)
|
14,849
|
-
|
-
|
14,849
|
||||||||||||
Segregated funds net assets
(3)
|
315,177
|
278,066
|
32,537
|
4,574
|
||||||||||||
Total
|
$
|
546,051
|
$
|
300,732
|
$
|
212,037
|
$
|
33,282
|
(1) |
For real estate investment property, the significant unobservable inputs are capitalization rates (ranging from 3.50% to 9.00% during the period and ranging from 3.75% to 9.75% during the year 2016) and terminal capitalization rates (ranging from 4.1% to 9.25% during the period and ranging from 4.1% to 10.00% during the year 2016). Holding other factors constant, a lower capitalization or terminal capitalization rate will tend to increase the fair value of an investment property. Changes in fair value based on variations in unobservable inputs generally cannot be extrapolated because the relationship between the directional changes of each input is not usually linear.
|
(2) |
Other invested assets measured at fair value are held primarily in the power and infrastructure and timber sectors. The significant inputs used in the valuation of the Company's power and infrastructure investments are primarily future distributable cash flows, terminal values and discount rates. Holding other factors constant, an increase to future distributable cash flows or terminal values would tend to increase the fair value of a power and infrastructure investment, while an increase in the discount rate would have the opposite effect. Discount rates during the period ranged from 9.20% to 15.0% (for the year ended December 31, 2016 – ranged from 9.63% to 16.0%). Disclosure of distributable cash flow and terminal value ranges are not meaningful given the disparity in estimates by project. The significant inputs used in the valuation of the Company's investments in timberland are timber prices and discount rates. Holding other factors constant, an increase to timber prices would tend to increase the fair value of a timberland investment, while an increase in the discount rates would have the opposite effect. Discount rates during the period ranged from 5.0% to 7.5% (for the year ended December 31, 2016 – ranged from 5.0% to 7.5%). A range of prices for timber is
not meaningful as the market price depends on factors such as property location and proximity to markets and export yards.
|
(3) |
Segregated funds net assets are measured at fair value. The Company's Level 3 segregated funds assets are predominantly invested in timberland properties valued as described above.
|
As at September 30, 2017
|
Carrying value
|
Total fair value
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||||
Mortgages
|
$
|
44,639
|
$
|
46,005
|
$
|
-
|
$
|
-
|
$
|
46,005
|
||||||||||
Private placements
|
31,033
|
33,150
|
-
|
27,294
|
5,856
|
|||||||||||||||
Policy loans
|
5,739
|
5,739
|
-
|
5,739
|
-
|
|||||||||||||||
Loans to Bank clients
|
1,735
|
1,738
|
-
|
1,738
|
-
|
|||||||||||||||
Real estate - own use property
|
1,322
|
2,448
|
-
|
-
|
2,448
|
|||||||||||||||
Other invested assets
(1)
|
8,193
|
8,419
|
62
|
-
|
8,357
|
|||||||||||||||
Total invested assets disclosed at fair value
|
$
|
92,661
|
$
|
97,499
|
$
|
62
|
$
|
34,771
|
$
|
62,666
|
||||||||||
As at December 31, 2016
|
Carrying value
|
Total fair value
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||||
Mortgages
|
$
|
44,193
|
$
|
45,665
|
$
|
-
|
$
|
-
|
$
|
45,665
|
||||||||||
Private placements
|
29,729
|
31,459
|
-
|
26,073
|
5,386
|
|||||||||||||||
Policy loans
|
6,041
|
6,041
|
-
|
6,041
|
-
|
|||||||||||||||
Loans to Bank clients
|
1,745
|
1,746
|
-
|
1,746
|
-
|
|||||||||||||||
Real estate - own use property
|
1,376
|
2,524
|
-
|
-
|
2,524
|
|||||||||||||||
Other invested assets
(1)
|
7,911
|
8,254
|
54
|
-
|
8,200
|
|||||||||||||||
Total invested assets disclosed at fair value
|
$
|
90,995
|
$
|
95,689
|
$
|
54
|
$
|
33,860
|
$
|
61,775
|
(1) |
Other invested assets disclosed at fair value include $3,223 (December 31, 2016
–
$3,368) of leveraged leases which are disclosed at their carrying values as fair value is not routinely calculated on these investments.
|
For the three months ended September 30, 2017
|
Balance as at July 1, 2017
|
Net realized/ unrealized gains (losses) included in net income
(1)
|
Net realized/ unrealized gains (losses) included in AOCI
(2)
|
Purchases
|
Sales
(3)
|
Settlements
|
Transfer
into
Level 3
(4)
|
Transfer
out of
Level 3
(4)
|
Currency movement
|
Balance as at September 30, 2017
|
Change in unrealized gains (losses) on assets still held
|
|||||||||||||||||||||||||||||||||
Debt securities
|
||||||||||||||||||||||||||||||||||||||||||||
FVTPL
|
||||||||||||||||||||||||||||||||||||||||||||
Other government & agency
|
$
|
247
|
$
|
(7
|
)
|
$
|
-
|
$
|
9
|
$
|
(21
|
)
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
(4
|
)
|
$
|
224
|
$
|
(7
|
)
|
||||||||||||||||||
Corporate
|
674
|
12
|
-
|
45
|
(8
|
)
|
(1
|
)
|
-
|
-
|
(21
|
)
|
701
|
13
|
||||||||||||||||||||||||||||||
Residential mortgage/asset-backed securities
|
2
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(1
|
)
|
1
|
-
|
||||||||||||||||||||||||||||||||
Commercial mortgage/asset-backed securities
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||||||||||||
Other securitized assets
|
29
|
-
|
-
|
-
|
-
|
(2
|
)
|
-
|
-
|
-
|
27
|
-
|
||||||||||||||||||||||||||||||||
952
|
5
|
-
|
54
|
(29
|
)
|
(3
|
)
|
-
|
-
|
(26
|
)
|
953
|
6
|
|||||||||||||||||||||||||||||||
AFS
|
||||||||||||||||||||||||||||||||||||||||||||
Other government & agency
|
53
|
-
|
(4
|
)
|
2
|
(7
|
)
|
-
|
-
|
-
|
(1
|
)
|
43
|
-
|
||||||||||||||||||||||||||||||
Corporate
|
84
|
-
|
4
|
2
|
(4
|
)
|
-
|
-
|
-
|
(1
|
)
|
85
|
-
|
|||||||||||||||||||||||||||||||
Residential mortgage/asset-
backed securities
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||||||||||||
Commercial mortgage/asset-backed securities
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||||||||||||
Other securitized assets
|
1
|
-
|
-
|
-
|
-
|
(1
|
)
|
-
|
-
|
1
|
1
|
-
|
||||||||||||||||||||||||||||||||
138
|
-
|
-
|
4
|
(11
|
)
|
(1
|
)
|
-
|
-
|
(1
|
)
|
129
|
-
|
|||||||||||||||||||||||||||||||
Public equities
|
||||||||||||||||||||||||||||||||||||||||||||
FVTPL
|
7
|
-
|
-
|
-
|
(3
|
)
|
-
|
-
|
-
|
-
|
4
|
-
|
||||||||||||||||||||||||||||||||
7
|
-
|
-
|
-
|
(3
|
)
|
-
|
-
|
-
|
-
|
4
|
-
|
|||||||||||||||||||||||||||||||||
Real estate - investment property
|
12,748
|
74
|
-
|
246
|
(120
|
)
|
-
|
-
|
-
|
(299
|
)
|
12,649
|
56
|
|||||||||||||||||||||||||||||||
Other invested assets
|
15,113
|
196
|
2
|
1,092
|
(77
|
)
|
(213
|
)
|
-
|
-
|
(474
|
)
|
15,639
|
160
|
||||||||||||||||||||||||||||||
27,861
|
270
|
2
|
1,338
|
(197
|
)
|
(213
|
)
|
-
|
-
|
(773
|
)
|
28,288
|
216
|
|||||||||||||||||||||||||||||||
Segregated funds net assets
|
4,231
|
34
|
-
|
56
|
(37
|
)
|
(5
|
)
|
-
|
-
|
(88
|
)
|
4,191
|
29
|
||||||||||||||||||||||||||||||
Total
|
$
|
33,189
|
$
|
309
|
$
|
2
|
$
|
1,452
|
$
|
(277
|
)
|
$
|
(222
|
)
|
$
|
-
|
$
|
-
|
$
|
(888
|
)
|
$
|
33,565
|
$
|
251
|
For the three months ended
September 30, 2016
|
Balance as at July 1, 2016
|
Net realized/ unrealized gains (losses) included in net income
(1)
|
Net realized/ unrealized gains (losses) included in AOCI
(2)
|
Purchases
|
Sales
(3)
|
Settlements
|
Transfer
into
Level 3
(4)
|
Transfer
out of
Level 3
(4)
|
Currency movement
|
Balance as at September 30, 2016
|
Change in unrealized gains (losses) on assets still held
|
|||||||||||||||||||||||||||||||||
Debt securities
|
||||||||||||||||||||||||||||||||||||||||||||
FVTPL
|
||||||||||||||||||||||||||||||||||||||||||||
Other government & agency
|
$
|
298
|
$
|
6
|
$
|
-
|
$
|
15
|
$
|
(4
|
)
|
$
|
(23
|
)
|
$
|
-
|
$
|
-
|
$
|
(4
|
)
|
$
|
288
|
$
|
6
|
|||||||||||||||||||
Corporate
|
783
|
11
|
-
|
10
|
(1
|
)
|
(68
|
)
|
-
|
-
|
3
|
738
|
9
|
|||||||||||||||||||||||||||||||
Residential mortgage/asset-
backed securities
|
2
|
(1
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
2
|
1
|
||||||||||||||||||||||||||||||||
Commercial mortgage/asset-backed securities
|
38
|
(1
|
)
|
-
|
-
|
(16
|
)
|
(1
|
)
|
-
|
-
|
-
|
20
|
1
|
||||||||||||||||||||||||||||||
Other securitized assets
|
43
|
-
|
-
|
-
|
-
|
(3
|
)
|
-
|
-
|
(1
|
)
|
39
|
-
|
|||||||||||||||||||||||||||||||
1,164
|
15
|
-
|
25
|
(21
|
)
|
(95
|
)
|
-
|
-
|
(1
|
)
|
1,087
|
17
|
|||||||||||||||||||||||||||||||
AFS
|
||||||||||||||||||||||||||||||||||||||||||||
Other government & agency
|
48
|
-
|
1
|
5
|
-
|
-
|
-
|
-
|
-
|
54
|
-
|
|||||||||||||||||||||||||||||||||
Corporate
|
85
|
-
|
-
|
5
|
-
|
-
|
-
|
-
|
(1
|
)
|
89
|
-
|
||||||||||||||||||||||||||||||||
Residential mortgage/asset-
backed securities
|
1
|
(1
|
)
|
1
|
-
|
-
|
1
|
-
|
-
|
(1
|
)
|
1
|
-
|
|||||||||||||||||||||||||||||||
Commercial mortgage/asset-backed securities
|
2
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2
|
-
|
|||||||||||||||||||||||||||||||||
Other securitized assets
|
4
|
-
|
-
|
-
|
-
|
(1
|
)
|
-
|
-
|
-
|
3
|
-
|
||||||||||||||||||||||||||||||||
140
|
(1
|
)
|
2
|
10
|
-
|
-
|
-
|
-
|
(2
|
)
|
149
|
-
|
||||||||||||||||||||||||||||||||
Public equities
|
||||||||||||||||||||||||||||||||||||||||||||
FVTPL
|
4
|
-
|
-
|
4
|
-
|
-
|
-
|
-
|
(1
|
)
|
7
|
-
|
||||||||||||||||||||||||||||||||
4
|
-
|
-
|
4
|
-
|
-
|
-
|
-
|
(1
|
)
|
7
|
-
|
|||||||||||||||||||||||||||||||||
Real estate - investment property
|
12,066
|
127
|
-
|
337
|
(39
|
)
|
-
|
-
|
-
|
79
|
12,570
|
119
|
||||||||||||||||||||||||||||||||
Other invested assets
|
13,190
|
410
|
1
|
581
|
(34
|
)
|
(190
|
)
|
-
|
-
|
110
|
14,068
|
421
|
|||||||||||||||||||||||||||||||
25,256
|
537
|
1
|
918
|
(73
|
)
|
(190
|
)
|
-
|
-
|
189
|
26,638
|
540
|
||||||||||||||||||||||||||||||||
Segregated funds net assets
|
4,714
|
43
|
-
|
57
|
(149
|
)
|
(1
|
)
|
(13
|
)
|
(99
|
)
|
18
|
4,570
|
44
|
|||||||||||||||||||||||||||||
Total
|
$
|
31,278
|
$
|
594
|
$
|
3
|
$
|
1,014
|
$
|
(243
|
)
|
$
|
(286
|
)
|
$
|
(13
|
)
|
$
|
(99
|
)
|
$
|
203
|
$
|
32,451
|
$
|
601
|
(1) |
These amounts, except for the amount related to segregated funds net assets, are included in net investment income on the Consolidated Statements of Income.
|
(2) |
These amounts, except for the amount related to segregated funds net assets, are included in AOCI on the Consolidated Statements of Financial Position.
|
(4) |
For assets that are transferred into and/or out of Level 3, the Company uses the fair value of the assets at the beginning of period.
|
For the nine months ended September 30, 2017
|
Balance as at January 1, 2017
|
Net realized/ unrealized gains (losses) included in net income
(1)
|
Net realized/ unrealized gains (losses) included in AOCI
(2)
|
Purchases
|
Sales
(3)
|
Settlements
|
Transfer
into
Level 3
(4)
|
Transfer
out of
Level 3
(4)
|
Currency movement
|
Balance as at September 30, 2017
|
Change in unrealized gains (losses) on assets still held
|
|||||||||||||||||||||||||||||||||
Debt securities
|
||||||||||||||||||||||||||||||||||||||||||||
FVTPL
|
||||||||||||||||||||||||||||||||||||||||||||
Other government & agency
|
$
|
272
|
$
|
(3
|
)
|
$
|
-
|
$
|
21
|
$
|
(58
|
)
|
$
|
(6
|
)
|
$
|
-
|
$
|
-
|
$
|
(2
|
)
|
$
|
224
|
$
|
(2
|
)
|
|||||||||||||||||
Corporate
|
651
|
28
|
-
|
95
|
(33
|
)
|
(19
|
)
|
24
|
(21
|
)
|
(24
|
)
|
701
|
14
|
|||||||||||||||||||||||||||||
Residential mortgage/asset-
backed securities
|
2
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(1
|
)
|
1
|
(1
|
)
|
|||||||||||||||||||||||||||||||
Commercial mortgage/asset-backed securities
|
6
|
-
|
-
|
-
|
(5
|
)
|
(1
|
)
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||||||||||
Other securitized assets
|
35
|
-
|
-
|
-
|
-
|
(6
|
)
|
-
|
-
|
(2
|
)
|
27
|
-
|
|||||||||||||||||||||||||||||||
966
|
25
|
-
|
116
|
(96
|
)
|
(32
|
)
|
24
|
(21
|
)
|
(29
|
)
|
953
|
11
|
||||||||||||||||||||||||||||||
AFS
|
||||||||||||||||||||||||||||||||||||||||||||
Other government & agency
|
51
|
-
|
(3
|
)
|
13
|
(15
|
)
|
(2
|
)
|
-
|
-
|
(1
|
)
|
43
|
-
|
|||||||||||||||||||||||||||||
Corporate
|
74
|
-
|
4
|
19
|
(10
|
)
|
(2
|
)
|
-
|
-
|
-
|
85
|
-
|
|||||||||||||||||||||||||||||||
Residential mortgage/asset-
backed securities
|
1
|
-
|
(1
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||||||||
Commercial mortgage/asset-backed securities
|
2
|
-
|
-
|
-
|
(1
|
)
|
(1
|
)
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||||||||||
Other securitized assets
|
2
|
-
|
-
|
-
|
-
|
(1
|
)
|
-
|
-
|
-
|
1
|
-
|
||||||||||||||||||||||||||||||||
130
|
-
|
-
|
32
|
(26
|
)
|
(6
|
)
|
-
|
-
|
(1
|
)
|
129
|
-
|
|||||||||||||||||||||||||||||||
Public equities
|
||||||||||||||||||||||||||||||||||||||||||||
FVTPL
|
7
|
-
|
-
|
-
|
(3
|
)
|
-
|
-
|
-
|
-
|
4
|
-
|
||||||||||||||||||||||||||||||||
7
|
-
|
-
|
-
|
(3
|
)
|
-
|
-
|
-
|
-
|
4
|
-
|
|||||||||||||||||||||||||||||||||
Real estate - investment property
|
12,756
|
239
|
-
|
1,060
|
(849
|
)
|
-
|
-
|
-
|
(557
|
)
|
12,649
|
207
|
|||||||||||||||||||||||||||||||
Other invested assets
|
14,849
|
258
|
1
|
2,466
|
(436
|
)
|
(641
|
)
|
-
|
-
|
(858
|
)
|
15,639
|
80
|
||||||||||||||||||||||||||||||
27,605
|
497
|
1
|
3,526
|
(1,285
|
)
|
(641
|
)
|
-
|
-
|
(1,415
|
)
|
28,288
|
287
|
|||||||||||||||||||||||||||||||
Segregated funds net assets
|
4,574
|
59
|
-
|
107
|
(180
|
)
|
(19
|
)
|
-
|
(184
|
)
|
(166
|
)
|
4,191
|
35
|
|||||||||||||||||||||||||||||
Total
|
$
|
33,282
|
$
|
581
|
$
|
1
|
$
|
3,781
|
$
|
(1,590
|
)
|
$
|
(698
|
)
|
$
|
24
|
$
|
(205
|
)
|
$
|
(1,611
|
)
|
$
|
33,565
|
$
|
333
|
For the nine months ended September 30, 2016
|
Balance as at January 1, 2016
|
Net realized/ unrealized gains (losses) included in net income
(1)
|
Net realized/ unrealized gains (losses) included in AOCI
(2)
|
Purchases
|
Sales
(3)
|
Settlements
|
Transfer
into
Level 3
(4)
|
Transfer
out of
Level 3
(4)
|
Currency movement
|
Balance as at September 30, 2016
|
Change in unrealized gains (losses) on assets still held
|
|||||||||||||||||||||||||||||||||
Debt securities
|
||||||||||||||||||||||||||||||||||||||||||||
FVTPL
|
||||||||||||||||||||||||||||||||||||||||||||
Other government & agency
|
$
|
310
|
$
|
18
|
$
|
-
|
$
|
20
|
$
|
(27
|
)
|
$
|
(27
|
)
|
$
|
-
|
$
|
-
|
$
|
(6
|
)
|
$
|
288
|
$
|
17
|
|||||||||||||||||||
Corporate
|
903
|
18
|
-
|
73
|
(72
|
)
|
(115
|
)
|
-
|
(83
|
)
|
14
|
738
|
5
|
||||||||||||||||||||||||||||||
Residential mortgage/asset-
backed securities
|
15
|
(1
|
)
|
-
|
-
|
(11
|
)
|
(1
|
)
|
-
|
-
|
-
|
2
|
1
|
||||||||||||||||||||||||||||||
Commercial mortgage/asset-backed securities
|
70
|
-
|
-
|
-
|
(42
|
)
|
(4
|
)
|
-
|
-
|
(4
|
)
|
20
|
(2
|
)
|
|||||||||||||||||||||||||||||
Other securitized assets
|
48
|
1
|
-
|
-
|
(1
|
)
|
(6
|
)
|
-
|
-
|
(3
|
)
|
39
|
1
|
||||||||||||||||||||||||||||||
1,346
|
36
|
-
|
93
|
(153
|
)
|
(153
|
)
|
-
|
(83
|
)
|
1
|
1,087
|
22
|
|||||||||||||||||||||||||||||||
AFS
|
||||||||||||||||||||||||||||||||||||||||||||
Other government & agency
|
42
|
-
|
3
|
14
|
(5
|
)
|
-
|
-
|
-
|
-
|
54
|
-
|
||||||||||||||||||||||||||||||||
Corporate
|
90
|
-
|
(1
|
)
|
27
|
(25
|
)
|
(3
|
)
|
-
|
-
|
1
|
89
|
-
|
||||||||||||||||||||||||||||||
Residential mortgage/asset-
backed securities
|
8
|
(1
|
)
|
1
|
-
|
(6
|
)
|
-
|
-
|
-
|
(1
|
)
|
1
|
-
|
||||||||||||||||||||||||||||||
Commercial mortgage/asset-backed securities
|
4
|
-
|
-
|
-
|
-
|
(1
|
)
|
-
|
-
|
(1
|
)
|
2
|
-
|
|||||||||||||||||||||||||||||||
Other securitized assets
|
5
|
1
|
1
|
-
|
-
|
(3
|
)
|
-
|
-
|
(1
|
)
|
3
|
-
|
|||||||||||||||||||||||||||||||
149
|
-
|
4
|
41
|
(36
|
)
|
(7
|
)
|
-
|
-
|
(2
|
)
|
149
|
-
|
|||||||||||||||||||||||||||||||
Public equities
|
||||||||||||||||||||||||||||||||||||||||||||
FVTPL
|
1
|
-
|
-
|
6
|
-
|
-
|
-
|
-
|
-
|
7
|
-
|
|||||||||||||||||||||||||||||||||
1
|
-
|
-
|
6
|
-
|
-
|
-
|
-
|
-
|
7
|
-
|
||||||||||||||||||||||||||||||||||
Real estate - investment property
|
13,968
|
158
|
-
|
542
|
(1,661
|
)
|
-
|
-
|
-
|
(437
|
)
|
12,570
|
196
|
|||||||||||||||||||||||||||||||
Other invested assets
|
12,977
|
637
|
7
|
1,585
|
(58
|
)
|
(529
|
)
|
-
|
-
|
(551
|
)
|
14,068
|
682
|
||||||||||||||||||||||||||||||
26,945
|
795
|
7
|
2,127
|
(1,719
|
)
|
(529
|
)
|
-
|
-
|
(988
|
)
|
26,638
|
878
|
|||||||||||||||||||||||||||||||
Segregated funds net assets
|
4,656
|
114
|
-
|
334
|
(248
|
)
|
(18
|
)
|
(25
|
)
|
(103
|
)
|
(140
|
)
|
4,570
|
106
|
||||||||||||||||||||||||||||
Total
|
$
|
33,097
|
$
|
945
|
$
|
11
|
$
|
2,601
|
$
|
(2,156
|
)
|
$
|
(707
|
)
|
$
|
(25
|
)
|
$
|
(186
|
)
|
$
|
(1,129
|
)
|
$
|
32,451
|
$
|
1,006
|
(1) |
These amounts, except for the amount related to segregated funds net assets, are included in net investment income on the Consolidated Statements of Income.
|
(2) |
These amounts, except for the amount related to segregated funds net assets, are included in AOCI on the Consolidated Statements of Financial Position.
|
(3) |
Sales in 2017 include $619 of U.S. commercial real estate sold to the Hancock US Real Estate Fund, L.P., an associate of the Company which is a structured entity based on partnership voting rights. The Company provides management services to the fund and owns approximately 11.7% of its partnership interests. Sales in 2016 include $1,011 of U.S. commercial real estate sold to the Manulife US Real Estate Investment Trust in Singapore, an associate of the Company which is a structured entity based on unitholder voting rights. The Company provides management services to the trust and owns approximately 9.5% of its units.
|
(4) |
For assets that are transferred into and/or out of Level 3, the Company uses fair value of the assets at the beginning of period.
|
Remaining term to maturity
|
||||||||||||||||||||
As at September 30, 2017
|
Less than
1 year
|
1 to 3
years
|
3 to 5
years
|
Over 5
years
|
Total
|
|||||||||||||||
Derivative assets
|
$
|
465
|
$
|
719
|
$
|
621
|
$
|
14,409
|
$
|
16,214
|
||||||||||
Derivative liabilities
|
319
|
142
|
249
|
8,210
|
8,920
|
|||||||||||||||
Remaining term to maturity
|
||||||||||||||||||||
As at December 31, 2016
|
Less than
1 year
|
1 to 3
years
|
3 to 5
years
|
Over 5
years
|
Total
|
|||||||||||||||
Derivative assets
|
$
|
467
|
$
|
680
|
$
|
719
|
$
|
21,806
|
$
|
23,672
|
||||||||||
Derivative liabilities
|
593
|
595
|
511
|
12,452
|
14,151
|
As at September 30, 2017
|
Total fair value
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
Derivative assets
|
||||||||||||||||
Interest rate contracts
|
$
|
15,069
|
$
|
-
|
$
|
14,339
|
$
|
730
|
||||||||
Foreign exchange contracts
|
447
|
-
|
447
|
-
|
||||||||||||
Equity contracts
|
683
|
-
|
601
|
82
|
||||||||||||
Credit default swaps
|
15
|
-
|
15
|
-
|
||||||||||||
Total derivative assets
|
$
|
16,214
|
$
|
-
|
$
|
15,402
|
$
|
812
|
||||||||
Derivative liabilities
|
||||||||||||||||
Interest rate contracts
|
$
|
7,358
|
$
|
-
|
$
|
6,922
|
$
|
436
|
||||||||
Foreign exchange contracts
|
1,536
|
-
|
1,536
|
-
|
||||||||||||
Equity contracts
|
26
|
-
|
8
|
18
|
||||||||||||
Total derivative liabilities
|
$
|
8,920
|
$
|
-
|
$
|
8,466
|
$
|
454
|
||||||||
As at December 31, 2016
|
Total fair value
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
Derivative assets
|
||||||||||||||||
Interest rate contracts
|
$
|
22,602
|
$
|
-
|
$
|
22,045
|
$
|
557
|
||||||||
Foreign exchange contracts
|
362
|
-
|
361
|
1
|
||||||||||||
Equity contracts
|
690
|
-
|
182
|
508
|
||||||||||||
Credit default swaps
|
18
|
-
|
18
|
-
|
||||||||||||
Total derivative assets
|
$
|
23,672
|
$
|
-
|
$
|
22,606
|
$
|
1,066
|
||||||||
Derivative liabilities
|
||||||||||||||||
Interest rate contracts
|
$
|
11,984
|
$
|
-
|
$
|
11,114
|
$
|
870
|
||||||||
Foreign exchange contracts
|
2,133
|
-
|
2,133
|
-
|
||||||||||||
Equity contracts
|
34
|
-
|
1
|
33
|
||||||||||||
Total derivative liabilities
|
$
|
14,151
|
$
|
-
|
$
|
13,248
|
$
|
903
|
three months ended
September 30,
|
nine months ended
September 30,
|
|||||||||||||||
For the
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
Balance at the beginning of the period
|
$
|
757
|
$
|
1,628
|
$
|
163
|
$
|
350
|
||||||||
Net realized / unrealized gains (losses) included in:
|
||||||||||||||||
Net income
(1)
|
49
|
149
|
669
|
1,418
|
||||||||||||
OCI
(2)
|
-
|
10
|
(8
|
)
|
4
|
|||||||||||
Purchases
|
7
|
237
|
15
|
360
|
||||||||||||
Sales
|
-
|
25
|
-
|
(124
|
)
|
|||||||||||
Settlements
|
(5
|
)
|
-
|
(17
|
)
|
-
|
||||||||||
Transfers
|
||||||||||||||||
Into Level 3
(3)
|
-
|
-
|
-
|
-
|
||||||||||||
Out of Level 3
(3)
|
(438
|
)
|
(292
|
)
|
(446
|
)
|
(211
|
)
|
||||||||
Currency movement
|
(12
|
)
|
14
|
(18
|
)
|
(26
|
)
|
|||||||||
Balance at the end of the period
|
$
|
358
|
$
|
1,771
|
$
|
358
|
$
|
1,771
|
||||||||
Change in unrealized gains (losses) on instruments still held
|
$
|
30
|
$
|
170
|
$
|
471
|
$
|
1,505
|
(1) |
These amounts are included in investment income on the Consolidated Statements of Income.
|
(2) |
These amounts are included in AOCI on the Consolidated Statements of Financial Position.
|
(3) |
For items that are transferred into and out of Level 3, the Company uses the fair value of the items at the end and beginning of the period, respectively. Transfers into Level 3 occur when the inputs used to price the assets and liabilities lack observable market data (versus the previous period). Transfers out of Level 3 occur when inputs used to price the assets and liabilities become available from observable market data.
|
Note 5 |
Insurance and Investment Contract Liabilities
|
(a) |
Insurance and investment contracts
|
For the three and nine months ended September 30, 2017
|
||||||||||||
Assumption
|
Change in gross insurance and investment contract liabilities
|
Change in insurance and investment contract liabilities net of reinsurance
(1)
|
Change in net income attributed to shareholders (post-tax)
|
|||||||||
Mortality and morbidity updates
|
$
|
(26
|
)
|
$
|
(235
|
)
|
$
|
285
|
||||
Lapses and policyholder behaviour
|
1,057
|
1,019
|
(783
|
)
|
||||||||
Other updates
|
||||||||||||
ALDA and public equity investment return assumptions
|
1,4
0
3
|
1,296
|
(892
|
)
|
||||||||
Corporate spread assumptions
|
(554
|
)
|
(515
|
)
|
344
|
|||||||
Refinements to liability and tax cash flows
|
(1,273
|
)
|
(1,049
|
)
|
696
|
|||||||
Other
|
(339
|
)
|
(463
|
)
|
348
|
|||||||
Net impact
|
$
|
268
|
$
|
53
|
$
|
(2
|
)
|
For the three months ended
|
For the nine months ended
|
|||||||||||||||||||||||
September 30, 2016
|
September 30, 2016
|
|||||||||||||||||||||||
Assumption
|
Change in gross insurance and investment contract liabilities
|
Change in insurance and investment contract liabilities net of reinsurance
|
Change in net income attributed to shareholders (post-tax)
|
Change in gross insurance and investment contract liabilities
|
Change in insurance and investment contract liabilities net of reinsurance
|
Change in net income
attributed to shareholders
(post-tax)
|
||||||||||||||||||
JH Long Term Care triennial review
|
$
|
639
|
$
|
639
|
$
|
(415
|
)
|
$
|
639
|
$
|
639
|
$
|
(415
|
)
|
||||||||||
Mortality and morbidity updates
|
(12
|
)
|
(53
|
)
|
76
|
(12
|
)
|
(53
|
)
|
76
|
||||||||||||||
Lapses and policyholder behaviour
|
||||||||||||||||||||||||
U.S. Variable Annuities guaranteed minimum withdrawal benefit incidence and utilization
|
(1,024
|
)
|
(1,024
|
)
|
665
|
(1,024
|
)
|
(1,024
|
)
|
665
|
||||||||||||||
Other lapses and policyholder behaviour
|
509
|
427
|
(353
|
)
|
509
|
427
|
(353
|
)
|
||||||||||||||||
Economic reinvestment assumptions
|
459
|
443
|
(313
|
)
|
459
|
443
|
(313
|
)
|
||||||||||||||||
Other updates
|
650
|
250
|
(115
|
)
|
531
|
215
|
(103
|
)
|
||||||||||||||||
Net impact
|
$
|
1,221
|
$
|
682
|
$
|
(455
|
)
|
$
|
1,102
|
$
|
647
|
$
|
(443
|
)
|
(b) |
Investment contracts – Fair value measurement
|
three months ended
September 30,
|
nine months ended
September 30,
|
|||||||||||||||
For the
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
Death, disability and other claims
|
$
|
3,760
|
$
|
3,310
|
$
|
11,481
|
$
|
10,309
|
||||||||
Maturity and surrender benefits
|
1,633
|
1,697
|
4,849
|
4,928
|
||||||||||||
Annuity payments
|
1,094
|
1,076
|
3,320
|
3,219
|
||||||||||||
Policyholder dividends and experience rating refunds
|
264
|
329
|
829
|
859
|
||||||||||||
Net transfers from segregated funds
|
(692
|
)
|
(294
|
)
|
(1,292
|
)
|
(587
|
)
|
||||||||
Total
|
$
|
6,059
|
$
|
6,118
|
$
|
19,187
|
$
|
18,728
|
Note 6 |
Risk Management
|
(a) |
Risk disclosures included in the third quarter's MD&A
|
(i) |
Credit quality
|
As at September 30, 2017
|
AAA
|
AA
|
A |
|
BBB
|
BB
|
B and lower
|
Total
|
||||||||||||||||||||||||
Commercial mortgages
|
||||||||||||||||||||||||||||||||
Retail
|
$
|
112
|
$
|
1,634
|
$
|
4,391
|
$
|
2,064
|
$
|
44
|
$
|
15
|
$
|
8,260
|
||||||||||||||||||
Office
|
57
|
1,242
|
4,631
|
1,679
|
37
|
29
|
7,675
|
|||||||||||||||||||||||||
Multi-family residential
|
524
|
1,388
|
1,812
|
795
|
-
|
-
|
4,519
|
|||||||||||||||||||||||||
Industrial
|
18
|
367
|
1,565
|
506
|
181
|
-
|
2,637
|
|||||||||||||||||||||||||
Other
|
386
|
308
|
1,251
|
596
|
64
|
-
|
2,605
|
|||||||||||||||||||||||||
Total commercial mortgages
|
1,097
|
4,939
|
13,650
|
5,640
|
326
|
44
|
25,696
|
|||||||||||||||||||||||||
Agricultural mortgages
|
-
|
137
|
56
|
464
|
26
|
-
|
683
|
|||||||||||||||||||||||||
Private placements
|
1,047
|
4,028
|
11,691
|
12,625
|
721
|
921
|
31,033
|
|||||||||||||||||||||||||
Total
|
$
|
2,144
|
$
|
9,104
|
$
|
25,397
|
$
|
18,729
|
$
|
1,073
|
$
|
965
|
$
|
57,412
|
||||||||||||||||||
As at December 31, 2016
|
AAA
|
AA
|
A |
|
BBB
|
BB
|
B and lower
|
Total
|
||||||||||||||||||||||||
Commercial mortgages
|
||||||||||||||||||||||||||||||||
Retail
|
$
|
97
|
$
|
1,620
|
$
|
4,391
|
$
|
2,085
|
$
|
-
|
$
|
7
|
$
|
8,200
|
||||||||||||||||||
Office
|
68
|
1,255
|
3,972
|
1,938
|
55
|
36
|
7,324
|
|||||||||||||||||||||||||
Multi-family residential
|
656
|
1,362
|
1,944
|
844
|
-
|
-
|
4,806
|
|||||||||||||||||||||||||
Industrial
|
22
|
360
|
1,452
|
831
|
169
|
-
|
2,834
|
|||||||||||||||||||||||||
Other
|
428
|
261
|
1,323
|
493
|
60
|
-
|
2,565
|
|||||||||||||||||||||||||
Total commercial mortgages
|
1,271
|
4,858
|
13,082
|
6,191
|
284
|
43
|
25,729
|
|||||||||||||||||||||||||
Agricultural mortgages
|
-
|
151
|
61
|
469
|
141
|
-
|
822
|
|||||||||||||||||||||||||
Private placements
|
1,086
|
4,466
|
10,672
|
11,605
|
936
|
964
|
29,729
|
|||||||||||||||||||||||||
Total
|
$
|
2,357
|
$
|
9,475
|
$
|
23,815
|
$
|
18,265
|
$
|
1,361
|
$
|
1,007
|
$
|
56,280
|
As at
|
September 30, 2017
|
December 31, 2016
|
||||||||||||||||||||||
Insured
|
Uninsured
|
Total
|
Insured
|
Uninsured
|
Total
|
|||||||||||||||||||
Residential mortgages
|
||||||||||||||||||||||||
Performing
|
$
|
7,356
|
$
|
10,884
|
$
|
18,240
|
$
|
7,574
|
$
|
10,050
|
$
|
17,624
|
||||||||||||
Non-performing
(1)
|
6
|
14
|
20
|
6
|
13
|
19
|
||||||||||||||||||
Loans to Bank clients
|
||||||||||||||||||||||||
Performing
|
n/a
|
1,733
|
1,733
|
n/a
|
1,743
|
1,743
|
||||||||||||||||||
Non-performing
(1)
|
n/a
|
2
|
2
|
n/a
|
2
|
2
|
||||||||||||||||||
Total
|
$
|
7,362
|
$
|
12,633
|
$
|
19,995
|
$
|
7,580
|
$
|
11,808
|
$
|
19,388
|
(1) |
Non-performing refers to assets that are 90 days or more past due if uninsured and 365 days or more if insured.
|
(ii) |
Past due or credit impaired financial assets
|
Past due but not impaired
|
||||||||||||||||||||
As at September 30, 2017
|
Less than 90
days
|
90 days and
greater
|
Total
|
Impaired assets
net of allowance
for losses
|
Allowance for
losses
|
|||||||||||||||
Debt securities
|
||||||||||||||||||||
FVTPL
|
$
|
17
|
$
|
-
|
$
|
17
|
$
|
49
|
$
|
-
|
||||||||||
AFS
|
-
|
2
|
2
|
2
|
-
|
|||||||||||||||
Private placements
|
130
|
-
|
130
|
38
|
39
|
|||||||||||||||
Mortgages and loans to Bank clients
|
62
|
21
|
83
|
47
|
28
|
|||||||||||||||
Other financial assets
|
45
|
50
|
95
|
1
|
-
|
|||||||||||||||
Total
|
$
|
254
|
$
|
73
|
$
|
327
|
$
|
137
|
$
|
67
|
||||||||||
Past due but not impaired
|
||||||||||||||||||||
As at December 31, 2016
|
Less than 90
days
|
90 days and
greater
|
Total
|
Impaired assets
net of allowance
for losses
|
Allowance for
losses
|
|||||||||||||||
Debt securities
|
||||||||||||||||||||
FVTPL
|
$
|
90
|
$
|
-
|
$
|
90
|
$
|
38
|
$
|
-
|
||||||||||
AFS
|
16
|
9
|
25
|
-
|
-
|
|||||||||||||||
Private placements
|
215
|
64
|
279
|
152
|
92
|
|||||||||||||||
Mortgages and loans to Bank clients
|
50
|
20
|
70
|
33
|
26
|
|||||||||||||||
Other financial assets
|
57
|
54
|
111
|
8
|
-
|
|||||||||||||||
Total
|
$
|
428
|
$
|
147
|
$
|
575
|
$
|
231
|
$
|
118
|
(c) |
Securities lending, repurchase and reverse repurchase transactions
|
(d) |
Credit default swaps
|
As at September 30, 2017
|
Notional
amount
(2)
|
Fair value
|
Weighted average maturity
(in years)
(3)
|
||||||||||||||
Single name CDSs
(1)
|
|||||||||||||||||
Corporate debt
|
|||||||||||||||||
AAA
|
$
|
12
|
$
|
-
|
1
|
||||||||||||
AA
|
35
|
1
|
2
|
||||||||||||||
A
|
450
|
11
|
3
|
||||||||||||||
BBB
|
150
|
3
|
3
|
||||||||||||||
Total single name CDSs
|
$
|
647
|
$
|
15
|
3
|
||||||||||||
Total CDS protection sold
|
$
|
647
|
$
|
15
|
3
|
As at December 31, 2016
|
Notional amount
(2)
|
Fair value
|
Weighted average maturity
(in years)
(3)
|
||||||||||||||
Single name CDSs
(1)
|
|||||||||||||||||
Corporate debt
|
|||||||||||||||||
|
AAA |
$
|
13
|
$
|
-
|
2
|
|||||||||||
|
AA |
37
|
1
|
3
|
|||||||||||||
A
|
|
457
|
13
|
4
|
|||||||||||||
|
BBB |
155
|
4
|
3
|
|||||||||||||
Total single name CDSs
|
$
|
662
|
$
|
18
|
4
|
||||||||||||
Total CDS protection sold
|
$
|
662
|
$
|
18
|
4
|
(1) |
Rating agency designations are based on S&P where available followed by Moody's, DBRS and Fitch. If no rating is available from a rating agency, an internally developed rating is used.
|
(2) |
Notional amounts represent the maximum future payments the Company would have to pay its counterparties assuming a default of the underlying credit and zero recovery on the underlying issuer obligation.
|
(3) |
The weighted average maturity of the CDS is weighted based on notional amounts.
|
(e) |
Derivatives
|
(f) |
Offsetting financial assets and financial liabilities
|
Related amounts not set off in the Consolidated Statements of Financial Position
|
||||||||||||||||||||
As at September 30, 2017
|
Gross amounts of financial instruments presented in the Consolidated Statements of Financial Position
(1)
|
Amounts subject to an enforceable master netting arrangement or similar agreements
|
Financial and cash collateral pledged (received)
(2)
|
Net amount including financing trusts
(3)
|
Net amounts excluding financing trusts
|
|||||||||||||||
Financial assets
|
||||||||||||||||||||
Derivative assets
|
$
|
16,817
|
$
|
(7,792
|
)
|
$
|
(8,936
|
)
|
$
|
89
|
$
|
88
|
||||||||
Securities lending
|
1,116
|
-
|
(1,116
|
)
|
-
|
-
|
||||||||||||||
Reverse repurchase agreements
|
140
|
(27
|
)
|
(113
|
)
|
-
|
-
|
|||||||||||||
Total financial assets
|
$
|
18,073
|
$
|
(7,819
|
)
|
$
|
(10,165
|
)
|
$
|
89
|
$
|
88
|
||||||||
Financial liabilities
|
||||||||||||||||||||
Derivative liabilities
|
$
|
(9,783
|
)
|
$
|
7,792
|
$
|
1,759
|
$
|
(232
|
)
|
$
|
(46
|
)
|
|||||||
Repurchase agreements
|
(139
|
)
|
27
|
112
|
-
|
-
|
||||||||||||||
Total financial liabilities
|
$
|
(9,922
|
)
|
$
|
7,819
|
$
|
1,871
|
$
|
(232
|
)
|
$
|
(46
|
)
|
|||||||
Related amounts not set off in the Consolidated Statements of Financial Position
|
||||||||||||||||||||
As at December 31, 2016
|
Gross amounts of financial instruments presented in the Consolidated Statements of Financial Position
(1)
|
Amounts subject to an enforceable master netting arrangement or similar agreements
|
Financial and cash collateral pledged (received)
(2)
|
Net amount including financing trusts
(3)
|
Net amounts excluding financing trusts
|
|||||||||||||||
Financial assets
|
||||||||||||||||||||
Derivative assets
|
$
|
24,603
|
$
|
(12,031
|
)
|
$
|
(12,382
|
)
|
$
|
190
|
$
|
189
|
||||||||
Securities lending
|
1,956
|
-
|
(1,956
|
)
|
-
|
-
|
||||||||||||||
Reverse repurchase agreements
|
250
|
-
|
(250
|
)
|
-
|
-
|
||||||||||||||
Total financial assets
|
$
|
26,809
|
$
|
(12,031
|
)
|
$
|
(14,588
|
)
|
$
|
190
|
$
|
189
|
||||||||
Financial liabilities
|
||||||||||||||||||||
Derivative liabilities
|
$
|
(15,095
|
)
|
$
|
12,031
|
$
|
2,800
|
$
|
(264
|
)
|
$
|
(42
|
)
|
|||||||
Repurchase agreements
|
(255
|
)
|
-
|
255
|
-
|
-
|
||||||||||||||
Total financial liabilities
|
$
|
(15,350
|
)
|
$
|
12,031
|
$
|
3,055
|
$
|
(264
|
)
|
$
|
(42
|
)
|
(1) |
Financial assets and financial liabilities in the above table include accrued interest of $609 and $863, respectively (December 31, 2016 – $935 and $944, respectively).
|
(2) |
Financial and cash collateral pledged excludes over-collateralization. As at September 30, 2017 the Company was over-collateralized on OTC derivative assets, OTC derivative liabilities, securities lending and reverse purchase agreements and repurchase agreements in the amounts of $749, $407, $80 and $ nil, respectively (December 31, 2016 – $398, $494, $107 and $1, respectively). As at September 30, 2017, collateral pledged (received) does not include collateral in transit on OTC instruments or include initial margin on exchange traded contracts or cleared contracts.
|
(3) |
The net amount includes derivative contracts entered between the Company and its financing trusts which it does not consolidate. The Company does not exchange collateral on derivative contracts entered with these trusts.
|
(a) |
Carrying value of long-term debt instruments
|
September 30,
|
December 31,
|
|||||||||||||
As at
|
Issue date
|
Maturity date
|
Par value
|
2017
|
2016
|
|||||||||
4.70% Senior notes
(1)
|
June 23, 2016
|
June 23, 2046
|
US$1,000
|
$
|
1,240
|
$
|
1,333
|
|||||||
5.375% Senior notes
(1)
|
March 4, 2016
|
March 4, 2046
|
US$750
|
924
|
994
|
|||||||||
3.527% Senior notes
(1)
|
December 2, 2016
|
December 2, 2026
|
US$270
|
336
|
361
|
|||||||||
4.150% Senior notes
(1)
|
March 4, 2016
|
March 4, 2026
|
US$1,000
|
1,239
|
1,333
|
|||||||||
4.90% Senior notes
(1)
|
September 17, 2010
|
September 17, 2020
|
US$500
|
622
|
669
|
|||||||||
7.768% Medium term notes
(2)
|
April 8, 2009
|
April 8, 2019
|
$600 |
600
|
599
|
|||||||||
5.505% Medium term notes
|
June 26, 2008
|
June 26, 2018
|
$400 |
400
|
400
|
|||||||||
Other notes payable
|
n/a
|
n/a
|
n/a |
1
|
7
|
|||||||||
Total
|
$
|
5,362
|
$
|
5,696
|
(1) |
These U.S. dollar
senior notes have been designated as hedges of the Company's net investment in its U.S. operations which reduces the earnings volatility that would otherwise arise from the re-measurement of these senior notes into Canadian dollars.
|
(b) |
Fair value measurement
|
(a) |
Carrying value of capital instruments
|
September 30,
|
December 31,
|
|||||||||||||
As at
|
Issue date
|
Maturity date
|
Par value
|
2017
|
2016
|
|||||||||
Senior debenture notes - 7.535% fixed/floating
|
July 10, 2009
|
December 31, 2108
|
$
|
1,000
|
$
|
1,000
|
$
|
1,000
|
||||||
Subordinated note - floating
|
December 14, 2006
|
December 15, 2036
|
$
|
650
|
647
|
647
|
||||||||
Subordinated notes - 4.061% fixed/fixed reset
(1)
|
February 24, 2017
|
February 24, 2032
|
US$
|
750 |
930
|
-
|
||||||||
Subordinated debentures - 3.049% fixed/floating
(2)
|
August 18, 2017
|
August 20, 2029
|
$
|
750
|
746
|
-
|
||||||||
Subordinated debentures - 3.181% fixed/floating
|
November 20, 2015
|
November 22, 2027
|
$
|
1,000
|
996
|
996
|
||||||||
Subordinated debentures - 3.85% fixed/fixed reset
|
May 25, 2016
|
May 25, 2026
|
S$
|
500
|
458
|
461
|
||||||||
Subordinated debentures - 2.389% fixed/floating
|
June 1, 2015
|
January 5, 2026
|
$
|
350
|
349
|
349
|
||||||||
Subordinated debentures - 2.10% fixed/floating
|
March 10, 2015
|
June 1, 2025
|
$
|
750
|
748
|
747
|
||||||||
Subordinated debentures - 2.64% fixed/floating
|
December 1, 2014
|
January 15, 2025
|
$
|
500
|
499
|
499
|
||||||||
Subordinated debentures - 2.811% fixed/floating
|
February 21, 2014
|
February 21, 2024
|
$
|
500
|
499
|
499
|
||||||||
Surplus notes - 7.375% U.S. dollar
|
February 25, 1994
|
February 15, 2024
|
US$
|
450 |
581
|
627
|
||||||||
Subordinated debentures - 2.926% fixed/floating
|
November 29, 2013
|
November 29, 2023
|
$
|
250
|
250
|
249
|
||||||||
Subordinated debentures - 2.819% fixed/floating
|
February 25, 2013
|
February 26, 2023
|
$
|
200
|
200
|
200
|
||||||||
Subordinated debentures - 3.938% fixed/floating
(3)
|
September 21, 2012
|
September 21, 2022
|
$
|
400
|
-
|
407
|
||||||||
Subordinated debentures - 4.165% fixed/floating
(4)
|
February 17, 2012
|
June 1, 2022
|
$
|
500
|
-
|
499
|
||||||||
Total
|
$
|
7,903
|
$
|
7,180
|
(1) |
Issued by MFC during the year, interest is payable semi-annually. After February 24, 2027, the interest rate will reset to equal the 5-Year Mid-Swap rate plus 1.647%. With regulatory approval, MFC may redeem the notes, in whole, but not in part, on February 24, 2027, at a redemption price equal to par, together with accrued and unpaid interest.
|
(2) |
Issued by MFC during the year, interest is payable semi-annually. After August 20, 2024, the interest rate will reset to equal the 90-day Bankers' Acceptance rate plus 1.05%. With regulatory approval, MFC may redeem the notes, in whole, or in part, on or after August 20, 2024, at a redemption price equal to par, together with accrued and unpaid interest.
|
(3) |
MLI redeemed in full the 3.938% subordinated debentures on September 21, 2017, the first par redemption date.
|
(4) |
MLI redeemed in full the 4.165% subordinated debentures on June 1, 2017, the first par redemption date.
|
(b) |
Fair value measurement
|
(a) |
Preferred shares
|
2017
|
2016
|
|||||||||||||||
For the periods ended September 30,
|
Number of shares
(in millions)
|
Amount
|
Number of shares
(in millions)
|
Amount
|
||||||||||||
Balance, January 1
|
146
|
$
|
3,577
|
110
|
$
|
2,693
|
||||||||||
Issued, Class 1 shares, Series 21
|
-
|
-
|
17
|
425
|
||||||||||||
Converted, Class 1 shares, Series 3
|
-
|
-
|
(2
|
)
|
(42
|
)
|
||||||||||
Issued, Class 1 shares, Series 4
|
-
|
-
|
2
|
42
|
||||||||||||
Issuance costs, net of tax
|
-
|
-
|
-
|
(8
|
)
|
|||||||||||
Balance, September 30
|
146
|
$
|
3,577
|
127
|
$
|
3,110
|
(1) |
Holders of Class A and Class 1 preferred shares
are entitled to receive non-cumulative preferential cash dividends on a quarterly basis, as and when declared by the Board of Directors.
|
(2) |
Redemption of all preferred shares is subject to regulatory approval. With the exception of Class A Series 2, Class A Series 3 and Class 1 Series 4 preferred shares, MFC may redeem each series, in whole or in part, at par, on the earliest redemption date or every five years thereafter. Class A Series 2 and Series 3 preferred shares are past their respective earliest redemption date and MFC may redeem these shares, in whole or in part, at par at any time, subject to regulatory approval, as noted. MFC may redeem the Class 1 Series 4, in whole or in part, at any time, at $25.00 per share if redeemed on June 19, 2021 and on June 19 every five years thereafter, or at $25.50 per share if redeemed on any other date after June 19, 2016, subject to regulatory approval, as noted.
|
(3) |
Net of after-tax issuance costs.
|
(4) |
On the earliest redemption date and every five years thereafter, the annual dividend rate will be reset to the five year Government of Canada bond yield plus a yield specified for each series. The specified yield for Class 1 shares is: Series 3 – 1.41%, Series 5 – 2.90%, Series 7 – 3.13%, Series 9 – 2.86%, Series 11 – 2.61%, Series 13 – 2.22%, Series 15 – 2.16%, Series 17 – 2.36%, Series 19 – 2.30%, Series 21 – 4.97% and Series 23 – 3.83%
.
|
(5) |
On the earliest redemption date and every five years thereafter, Class 1 preferred shares are convertible at the option of the holder into a new series that is one number higher than their existing series, and the holders are entitled to non-cumulative preferential cash dividends, payable quarterly if and when declared by the Board of Directors, at a rate equal to the three month Government of Canada treasury bill yield plus the rate specified in footnote 4 above.
|
(6) |
The floating dividend rate for the Class 1 Shares Series 4 will equal the three month Government of Canada Treasury bill yield plus 1.41%.
|
(7) |
MFC did not exercise its right to redeem all or any of the outstanding Class 1 Shares Series 7 on March 19, 2017 (the earliest redemption date). Dividend rate for Class 1 Shares Series 7 was reset as specified in footnote 4 above to an annual fixed rate of 4.312% for a five year period commencing on March 20, 2017.
|
(8) |
MFC did not exercise its right to redeem all or any of the outstanding Class 1 Shares Series 9 on September 19, 2017 (the earliest redemption date). Dividend rate for Class 1 Shares Series 9 was reset as specified in footnote 4 above to an annual fixed rate of 4.351% for a five year period commencing on September 20, 2017.
|
(b) |
Common shares
|
For the
|
nine months ended
|
year ended
|
||||||
Number of common shares (in millions)
|
September 30, 2017
|
December 31, 2016
|
||||||
Balance, beginning of period
|
1,975
|
1,972
|
||||||
Issued on exercise of stock options and deferred share units
|
3
|
3
|
||||||
Balance, end of period
|
1,978
|
1,975
|
three months ended
|
nine months ended
|
|||||||||||||||
For the
|
September 30,
|
September 30,
|
||||||||||||||
(in millions)
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
Weighted average number of common shares
|
1,978
|
1,973
|
1,977
|
1,972
|
||||||||||||
Dilutive stock-based awards
(1)
|
8
|
3
|
8
|
4
|
||||||||||||
Weighted average number of diluted common shares
|
1,986
|
1,976
|
1,985
|
1,976
|
(1) |
The dilutive effect of stock-based awards was calculated using the treasury stock method. This method calculates the number of incremental shares by assuming the outstanding stock-based awards are (i) exercised and (ii) then reduced by the number of shares assumed to be repurchased from the issuance proceeds, using the average market price of MFC common shares for the period.
|
(c) |
Earnings per share
|
three months ended
|
nine months ended
|
|||||||||||||||
For the
|
September 30,
|
September 30,
|
||||||||||||||
2017
|
2016
|
2017
|
2016
|
|||||||||||||
Basic earnings per common share
|
$
|
0.54
|
$
|
0.55
|
$
|
1.82
|
$
|
1.40
|
||||||||
Diluted earnings per common share
|
0.54
|
0.55
|
1.81
|
1.40
|
Pension plans
|
Retiree welfare plans
|
|||||||||||||||
For the three months ended September 30,
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
Defined benefit current service cost
|
$
|
11
|
$
|
14
|
$
|
-
|
$
|
-
|
||||||||
Defined benefit administrative expenses
|
2
|
2
|
1
|
1
|
||||||||||||
Service cost
|
13
|
16
|
1
|
1
|
||||||||||||
Interest on net defined benefit (asset) liability
|
3
|
7
|
1
|
1
|
||||||||||||
Defined benefit cost
|
16
|
23
|
2
|
2
|
||||||||||||
Defined contribution cost
|
17
|
10
|
-
|
-
|
||||||||||||
Net benefit cost
|
$
|
33
|
$
|
33
|
$
|
2
|
$
|
2
|
Pension plans
|
Retiree welfare plans
|
|||||||||||||||
For the nine months ended September 30,
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
Defined benefit current service cost
|
$
|
37
|
$
|
39
|
$
|
-
|
$
|
-
|
||||||||
Defined benefit administrative expenses
|
4
|
5
|
2
|
2
|
||||||||||||
Service cost
|
41
|
44
|
2
|
2
|
||||||||||||
Interest on net defined benefit (asset) liability
|
12
|
21
|
2
|
3
|
||||||||||||
Defined benefit cost
|
53
|
65
|
4
|
5
|
||||||||||||
Defined contribution cost
|
58
|
46
|
-
|
-
|
||||||||||||
Net benefit cost
|
$
|
111
|
$
|
111
|
$
|
4
|
$
|
5
|
Note 11 |
Commitments and Contingencies
|
(a) |
Legal proceedings
|
(b) |
Guarantees
|
(i) |
Guarantees regarding Manulife Finance (Delaware), L.P. ("MFLP")
|
(ii) |
Guarantees regarding The Manufacturers Life Insurance Company
|
(iii) |
Guarantees regarding John Hancock Life Insurance Company (U.S.A.) ("JHUSA")
|
Note 12 |
Segmented Information
|
For the three months ended
|
Asia
|
Canadian
|
U.S.
|
Corporate
|
||||||||||||||||
September 30, 2017
|
Division
|
Division
|
Division
|
and Other
|
Total
|
|||||||||||||||
Revenue
|
||||||||||||||||||||
Premium income
|
||||||||||||||||||||
Life and health insurance
|
$
|
3,440
|
$
|
1,013
|
$
|
1,821
|
$
|
47
|
$
|
6,321
|
||||||||||
Annuities and pensions
|
599
|
105
|
218
|
-
|
922
|
|||||||||||||||
Net premium income
|
4,039
|
1,118
|
2,039
|
47
|
7,243
|
|||||||||||||||
Net investment income
|
846
|
(782
|
)
|
2,087
|
(5
|
)
|
2,146
|
|||||||||||||
Other revenue
|
341
|
852
|
1,512
|
(161
|
)
|
2,544
|
||||||||||||||
Total revenue
|
5,226
|
1,188
|
5,638
|
(119
|
)
|
11,933
|
||||||||||||||
Contract benefits and expenses
|
||||||||||||||||||||
Life and health insurance
|
2,894
|
714
|
3,084
|
425
|
7,117
|
|||||||||||||||
Annuities and pensions
|
481
|
(1,196
|
)
|
206
|
-
|
(509
|
)
|
|||||||||||||
Net benefits and claims
|
3,375
|
(482
|
)
|
3,290
|
425
|
6,608
|
||||||||||||||
Interest expense
|
41
|
66
|
10
|
189
|
306
|
|||||||||||||||
Other expenses
|
1,216
|
1,081
|
1,472
|
(19
|
)
|
3,750
|
||||||||||||||
Total contract benefits and expenses
|
4,632
|
665
|
4,772
|
595
|
10,664
|
|||||||||||||||
Income (loss) before income taxes
|
594
|
523
|
866
|
(714
|
)
|
1,269
|
||||||||||||||
Income tax recovery (expense)
|
(101
|
)
|
-
|
(232
|
)
|
320
|
(13
|
)
|
||||||||||||
Net income (loss)
|
493
|
523
|
634
|
(394
|
)
|
1,256
|
||||||||||||||
Less net income (loss) attributed to:
|
||||||||||||||||||||
Non-controlling interests
|
40
|
-
|
-
|
(7
|
)
|
33
|
||||||||||||||
Participating policyholders
|
44
|
75
|
(1
|
)
|
-
|
118
|
||||||||||||||
Net income (loss) attributed to shareholders
|
$
|
409
|
$
|
448
|
$
|
635
|
$
|
(387
|
)
|
$
|
1,105
|
For the three months ended
|
Asia
|
Canadian
|
U.S.
|
Corporate
|
||||||||||||||||
September 30, 2016
|
Division
|
Division
|
Division
|
and Other
|
Total
|
|||||||||||||||
Revenue
|
||||||||||||||||||||
Premium income
|
||||||||||||||||||||
Life and health insurance
|
$
|
3,104
|
$
|
1,074
|
$
|
1,750
|
$
|
22
|
$
|
5,950
|
||||||||||
Annuities and pensions
|
905
|
139
|
203
|
-
|
1,247
|
|||||||||||||||
Net premium income
|
4,009
|
1,213
|
1,953
|
22
|
7,197
|
|||||||||||||||
Net investment income
|
228
|
1,892
|
2,035
|
184
|
4,339
|
|||||||||||||||
Other revenue
|
428
|
924
|
1,514
|
55
|
2,921
|
|||||||||||||||
Total revenue
|
4,665
|
4,029
|
5,502
|
261
|
14,457
|
|||||||||||||||
Contract benefits and expenses
|
||||||||||||||||||||
Life and health insurance
|
2,137
|
1,553
|
2,948
|
588
|
7,226
|
|||||||||||||||
Annuities and pensions
|
669
|
856
|
298
|
-
|
1,823
|
|||||||||||||||
Net benefits and claims
|
2,806
|
2,409
|
3,246
|
588
|
9,049
|
|||||||||||||||
Interest expense
|
37
|
87
|
13
|
151
|
288
|
|||||||||||||||
Other expenses
|
1,092
|
1,062
|
1,491
|
161
|
3,806
|
|||||||||||||||
Total contract benefits and expenses
|
3,935
|
3,558
|
4,750
|
900
|
13,143
|
|||||||||||||||
Income (loss) before income taxes
|
730
|
471
|
752
|
(639
|
)
|
1,314
|
||||||||||||||
Income tax recovery (expense)
|
(83
|
)
|
(69
|
)
|
(193
|
)
|
228
|
(117
|
)
|
|||||||||||
Net income (loss)
|
647
|
402
|
559
|
(411
|
)
|
1,197
|
||||||||||||||
Less net income (loss) attributed to:
|
||||||||||||||||||||
Non-controlling interests
|
40
|
-
|
-
|
27
|
67
|
|||||||||||||||
Participating policyholders
|
46
|
(33
|
)
|
-
|
-
|
13
|
||||||||||||||
Net income (loss) attributed to shareholders
|
$
|
561
|
$
|
435
|
$
|
559
|
$
|
(438
|
)
|
$
|
1,117
|
As at and for the nine months ended
|
Asia
|
Canadian
|
U.S.
|
Corporate
|
||||||||||||||||
September 30, 2017
|
Division
|
Division
|
Division
|
and Other
|
Total
|
|||||||||||||||
Revenue
|
||||||||||||||||||||
Premium income
|
||||||||||||||||||||
Life and health insurance
|
$
|
9,948
|
$
|
3,198
|
$
|
5,119
|
$
|
90
|
$
|
18,355
|
||||||||||
Annuities and pensions
|
1,947
|
348
|
617
|
-
|
2,912
|
|||||||||||||||
Net premium income
|
11,895
|
3,546
|
5,736
|
90
|
21,267
|
|||||||||||||||
Net investment income
|
3,094
|
1,990
|
7,716
|
-
|
12,800
|
|||||||||||||||
Other revenue
|
1,216
|
2,617
|
4,675
|
(499
|
)
|
8,009
|
||||||||||||||
Total revenue
|
16,205
|
8,153
|
18,127
|
(409
|
)
|
42,076
|
||||||||||||||
Contract benefits and expenses
|
||||||||||||||||||||
Life and health insurance
|
9,025
|
3,538
|
10,628
|
440
|
23,631
|
|||||||||||||||
Annuities and pensions
|
1,312
|
411
|
(72
|
)
|
-
|
1,651
|
||||||||||||||
Net benefits and claims
|
10,337
|
3,949
|
10,556
|
440
|
25,282
|
|||||||||||||||
Interest expense
|
122
|
203
|
24
|
495
|
844
|
|||||||||||||||
Other expenses
|
3,651
|
3,288
|
4,469
|
(82
|
)
|
11,326
|
||||||||||||||
Total contract benefits and expenses
|
14,110
|
7,440
|
15,049
|
853
|
37,452
|
|||||||||||||||
Income (loss) before income taxes
|
2,095
|
713
|
3,078
|
(1,262
|
)
|
4,624
|
||||||||||||||
Income tax recovery (expense)
|
(321
|
)
|
40
|
(901
|
)
|
519
|
(663
|
)
|
||||||||||||
Net income (loss)
|
1,774
|
753
|
2,177
|
(743
|
)
|
3,961
|
||||||||||||||
Less net income (loss) attributed to:
|
||||||||||||||||||||
Non-controlling interests
|
153
|
-
|
-
|
(5
|
)
|
148
|
||||||||||||||
Participating policyholders
|
70
|
33
|
-
|
-
|
103
|
|||||||||||||||
Net income (loss) attributed to shareholders
|
$
|
1,551
|
$
|
720
|
$
|
2,177
|
$
|
(738
|
)
|
$
|
3,710
|
|||||||||
Total assets
|
$
|
99,948
|
$
|
215,783
|
$
|
376,925
|
$
|
20,720
|
$
|
713,376
|
As at and for the nine months ended
|
Asia
|
Canadian
|
U.S.
|
Corporate
|
||||||||||||||||
September 30, 2016
|
Division
|
Division
|
Division
|
and Other
|
Total
|
|||||||||||||||
Revenue
|
||||||||||||||||||||
Premium income
|
||||||||||||||||||||
Life and health insurance
|
$
|
8,962
|
$
|
3,249
|
$
|
4,899
|
$
|
65
|
$
|
17,175
|
||||||||||
Annuities and pensions
|
2,929
|
462
|
65
|
-
|
3,456
|
|||||||||||||||
Net premium income
|
11,891
|
3,711
|
4,964
|
65
|
20,631
|
|||||||||||||||
Net investment income
|
3,584
|
7,777
|
15,737
|
538
|
27,636
|
|||||||||||||||
Other revenue
|
1,042
|
2,681
|
4,379
|
442
|
8,544
|
|||||||||||||||
Total revenue
|
16,517
|
14,169
|
25,080
|
1,045
|
56,811
|
|||||||||||||||
Contract benefits and expenses
|
||||||||||||||||||||
Life and health insurance
|
9,699
|
4,671
|
14,565
|
818
|
29,753
|
|||||||||||||||
Annuities and pensions
|
2,590
|
4,481
|
4,732
|
-
|
11,803
|
|||||||||||||||
Net benefits and claims
|
12,289
|
9,152
|
19,297
|
818
|
41,556
|
|||||||||||||||
Interest expense
|
107
|
218
|
26
|
396
|
747
|
|||||||||||||||
Other expenses
|
3,108
|
3,124
|
4,112
|
550
|
10,894
|
|||||||||||||||
Total contract benefits and expenses
|
15,504
|
12,494
|
23,435
|
1,764
|
53,197
|
|||||||||||||||
Income (loss) before income taxes
|
1,013
|
1,675
|
1,645
|
(719
|
)
|
3,614
|
||||||||||||||
Income tax recovery (expense)
|
(155
|
)
|
(350
|
)
|
(438
|
)
|
297
|
(646
|
)
|
|||||||||||
Net income (loss)
|
858
|
1,325
|
1,207
|
(422
|
)
|
2,968
|
||||||||||||||
Less net income (loss) attributed to:
|
||||||||||||||||||||
Non-controlling interests
|
97
|
-
|
-
|
23
|
120
|
|||||||||||||||
Participating policyholders
|
51
|
(69
|
)
|
-
|
-
|
(18
|
)
|
|||||||||||||
Net income (loss) attributed to shareholders
|
$
|
710
|
$
|
1,394
|
$
|
1,207
|
$
|
(445
|
)
|
$
|
2,866
|
|||||||||
Total assets
|
$
|
95,916
|
$
|
218,291
|
$
|
388,150
|
$
|
39,942
|
$
|
742,299
|
For the three months ended
|
||||||||||||||||||||
September 30, 2017
|
Asia
|
Canada
|
U.S.
|
Other
|
Total
|
|||||||||||||||
Revenue
|
||||||||||||||||||||
Premium income
|
||||||||||||||||||||
Life and health insurance
|
$
|
3,456
|
$
|
910
|
$
|
1,821
|
$
|
134
|
$
|
6,321
|
||||||||||
Annuities and pensions
|
599
|
105
|
218
|
-
|
922
|
|||||||||||||||
Net premium income
|
4,055
|
1,015
|
2,039
|
134
|
7,243
|
|||||||||||||||
Net investment income
|
889
|
(797
|
)
|
2,027
|
27
|
2,146
|
||||||||||||||
Other revenue
|
314
|
784
|
1,444
|
2
|
2,544
|
|||||||||||||||
Total revenue
|
$
|
5,258
|
$
|
1,002
|
$
|
5,510
|
$
|
163
|
$
|
11,933
|
For the three months ended
|
||||||||||||||||||||
September 30, 2016
|
Asia
|
Canada
|
U.S.
|
Other
|
Total
|
|||||||||||||||
Revenue
|
||||||||||||||||||||
Premium income
|
||||||||||||||||||||
Life and health insurance
|
$
|
3,122
|
$
|
963
|
$
|
1,750
|
$
|
115
|
$
|
5,950
|
||||||||||
Annuities and pensions
|
905
|
139
|
203
|
-
|
1,247
|
|||||||||||||||
Net premium income
|
4,027
|
1,102
|
1,953
|
115
|
7,197
|
|||||||||||||||
Net investment income
|
345
|
1,926
|
2,022
|
46
|
4,339
|
|||||||||||||||
Other revenue
|
447
|
872
|
1,595
|
7
|
2,921
|
|||||||||||||||
Total revenue
|
$
|
4,819
|
$
|
3,900
|
$
|
5,570
|
$
|
168
|
$
|
14,457
|
For the nine months ended
|
||||||||||||||||||||
September 30, 2017
|
Asia
|
Canada
|
U.S.
|
Other
|
Total
|
|||||||||||||||
Revenue
|
||||||||||||||||||||
Premium income
|
||||||||||||||||||||
Life and health insurance
|
$
|
10,003
|
$
|
2,864
|
$
|
5,120
|
$
|
368
|
$
|
18,355
|
||||||||||
Annuities and pensions
|
1,947
|
348
|
617
|
-
|
2,912
|
|||||||||||||||
Net premium income
|
11,950
|
3,212
|
5,737
|
368
|
21,267
|
|||||||||||||||
Net investment income
|
3,213
|
2,030
|
7,517
|
40
|
12,800
|
|||||||||||||||
Other revenue
|
1,130
|
2,375
|
4,487
|
17
|
8,009
|
|||||||||||||||
Total revenue
|
$
|
16,293
|
$
|
7,617
|
$
|
17,741
|
$
|
425
|
$
|
42,076
|
For the nine months ended
|
||||||||||||||||||||
September 30, 2016
|
Asia
|
Canada
|
U.S.
|
Other
|
Total
|
|||||||||||||||
Revenue
|
||||||||||||||||||||
Premium income
|
||||||||||||||||||||
Life and health insurance
|
$
|
9,017
|
$
|
2,902
|
$
|
4,900
|
$
|
356
|
$
|
17,175
|
||||||||||
Annuities and pensions
|
2,929
|
462
|
65
|
-
|
3,456
|
|||||||||||||||
Net premium income
|
11,946
|
3,364
|
4,965
|
356
|
20,631
|
|||||||||||||||
Net investment income
|
3,928
|
7,748
|
15,800
|
160
|
27,636
|
|||||||||||||||
Other revenue
|
1,086
|
2,624
|
4,809
|
25
|
8,544
|
|||||||||||||||
Total revenue
|
$
|
16,960
|
$
|
13,736
|
$
|
25,574
|
$
|
541
|
$
|
56,811
|
Note 13 |
Segregated Funds
|
As at
|
September 30, 2017
|
December 31, 2016
|
||||||
Investments at market value
|
||||||||
Cash and short-term securities
|
$
|
3,133
|
$
|
4,524
|
||||
Debt securities
|
15,582
|
15,651
|
||||||
Equities
|
12,104
|
12,458
|
||||||
Mutual funds
|
282,793
|
278,966
|
||||||
Other investments
|
4,418
|
4,552
|
||||||
Accrued investment income
|
208
|
201
|
||||||
Other assets and liabilities, net
|
(722
|
)
|
(644
|
)
|
||||
Total segregated funds net assets
|
$
|
317,516
|
$
|
315,708
|
||||
Composition of segregated funds net assets
|
||||||||
Held by policyholders
|
$
|
316,977
|
$
|
315,177
|
||||
Held by the Company
|
539
|
531
|
||||||
Total segregated funds net assets
|
$
|
317,516
|
$
|
315,708
|
three months ended
September 30,
|
nine months ended
September 30,
|
|||||||||||||||
For the
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
Net policyholder cash flow
|
||||||||||||||||
Deposits from policyholders
|
$
|
8,179
|
$
|
8,291
|
$
|
26,355
|
$
|
24,883
|
||||||||
Net transfers to general fund
|
(692
|
)
|
(294
|
)
|
(1,292
|
)
|
(587
|
)
|
||||||||
Payments to policyholders
|
(10,181
|
)
|
(9,537
|
)
|
(33,043
|
)
|
(28,318
|
)
|
||||||||
(2,694
|
)
|
(1,540
|
)
|
(7,980
|
)
|
(4,022
|
)
|
|||||||||
Investment related
|
||||||||||||||||
Interest and dividends
|
3,528
|
4,666
|
5,372
|
6,212
|
||||||||||||
Net realized and unrealized investment gains
|
4,832
|
6,770
|
23,887
|
11,370
|
||||||||||||
8,360
|
11,436
|
29,259
|
17,582
|
|||||||||||||
Other
|
||||||||||||||||
Management and administration fees
|
(1,028
|
)
|
(1,068
|
)
|
(3,376
|
)
|
(3,327
|
)
|
||||||||
Impact of changes in foreign exchange rates
|
(8,931
|
)
|
1,939
|
(16,095
|
)
|
(9,555
|
)
|
|||||||||
(9,959
|
)
|
871
|
(19,471
|
)
|
(12,882
|
)
|
||||||||||
Net additions (deductions)
|
(4,293
|
)
|
10,767
|
1,808
|
678
|
|||||||||||
Segregated funds net assets, beginning of period
|
321,809
|
303,658
|
315,708
|
313,747
|
||||||||||||
Segregated funds net assets, end of period
|
$
|
317,516
|
$
|
314,425
|
$
|
317,516
|
$
|
314,425
|
Note 14 |
Information Provided in Connection with Investments in Deferred Annuity Contracts and SignatureNotes Issued or Assumed by John Hancock Life Insurance Company (U.S.A.)
|
As at September 30, 2017
|
MFC
(Guarantor)
|
JHUSA
(Issuer)
|
Other
subsidiaries
|
Consolidation adjustments
|
Consolidated
MFC
|
|||||||||||||||
Assets
|
||||||||||||||||||||
Invested assets
|
$
|
53
|
$
|
104,451
|
$
|
221,344
|
$
|
(742
|
)
|
$
|
325,106
|
|||||||||
Investments in unconsolidated subsidiaries
|
51,364
|
6,584
|
35,493
|
(93,441
|
)
|
-
|
||||||||||||||
Reinsurance assets
|
-
|
49,810
|
8,321
|
(27,746
|
)
|
30,385
|
||||||||||||||
Other assets
|
18,493
|
22,117
|
60,378
|
(60,080
|
)
|
40,908
|
||||||||||||||
Segregated funds net assets
|
-
|
173,798
|
144,915
|
(1,736
|
)
|
316,977
|
||||||||||||||
Total assets
|
$
|
69,910
|
$
|
356,760
|
$
|
470,451
|
$
|
(183,745
|
)
|
$
|
713,376
|
|||||||||
Liabilities and equity
|
||||||||||||||||||||
Insurance contract liabilities
|
$
|
-
|
$
|
141,689
|
$
|
179,919
|
$
|
(28,380
|
)
|
$
|
293,228
|
|||||||||
Investment contract liabilities
|
-
|
1,130
|
2,001
|
(3
|
)
|
3,128
|
||||||||||||||
Other liabilities
|
19,894
|
22,077
|
61,308
|
(60,256
|
)
|
43,023
|
||||||||||||||
Long-term debt
|
5,361
|
-
|
1
|
-
|
5,362
|
|||||||||||||||
Capital instruments
|
2,134
|
581
|
23,313
|
(18,125
|
)
|
7,903
|
||||||||||||||
Segregated funds net liabilities
|
-
|
173,798
|
144,915
|
(1,736
|
)
|
316,977
|
||||||||||||||
Shareholders' equity
|
42,521
|
17,485
|
57,760
|
(75,245
|
)
|
42,521
|
||||||||||||||
Participating policyholders' equity
|
-
|
-
|
351
|
-
|
351
|
|||||||||||||||
Non-controlling interests
|
-
|
-
|
883
|
-
|
883
|
|||||||||||||||
Total liabilities and equity
|
$
|
69,910
|
$
|
356,760
|
$
|
470,451
|
$
|
(183,745
|
)
|
$
|
713,376
|
As at December 31, 2016
|
MFC
(Guarantor)
|
JHUSA
(Issuer)
|
Other
subsidiaries
|
Consolidation adjustments
|
Consolidated
MFC
|
|||||||||||||||
Assets
|
||||||||||||||||||||
Invested assets
|
$
|
161
|
$
|
109,063
|
$
|
213,043
|
$
|
(398
|
)
|
$
|
321,869
|
|||||||||
Investments in unconsolidated subsidiaries
|
47,758
|
6,457
|
17,504
|
(71,719
|
)
|
-
|
||||||||||||||
Reinsurance assets
|
-
|
51,537
|
10,069
|
(26,654
|
)
|
34,952
|
||||||||||||||
Other assets
|
315
|
28,718
|
41,724
|
(22,074
|
)
|
48,683
|
||||||||||||||
Segregated funds net assets
|
-
|
174,917
|
142,400
|
(2,140
|
)
|
315,177
|
||||||||||||||
Total assets
|
$
|
48,234
|
$
|
370,692
|
$
|
424,740
|
$
|
(122,985
|
)
|
$
|
720,681
|
|||||||||
Liabilities and equity
|
||||||||||||||||||||
Insurance contract liabilities
|
$
|
-
|
$
|
147,504
|
$
|
177,524
|
$
|
(27,523
|
)
|
$
|
297,505
|
|||||||||
Investment contract liabilities
|
-
|
1,251
|
2,027
|
(3
|
)
|
3,275
|
||||||||||||||
Other liabilities
|
252
|
28,892
|
41,653
|
(21,772
|
)
|
49,025
|
||||||||||||||
Long-term debt
|
5,689
|
-
|
7
|
-
|
5,696
|
|||||||||||||||
Capital instruments
|
461
|
627
|
6,226
|
(134
|
)
|
7,180
|
||||||||||||||
Segregated funds net liabilities
|
-
|
174,917
|
142,400
|
(2,140
|
)
|
315,177
|
||||||||||||||
Shareholders' equity
|
41,832
|
17,501
|
53,912
|
(71,413
|
)
|
41,832
|
||||||||||||||
Participating policyholders' equity
|
-
|
-
|
248
|
-
|
248
|
|||||||||||||||
Non-controlling interests
|
-
|
-
|
743
|
-
|
743
|
|||||||||||||||
Total liabilities and equity
|
$
|
48,234
|
$
|
370,692
|
$
|
424,740
|
$
|
(122,985
|
)
|
$
|
720,681
|
For the three months ended
September 30, 2017
|
MFC
(Guarantor)
|
JHUSA
(Issuer)
|
Other
subsidiaries
|
Consolidation adjustments
|
Consolidated
MFC
|
|||||||||||||||
Revenue
|
||||||||||||||||||||
Net premium income
|
$
|
-
|
$
|
1,258
|
$
|
5,986
|
$
|
(1
|
)
|
$
|
7,243
|
|||||||||
Net investment income (loss)
|
87
|
1,482
|
789
|
(212
|
)
|
2,146
|
||||||||||||||
Net other revenue
|
-
|
621
|
2,452
|
(529
|
)
|
2,544
|
||||||||||||||
Total revenue
|
87
|
3,361
|
9,227
|
(742
|
)
|
11,933
|
||||||||||||||
Contract benefits and expenses
|
||||||||||||||||||||
Net benefits and claims
|
-
|
1,884
|
4,653
|
71
|
6,608
|
|||||||||||||||
Commissions, investment and general expenses
|
1
|
797
|
3,281
|
(421
|
)
|
3,658
|
||||||||||||||
Other expenses
|
137
|
47
|
606
|
(392
|
)
|
398
|
||||||||||||||
Total contract benefits and expenses
|
138
|
2,728
|
8,540
|
(742
|
)
|
10,664
|
||||||||||||||
Income (loss) before income taxes
|
(51
|
)
|
633
|
687
|
-
|
1,269
|
||||||||||||||
Income tax (expense) recovery
|
14
|
(124
|
)
|
97
|
-
|
(13
|
)
|
|||||||||||||
Income (loss) after income taxes
|
(37
|
)
|
509
|
784
|
-
|
1,256
|
||||||||||||||
Equity in net income (loss) of unconsolidated subsidiaries
|
1,142
|
101
|
616
|
(1,859
|
)
|
-
|
||||||||||||||
Net income (loss)
|
$
|
1,105
|
$
|
610
|
$
|
1,400
|
$
|
(1,859
|
)
|
$
|
1,256
|
|||||||||
Net income (loss) attributed to:
|
||||||||||||||||||||
Non-controlling interests
|
$
|
-
|
$
|
-
|
$
|
33
|
$
|
-
|
$
|
33
|
||||||||||
Participating policyholders
|
-
|
(3
|
)
|
118
|
3
|
118
|
||||||||||||||
Shareholders
|
1,105
|
613
|
1,249
|
(1,862
|
)
|
1,105
|
||||||||||||||
$
|
1,105
|
$
|
610
|
$
|
1,400
|
$
|
(1,859
|
)
|
$
|
1,256
|
For the three months ended
|
||||||||||||||||||||
September 30, 2016
|
MFC
(Guarantor)
|
JHUSA
(Issuer)
|
Other
subsidiaries
|
Consolidation adjustments
|
Consolidated
MFC
|
|||||||||||||||
Revenue
|
||||||||||||||||||||
Net premium income
|
$
|
-
|
$
|
1,296
|
$
|
5,901
|
$
|
-
|
$
|
7,197
|
||||||||||
Net investment income (loss)
|
162
|
1,493
|
3,061
|
(377
|
)
|
4,339
|
||||||||||||||
Net other revenue
|
(1
|
)
|
715
|
2,633
|
(426
|
)
|
2,921
|
|||||||||||||
Total revenue
|
161
|
3,504
|
11,595
|
(803
|
)
|
14,457
|
||||||||||||||
Contract benefits and expenses
|
||||||||||||||||||||
Net benefits and claims
|
-
|
2,765
|
6,280
|
4
|
9,049
|
|||||||||||||||
Commissions, investment and general expenses
|
(1
|
)
|
911
|
3,274
|
(472
|
)
|
3,712
|
|||||||||||||
Other expenses
|
80
|
66
|
571
|
(335
|
)
|
382
|
||||||||||||||
Total contract benefits and expenses
|
79
|
3,742
|
10,125
|
(803
|
)
|
13,143
|
||||||||||||||
Income (loss) before income taxes
|
82
|
(238
|
)
|
1,470
|
-
|
1,314
|
||||||||||||||
Income tax (expense) recovery
|
(22
|
)
|
155
|
(250
|
)
|
-
|
(117
|
)
|
||||||||||||
Income (loss) after income taxes
|
60
|
(83
|
)
|
1,220
|
-
|
1,197
|
||||||||||||||
Equity in net income (loss) of unconsolidated subsidiaries
|
1,057
|
(100
|
)
|
(183
|
)
|
(774
|
)
|
-
|
||||||||||||
Net income (loss)
|
$
|
1,117
|
$
|
(183
|
)
|
$
|
1,037
|
$
|
(774
|
)
|
$
|
1,197
|
||||||||
Net income (loss) attributed to:
|
||||||||||||||||||||
Non-controlling interests
|
$
|
-
|
$
|
-
|
$
|
67
|
$
|
-
|
$
|
67
|
||||||||||
Participating policyholders
|
-
|
(12
|
)
|
13
|
12
|
13
|
||||||||||||||
Shareholders
|
1,117
|
(171
|
)
|
957
|
(786
|
)
|
1,117
|
|||||||||||||
$
|
1,117
|
$
|
(183
|
)
|
$
|
1,037
|
$
|
(774
|
)
|
$
|
1,197
|
For the nine months ended
|
||||||||||||||||||||
September 30, 2017
|
MFC
(Guarantor)
|
JHUSA
(Issuer)
|
Other
subsidiaries
|
Consolidation adjustments
|
Consolidated
MFC
|
|||||||||||||||
Revenue
|
||||||||||||||||||||
Net premium income
|
$
|
-
|
$
|
3,428
|
$
|
17,842
|
$
|
(3
|
)
|
$
|
21,267
|
|||||||||
Net investment income (loss)
|
169
|
5,764
|
7,442
|
(575
|
)
|
12,800
|
||||||||||||||
Net other revenue
|
3
|
2,295
|
8,005
|
(2,294
|
)
|
8,009
|
||||||||||||||
Total revenue
|
172
|
11,487
|
33,289
|
(2,872
|
)
|
42,076
|
||||||||||||||
Contract benefits and expenses
|
||||||||||||||||||||
Net benefits and claims
|
-
|
8,325
|
17,415
|
(458
|
)
|
25,282
|
||||||||||||||
Commissions, investment and general expenses
|
4
|
2,338
|
10,381
|
(1,669
|
)
|
11,054
|
||||||||||||||
Other expenses
|
317
|
148
|
1,396
|
(745
|
)
|
1,116
|
||||||||||||||
Total contract benefits and expenses
|
321
|
10,811
|
29,192
|
(2,872
|
)
|
37,452
|
||||||||||||||
Income (loss) before income taxes
|
(149
|
)
|
676
|
4,097
|
-
|
4,624
|
||||||||||||||
Income tax (expense) recovery
|
40
|
(23
|
)
|
(680
|
)
|
-
|
(663
|
)
|
||||||||||||
Income (loss) after income taxes
|
(109
|
)
|
653
|
3,417
|
-
|
3,961
|
||||||||||||||
Equity in net income (loss) of unconsolidated subsidiaries
|
3,819
|
738
|
1,397
|
(5,954
|
)
|
-
|
||||||||||||||
Net income (loss)
|
$
|
3,710
|
$
|
1,391
|
$
|
4,814
|
$
|
(5,954
|
)
|
$
|
3,961
|
|||||||||
Net income (loss) attributed to:
|
||||||||||||||||||||
Non-controlling interests
|
$
|
-
|
$
|
-
|
$
|
148
|
$
|
-
|
$
|
148
|
||||||||||
Participating policyholders
|
-
|
(4
|
)
|
103
|
4
|
103
|
||||||||||||||
Shareholders
|
3,710
|
1,395
|
4,563
|
(5,958
|
)
|
3,710
|
||||||||||||||
$
|
3,710
|
$
|
1,391
|
$
|
4,814
|
$
|
(5,954
|
)
|
$
|
3,961
|
For the nine months ended
|
||||||||||||||||||||
September 30, 2016
|
MFC
(Guarantor)
|
JHUSA
(Issuer)
|
Other
subsidiaries
|
Consolidation adjustments
|
Consolidated
MFC
|
|||||||||||||||
Revenue
|
||||||||||||||||||||
Net premium income
|
$
|
-
|
$
|
3,378
|
$
|
17,253
|
$
|
-
|
$
|
20,631
|
||||||||||
Net investment income (loss)
|
264
|
12,947
|
15,342
|
(917
|
)
|
27,636
|
||||||||||||||
Net other revenue
|
42
|
2,156
|
11,862
|
(5,516
|
)
|
8,544
|
||||||||||||||
Total revenue
|
306
|
18,481
|
44,457
|
(6,433
|
)
|
56,811
|
||||||||||||||
Contract benefits and expenses
|
||||||||||||||||||||
Net benefits and claims
|
-
|
16,001
|
29,945
|
(4,390
|
)
|
41,556
|
||||||||||||||
Commissions, investment and general expenses
|
-
|
2,481
|
9,525
|
(1,398
|
)
|
10,608
|
||||||||||||||
Other expenses
|
179
|
(2
|
)
|
1,501
|
(645
|
)
|
1,033
|
|||||||||||||
Total contract benefits and expenses
|
179
|
18,480
|
40,971
|
(6,433
|
)
|
53,197
|
||||||||||||||
Income (loss) before income taxes
|
127
|
1
|
3,486
|
-
|
3,614
|
|||||||||||||||
Income tax (expense) recovery
|
60
|
127
|
(833
|
)
|
-
|
(646
|
)
|
|||||||||||||
Income (loss) after income taxes
|
187
|
128
|
2,653
|
-
|
2,968
|
|||||||||||||||
Equity in net income (loss) of unconsolidated subsidiaries
|
2,679
|
87
|
215
|
(2,981
|
)
|
-
|
||||||||||||||
Net income (loss)
|
$
|
2,866
|
$
|
215
|
$
|
2,868
|
$
|
(2,981
|
)
|
$
|
2,968
|
|||||||||
Net income (loss) attributed to:
|
||||||||||||||||||||
Non-controlling interests
|
$
|
-
|
$
|
-
|
$
|
120
|
$
|
-
|
$
|
120
|
||||||||||
Participating policyholders
|
-
|
(49
|
)
|
(18
|
)
|
49
|
(18
|
)
|
||||||||||||
Shareholders
|
2,866
|
264
|
2,766
|
(3,030
|
)
|
2,866
|
||||||||||||||
$
|
2,866
|
$
|
215
|
$
|
2,868
|
$
|
(2,981
|
)
|
$
|
2,968
|
For the nine months ended September 30, 2017
|
MFC
(Guarantor)
|
JHUSA
(Issuer)
|
Other
subsidiaries
|
Consolidation
adjustments
|
Consolidated
MFC
|
|||||||||||||||
Operating activities
|
||||||||||||||||||||
Net income (loss)
|
$
|
3,710
|
$
|
1,391
|
$
|
4,814
|
$
|
(5,954
|
)
|
$
|
3,961
|
|||||||||
Adjustments:
|
||||||||||||||||||||
Equity in net income of unconsolidated subsidiaries
|
(3,819
|
)
|
(738
|
)
|
(1,397
|
)
|
5,954
|
-
|
||||||||||||
Increase (decrease) in insurance contract liabilities
|
-
|
5,743
|
4,361
|
-
|
10,104
|
|||||||||||||||
Increase (decrease) in investment contract liabilities
|
-
|
41
|
101
|
-
|
142
|
|||||||||||||||
(Increase) decrease in reinsurance assets
|
-
|
(2,044
|
)
|
4,164
|
-
|
2,120
|
||||||||||||||
Amortization of (premium) discount on invested assets
|
-
|
12
|
166
|
-
|
178
|
|||||||||||||||
Other amortization
|
3
|
92
|
310
|
-
|
405
|
|||||||||||||||
Net realized and unrealized (gains) losses and impairment on assets
|
(5
|
)
|
(1,727
|
)
|
(2,230
|
)
|
-
|
(3,962
|
)
|
|||||||||||
Deferred income tax expense (recovery)
|
(37
|
)
|
(334
|
)
|
716
|
-
|
345
|
|||||||||||||
Stock option expense
|
-
|
(3
|
)
|
16
|
-
|
13
|
||||||||||||||
Cash provided by (used in) operating activities before undernoted items
|
(148
|
)
|
2,433
|
11,021
|
-
|
13,306
|
||||||||||||||
Dividends from unconsolidated subsidiary
|
-
|
13
|
338
|
(351
|
)
|
-
|
||||||||||||||
Changes in policy related and operating receivables and payables
|
(202
|
)
|
(1,048
|
)
|
599
|
-
|
(651
|
)
|
||||||||||||
Cash provided by (used in) operating activities
|
(350
|
)
|
1,398
|
11,958
|
(351
|
)
|
12,655
|
|||||||||||||
Investing activities
|
||||||||||||||||||||
Purchases and mortgage advances
|
-
|
(22,798
|
)
|
(44,757
|
)
|
-
|
(67,555
|
)
|
||||||||||||
Disposals and repayments
|
-
|
21,438
|
33,640
|
-
|
55,078
|
|||||||||||||||
Changes in investment broker net receivables and payables
|
-
|
39
|
155
|
-
|
194
|
|||||||||||||||
Investment in common shares of subsidiaries
|
(1,735
|
)
|
-
|
-
|
1,735
|
-
|
||||||||||||||
Net cash decrease from purchase of subsidiaries and businesses
|
-
|
-
|
(10
|
)
|
-
|
(10
|
)
|
|||||||||||||
Capital contribution to unconsolidated subsidiaries
|
-
|
(63
|
)
|
-
|
63
|
-
|
||||||||||||||
Return of capital from unconsolidated subsidiaries
|
-
|
11
|
-
|
(11
|
)
|
-
|
||||||||||||||
Notes receivable from parent
|
-
|
368
|
(19,870
|
)
|
19,502
|
-
|
||||||||||||||
Notes receivable from subsidiaries
|
(18,361
|
)
|
(31
|
)
|
-
|
18,392
|
-
|
|||||||||||||
Cash provided by (used in) investing activities
|
(20,096
|
)
|
(1,036
|
)
|
(30,842
|
)
|
39,681
|
(12,293
|
)
|
|||||||||||
Financing activities
|
||||||||||||||||||||
Increase (decrease) in repurchase agreements and securities sold but
not yet purchased
|
-
|
-
|
252
|
-
|
252
|
|||||||||||||||
Redemption of long-term debt
|
-
|
-
|
(7
|
)
|
-
|
(7
|
)
|
|||||||||||||
Issue of capital instruments, net
|
1,740
|
-
|
-
|
-
|
1,740
|
|||||||||||||||
Redemption of capital instruments
|
-
|
-
|
(899
|
)
|
-
|
(899
|
)
|
|||||||||||||
Secured borrowings from securitization transactions
|
-
|
-
|
643
|
-
|
643
|
|||||||||||||||
Changes in deposits from Bank clients, net
|
-
|
-
|
176
|
-
|
176
|
|||||||||||||||
Shareholders' dividends paid in cash
|
(1,334
|
)
|
-
|
-
|
-
|
(1,334
|
)
|
|||||||||||||
Dividends paid to parent
|
-
|
(338
|
)
|
(13
|
)
|
351
|
-
|
|||||||||||||
Contributions from (distributions to) non-controlling interests, net
|
-
|
-
|
(8
|
)
|
-
|
(8
|
)
|
|||||||||||||
Common shares issued, net
|
65
|
-
|
1,735
|
(1,735
|
)
|
65
|
||||||||||||||
Capital contributions by parent
|
-
|
-
|
63
|
(63
|
)
|
-
|
||||||||||||||
Return of capital to parent
|
-
|
-
|
(11
|
)
|
11
|
-
|
||||||||||||||
Notes payable to parent
|
-
|
-
|
18,392
|
(18,392
|
)
|
-
|
||||||||||||||
Notes payable to subsidiaries
|
19,870
|
-
|
(368
|
)
|
(19,502
|
)
|
-
|
|||||||||||||
Cash provided by (used in) financing activities
|
20,341
|
(338
|
)
|
19,955
|
(39,330
|
)
|
628
|
|||||||||||||
Cash and short-term securities
|
||||||||||||||||||||
Increase (decrease) during the period
|
(105
|
)
|
24
|
1,071
|
-
|
990
|
||||||||||||||
Effect of foreign exchange rate changes on cash and short-term securities
|
(3
|
)
|
(297
|
)
|
(418
|
)
|
-
|
(718
|
)
|
|||||||||||
Balance, beginning of period
|
161
|
3,787
|
10,290
|
-
|
14,238
|
|||||||||||||||
Balance, end of period
|
53
|
3,514
|
10,943
|
-
|
14,510
|
|||||||||||||||
Cash and short-term securities
|
||||||||||||||||||||
Beginning of period
|
||||||||||||||||||||
Gross cash and short-term securities
|
161
|
4,317
|
10,673
|
-
|
15,151
|
|||||||||||||||
Net payments in transit, included in other liabilities
|
-
|
(530
|
)
|
(383
|
)
|
-
|
(913
|
)
|
||||||||||||
Net cash and short-term securities, beginning of period
|
161
|
3,787
|
10,290
|
-
|
14,238
|
|||||||||||||||
End of period
|
||||||||||||||||||||
Gross cash and short-term securities
|
53
|
3,937
|
11,261
|
-
|
15,251
|
|||||||||||||||
Net payments in transit, included in other liabilities
|
-
|
(423
|
)
|
(318
|
)
|
-
|
(741
|
)
|
||||||||||||
Net cash and short-term securities, end of period
|
$
|
53
|
$
|
3,514
|
$
|
10,943
|
$
|
-
|
$
|
14,510
|
||||||||||
Supplemental disclosures on cash flow information:
|
||||||||||||||||||||
Interest received
|
$
|
213
|
$
|
3,359
|
$
|
4,793
|
$
|
(458
|
)
|
$
|
7,907
|
|||||||||
Interest paid
|
290
|
63
|
868
|
(458
|
)
|
763
|
||||||||||||||
Income taxes paid (received)
|
83
|
51
0
|
19
|
-
|
612
|
For the nine months ended September 30, 2016
|
MFC
(Guarantor)
|
JHUSA
(Issuer)
|
Other
subsidiaries
|
Consolidation
adjustments
|
Consolidated
MFC
|
|||||||||||||||
Operating activities
|
||||||||||||||||||||
Net income (loss)
|
$
|
2,866
|
$
|
215
|
$
|
2,868
|
$
|
(2,981
|
)
|
$
|
2,968
|
|||||||||
Adjustments:
|
||||||||||||||||||||
Equity in net income of unconsolidated subsidiaries
|
(2,679
|
)
|
(87
|
)
|
(215
|
)
|
2,981
|
-
|
||||||||||||
Increase (decrease) in insurance contract liabilities
|
-
|
12,328
|
17,330
|
-
|
29,658
|
|||||||||||||||
Increase (decrease) in investment contract liabilities
|
-
|
44
|
(56
|
)
|
-
|
(12
|
)
|
|||||||||||||
(Increase) decrease in reinsurance assets
|
-
|
(3,844
|
)
|
3,098
|
-
|
(746
|
)
|
|||||||||||||
Amortization of (premium) discount on invested assets
|
-
|
(5
|
)
|
46
|
-
|
41
|
||||||||||||||
Other amortization
|
1
|
249
|
299
|
-
|
549
|
|||||||||||||||
Net realized and unrealized (gains) losses and impairment on assets
|
(5
|
)
|
(9,042
|
)
|
(11,125
|
)
|
-
|
(20,172
|
)
|
|||||||||||
Deferred income tax expense (recovery)
|
3
|
818
|
(478
|
)
|
-
|
343
|
||||||||||||||
Stock option expense
|
-
|
2
|
14
|
-
|
16
|
|||||||||||||||
Cash provided by (used in) operating activities before undernoted items
|
186
|
678
|
11,781
|
-
|
12,645
|
|||||||||||||||
Dividends from unconsolidated subsidiary
|
-
|
104
|
-
|
(104
|
)
|
-
|
||||||||||||||
Changes in policy related and operating receivables and payables
|
(225
|
)
|
10
|
(240
|
)
|
-
|
(455
|
)
|
||||||||||||
Cash provided by (used in) operating activities
|
(39
|
)
|
792
|
11,541
|
(104
|
)
|
12,190
|
|||||||||||||
Investing activities
|
||||||||||||||||||||
Purchases and mortgage advances
|
-
|
(25,796
|
)
|
(55,327
|
)
|
-
|
(81,123
|
)
|
||||||||||||
Disposals and repayments
|
(29
|
)
|
25,419
|
39,566
|
-
|
64,956
|
||||||||||||||
Changes in investment broker net receivables and payables
|
-
|
81
|
(50
|
)
|
-
|
31
|
||||||||||||||
Investment in common shares of subsidiaries
|
(4,495
|
)
|
-
|
-
|
4,495
|
-
|
||||||||||||||
Net cash decrease from purchase of subsidiaries and businesses
|
-
|
-
|
(103
|
)
|
-
|
(103
|
)
|
|||||||||||||
Capital contribution to unconsolidated subsidiaries
|
-
|
(350
|
)
|
-
|
350
|
-
|
||||||||||||||
Return of capital from unconsolidated subsidiaries
|
-
|
1
|
-
|
(1
|
)
|
-
|
||||||||||||||
Notes receivable from parent
|
-
|
-
|
(24,792
|
)
|
24,792
|
-
|
||||||||||||||
Notes receivable from subsidiaries
|
(23,454
|
)
|
(39
|
)
|
-
|
23,493
|
-
|
|||||||||||||
Cash provided by (used in) investing activities
|
(27,978
|
)
|
(684
|
)
|
(40,706
|
)
|
53,129
|
(16,239
|
)
|
|||||||||||
Financing activities
|
||||||||||||||||||||
Increase (decrease) in repurchase agreements and securities sold but not yet purchased
|
-
|
296
|
472
|
-
|
768
|
|||||||||||||||
Issue of long-term debt, net
|
3,538
|
-
|
-
|
-
|
3,538
|
|||||||||||||||
Redemption of long-term debt
|
-
|
-
|
(8
|
)
|
-
|
(8
|
)
|
|||||||||||||
Issue of capital instruments, net
|
479
|
-
|
-
|
-
|
479
|
|||||||||||||||
Secured borrowings from securitization transactions
|
-
|
-
|
722
|
-
|
722
|
|||||||||||||||
Changes in deposits from Bank clients, net
|
-
|
-
|
198
|
-
|
198
|
|||||||||||||||
Shareholders' dividends paid in cash
|
(1,193
|
)
|
-
|
-
|
-
|
(1,193
|
)
|
|||||||||||||
Dividends paid to parent
|
-
|
-
|
(104
|
)
|
104
|
-
|
||||||||||||||
Contributions from (distributions to) non-controlling interests, net
|
-
|
-
|
14
|
-
|
14
|
|||||||||||||||
Common shares issued, net
|
20
|
-
|
4,495
|
(4,495
|
)
|
20
|
||||||||||||||
Preferred shares issued, net
|
417
|
-
|
-
|
-
|
417
|
|||||||||||||||
Capital contributions by parent
|
-
|
-
|
350
|
(350
|
)
|
-
|
||||||||||||||
Return of capital to parent
|
-
|
-
|
(1
|
)
|
1
|
-
|
||||||||||||||
Notes payable to parent
|
-
|
-
|
23,493
|
(23,493
|
)
|
-
|
||||||||||||||
Notes payable to subsidiaries
|
24,792
|
-
|
-
|
(24,792
|
)
|
-
|
||||||||||||||
Cash provided by (used in) financing activities
|
28,053
|
296
|
29,631
|
(53,025
|
)
|
4,955
|
||||||||||||||
Cash and short-term securities
|
||||||||||||||||||||
Increase (decrease) during the period
|
36
|
404
|
466
|
-
|
906
|
|||||||||||||||
Effect of foreign exchange rate changes on cash and short-term securities
|
(2
|
)
|
(260
|
)
|
(132
|
)
|
-
|
(394
|
)
|
|||||||||||
Balance, beginning of period
|
122
|
4,445
|
12,435
|
-
|
17,002
|
|||||||||||||||
Balance, end of period
|
156
|
4,589
|
12,769
|
-
|
17,514
|
|||||||||||||||
Cash and short-term securities
|
||||||||||||||||||||
Beginning of period
|
||||||||||||||||||||
Gross cash and short-term securities
|
122
|
4,938
|
12,825
|
-
|
17,885
|
|||||||||||||||
Net payments in transit, included in other liabilities
|
-
|
(493
|
)
|
(390
|
)
|
-
|
(883
|
)
|
||||||||||||
Net cash and short-term securities, beginning of period
|
122
|
4,445
|
12,435
|
-
|
17,002
|
|||||||||||||||
End of period
|
||||||||||||||||||||
Gross cash and short-term securities
|
156
|
4,982
|
13,041
|
-
|
18,179
|
|||||||||||||||
Net payments in transit, included in other liabilities
|
-
|
(393
|
)
|
(272
|
)
|
-
|
(665
|
)
|
||||||||||||
Net cash and short-term securities, end of period
|
$
|
156
|
$
|
4,589
|
$
|
12,769
|
$
|
-
|
$
|
17,514
|
||||||||||
Supplemental disclosures on cash flow information:
|
||||||||||||||||||||
Interest received
|
$
|
-
|
$
|
3,452
|
$
|
4,928
|
$
|
(524
|
)
|
$
|
7,856
|
|||||||||
Interest paid
|
133
|
129
|
912
|
(524
|
)
|
650
|
||||||||||||||
Income taxes paid
|
30
|
61
|
578
|
-
|
669
|
Note 15 |
Comparatives
|
MANULIFE
HEAD OFFICE
200 Bloor Street East
Toronto, ON Canada M4W 1E5
Telephone: 416 926-3000
Fax: 416 926-5454
Web site:
www.manulife.com
INVESTOR RELATIONS
Financial analysts, portfolio managers and
other investors requiring financial information
may contact our Investor Relations Department
or access our Web site at
www.manulife.com
Fax: 416 926-6285
E-mail:
investor_relations@manulife.com
SHAREHOLDER SERVICES
For information or assistance regarding
your share account, including dividends,
changes of address or ownership, lost
certificates, to eliminate duplicate mailings
or to receive shareholder material
electronically
, please contact our Transfer
Agents in Canada, the United States, Hong
Kong or the Philippines. If you live outside one
of these countries please contact our Canadian
Transfer Agent.
|
TRANSFER AGENTS
Canada
AST Trust Company (Canada)
P.O. Box 700, Station B
Montreal, QC Canada H3B 3K3
Toll Free: 1 800 783-9495
Collect: 416 682-3864
E-mail:
inquiries@astfinancial.com
Online:
www.astfinancial.com/ca-en
AST Trust Company offices are also located
in Toronto
,
Vancouver and Calgary.
United States
American Stock Transfer & Trust Company, LLC
P.O. Box 199036
Brooklyn, NY 11219
Toll Free: 1 800 249-7702
E-mail:
inquiries@astfinancial.com
Online:
www.astfinancial.com
Hong Kong
Tricor Investor Services Limited
Level 22, Hopewell Centre
183 Queen's Road East
Hong Kong
Telephone: (852) 2980-1333
E-mail:
is-enquiries@hk.tricorglobal.com
or
enquries@astfinancial.com
Online:
www.tricorglobal.com
|
Philippines
Rizal Commercial Banking Corporation
Ground Floor, West Wing
GPL (Grepalife) Building
221 Senator Gil Puyat Avenue
Makati City,
Philippines
Telephone: 632 318-8567
E-mail:
rcbcstocktransfer@rcbc.com
Online:
www.rcbc.com
AUDITORS
Ernst & Young LLP
Chartered Professional Accountants
Licensed Public Accountants
Toronto, Canada
|
The following Manulife documents
are available
online at
www.manulife.com
·
Annual Report and Proxy Circular
·
Notice of Annual Meeting
·
Shareholders Reports
·
Public Accountability Statement
·
Corporate Governance material
|
RATING
Financial strength is a key factor in generating new business, maintaining and expanding distribution relations and providing a base for expansion, acquisitions and growth. As at September 30, 2017, Manulife had total capital of C$51.8 billion, including C$42.5 billion of total shareholders’ equity. The Manufacturers Life Insurance Company’s financial strength and claims paying ability ratings are among the strongest in the insurance industry.
|
||||
Rating Agency
S&P Global Ratings
|
Rating
AA-
|
Rank
(4
th
of 21 ratings)
|
||
Moody’s Investors Services
|
A1
|
(5
th
of 21 ratings)
|
||
Fitch Ratings Inc.
|
AA-
|
(4
th
of 19 ratings)
|
||
DBRS Limited
|
AA (low)
|
(4
th
of 22 ratings)
|
||
A.M. Best Company
|
A+ (Superior)
|
(2
nd
of 13 ratings)
|
Consent to receive documents electronically
|
To receive documents electronically when they are available through
Manulife’s electronic delivery service, complete this form and
return it as indicated.
I have read and understand the statement on the reverse and consent to
receive electronically the Manulife documents listed in the
manner described. I acknowledge that I have the computer requirements
to access the documents that are made available on Manulife’s
Web site. I understand that I am not required to consent to electronic
delivery and that I may revoke my consent at any time.
Please note: We will contact you by phone only if there is a problem with
your email address.
The information provided is confidential and will not be used for any
purpose other than that described.
|
Please Print:
_________________________________________________________
Shareholder Name
_________________________________________________________
Contact Phone Number
_________________________________________________________
Shareholder email Address
_________________________________________________________
Shareholder Signature
_________________________________________________________
Date
|
1. |
Review
: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Manulife Financial Corporation
(the "issuer") for the interim period ended September 30, 2017.
|
2. |
No misrepresentations
: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.
|
3. |
Fair presentation
: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.
|
4. |
Responsibility
: The issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109
Certification of Disclosure in Issuer's Annual and Interim Filings,
for the issuer.
|
5. |
Design
: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer's other certifying officer(s) and I have, as at the end of the period covered by the interim filings
|
(a) |
designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
|
(i) |
material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and
|
(ii) |
information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
|
(b) |
designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer's GAAP.
|
5.1 |
Control framework
: The control framework the issuer's other certifying officer(s) and I used to design the issuer's ICFR is Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
|
5.2 |
N/A
|
5.3 |
N/A
|
6. |
Reporting changes in ICFR
: The issuer has disclosed in its interim MD&A any change in the issuer's ICFR that occurred during the period beginning on July 1, 2017 and ended on September 30, 2017 that has materially affected, or is reasonably likely to materially affect, the issuer's ICFR.
|
1. |
Review
: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Manulife Financial Corporation
(the "issuer") for the interim period ended September 30, 2017.
|
2. |
No misrepresentations
: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.
|
3. |
Fair presentation
: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.
|
4. |
Responsibility
: The issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109
Certification of Disclosure in Issuer's Annual and Interim Filings,
for the issuer.
|
5. |
Design
: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer's other certifying officer(s) and I have, as at the end of the period covered by the interim filings
|
(a) |
designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
|
(i) |
material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and
|
(ii) |
information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
|
(b) |
designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer's GAAP.
|
5.1 |
Control framework
: The control framework the issuer's other certifying officer(s) and I used to design the issuer's ICFR is Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
|
5.2 |
N/A
|
5.3 |
N/A
|
6. |
Reporting changes in ICFR
: The issuer has disclosed in its interim MD&A any change in the issuer's ICFR that occurred during the period beginning on July 1, 2017 and ended on September 30, 2017 that has materially affected, or is reasonably likely to materially affect, the issuer's ICFR.
|